# publications

title: Psychedelics Align Brain Activity with Context
journal: bioRxiv
publication_date: 2025-03-10
doi: 10.1101/2025.03.09.642197
source_url: https://doi.org/10.1101/2025.03.09.642197
source_record_id: DOI:10.1101/2025.03.09.642197
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness,Aging
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2025.03.09.642197
text_rights_status: unverified_not_redistributed
authors:
Stoliker D, Novelli L, Khajehnejad M, Biabani M, Greaves MD, Barta T, Williams M, Chopra S, Bazin O, Simonsson O, Chambers R, Barrett F, Deco G, Preller KH, Carhart-Harris R, Seth A, Sundram S, Egan GF, Razi A.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2025.03.09.642197","source_url":"https://doi.org/10.1101/2025.03.09.642197","doi":"10.1101/2025.03.09.642197","pmid":"","publication_date":"2025-03-10","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2026-06-09
source_url: https://osf.io/preprints/psyarxiv/6mj8n_v2
source_record_id: https://osf.io/preprints/psyarxiv/6mj8n_v2
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Mechanism of Action,Consciousness,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/6mj8n_v2
text_rights_status: unverified_not_redistributed
title:
Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/6mj8n_v2","source_url":"https://osf.io/preprints/psyarxiv/6mj8n_v2","doi":"","pmid":"","publication_date":"2026-06-09","importer_version":"2.1.3","text_redistributed":false}


title: Effects of psilocybin-assisted therapy on treatment-resistant depression
publication_date: 2021-08-12
source_url: https://europepmc.org/article/PMC/PMC9480034
source_record_id: https://europepmc.org/article/PMC/PMC9480034
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9480034
text_rights_status: unverified_not_redistributed
authors:
Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9480034","source_url":"https://europepmc.org/article/PMC/PMC9480034","doi":"","pmid":"","publication_date":"2021-08-12","importer_version":"2.1.3","text_redistributed":false}


title: The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype
authors: Kozłowska U, Klimczak A, Wiatr K, Figiel M.
journal: bioRxiv
publication_date: 2021-03-07
doi: 10.1101/2021.03.07.434103
source_url: https://doi.org/10.1101/2021.03.07.434103
source_record_id: DOI:10.1101/2021.03.07.434103
substance_tags: psilocin
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2021.03.07.434103
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Inflammation,Immune Function

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2021.03.07.434103","source_url":"https://doi.org/10.1101/2021.03.07.434103","doi":"10.1101/2021.03.07.434103","pmid":"","publication_date":"2021-03-07","importer_version":"2.1.3","text_redistributed":false}


title: 597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE
publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359505
source_record_id: https://europepmc.org/article/PMC/PMC12359505
substance_tags: psilocybin
topic_tags: Depression,Adverse Events
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359505","source_url":"https://europepmc.org/article/PMC/PMC12359505","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Depression: The ACE Model Manual
journal: PsyArXiv
publication_date: 2021-07-04
source_url: https://osf.io/preprints/psyarxiv/5x2bu_v1
source_record_id: https://osf.io/preprints/psyarxiv/5x2bu_v1
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/5x2bu_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/5x2bu_v1","source_url":"https://osf.io/preprints/psyarxiv/5x2bu_v1","doi":"","pmid":"","publication_date":"2021-07-04","importer_version":"2.1.3","text_redistributed":false}


title: 476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERS
publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359791
source_record_id: https://europepmc.org/article/PMC/PMC12359791
substance_tags: psilocybin
topic_tags: Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359791","source_url":"https://europepmc.org/article/PMC/PMC12359791","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


authors: Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM.
journal: bioRxiv
publication_date: 2025-07-02
doi: 10.1101/2025.07.02.662710
source_url: https://doi.org/10.1101/2025.07.02.662710
source_record_id: DOI:10.1101/2025.07.02.662710
substance_tags: psilocybin
study_type: Clinical Trial
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2025.07.02.662710
text_rights_status: unverified_not_redistributed
title:
Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging

topic_tags:
Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Clinical Trial

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2025.07.02.662710","source_url":"https://doi.org/10.1101/2025.07.02.662710","doi":"10.1101/2025.07.02.662710","pmid":"","publication_date":"2025-07-02","importer_version":"2.1.3","text_redistributed":false}


authors: Nkadimeng SM, Hay L, Steinmann CM, Eloff JN.
journal: Research Square
publication_date: 2023-07-17
doi: 10.21203/rs.3.rs-3088850/v1
source_url: https://doi.org/10.21203/rs.3.rs-3088850/v1
source_record_id: DOI:10.21203/rs.3.rs-3088850/v1
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study,Safety
study_type: Animal Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-3088850/v1
text_rights_status: unverified_not_redistributed
title:
Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-3088850/v1","source_url":"https://doi.org/10.21203/rs.3.rs-3088850/v1","doi":"10.21203/rs.3.rs-3088850/v1","pmid":"","publication_date":"2023-07-17","importer_version":"2.1.3","text_redistributed":false}


authors: Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T.
journal: bioRxiv
publication_date: 2022-07-22
doi: 10.1101/2022.07.22.501026
source_url: https://doi.org/10.1101/2022.07.22.501026
source_record_id: DOI:10.1101/2022.07.22.501026
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.07.22.501026
text_rights_status: unverified_not_redistributed
title:
Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.07.22.501026","source_url":"https://doi.org/10.1101/2022.07.22.501026","doi":"10.1101/2022.07.22.501026","pmid":"","publication_date":"2022-07-22","importer_version":"2.1.3","text_redistributed":false}


authors: Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM.
journal: medRxiv
publication_date: 2023-05-25
doi: 10.1101/2023.05.25.23290521
source_url: https://doi.org/10.1101/2023.05.25.23290521
source_record_id: DOI:10.1101/2023.05.25.23290521
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study
study_type: Clinical Trial
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2023.05.25.23290521
text_rights_status: unverified_not_redistributed
title:
Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2023.05.25.23290521","source_url":"https://doi.org/10.1101/2023.05.25.23290521","doi":"10.1101/2023.05.25.23290521","pmid":"","publication_date":"2023-05-25","importer_version":"2.1.3","text_redistributed":false}


journal: medRxiv
publication_date: 2022-07-09
doi: 10.1101/2022.07.10.22277414
source_url: https://doi.org/10.1101/2022.07.10.22277414
source_record_id: DOI:10.1101/2022.07.10.22277414
substance_tags: psilocybin
topic_tags: Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety
study_type: Clinical Trial
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2022.07.10.22277414
text_rights_status: unverified_not_redistributed
title:
Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity

authors:
Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM.

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2022.07.10.22277414","source_url":"https://doi.org/10.1101/2022.07.10.22277414","doi":"10.1101/2022.07.10.22277414","pmid":"","publication_date":"2022-07-09","importer_version":"2.1.3","text_redistributed":false}


title: A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds
journal: PsyArXiv
publication_date: 2022-05-09
source_url: https://osf.io/preprints/psyarxiv/pdbf5_v1
source_record_id: https://osf.io/preprints/psyarxiv/pdbf5_v1
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/pdbf5_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/pdbf5_v1","source_url":"https://osf.io/preprints/psyarxiv/pdbf5_v1","doi":"","pmid":"","publication_date":"2022-05-09","importer_version":"2.1.3","text_redistributed":false}


journal: Research Square
publication_date: 2026-04-27
doi: 10.21203/rs.3.rs-9266175/v1
source_url: https://doi.org/10.21203/rs.3.rs-9266175/v1
source_record_id: DOI:10.21203/rs.3.rs-9266175/v1
substance_tags: psilocybin
topic_tags: Brain Imaging,Drug Interactions
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-9266175/v1
text_rights_status: unverified_not_redistributed
title:
A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary Experiments

authors:
Zajaczkowski M, Koutsoftidis S, Sheeraz M, Barsakcioglu DY, Jia T, McGeady CA, Kundu A, Pizzi M, Tatti F, Bashford J, Bhavesh P, Farina D, Drakakis E.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-9266175/v1","source_url":"https://doi.org/10.21203/rs.3.rs-9266175/v1","doi":"10.21203/rs.3.rs-9266175/v1","pmid":"","publication_date":"2026-04-27","importer_version":"2.1.3","text_redistributed":false}


title: Natural language signatures of psilocybin microdosing
journal: bioRxiv
publication_date: 2022-02-21
doi: 10.1101/2022.02.20.481177
source_url: https://doi.org/10.1101/2022.02.20.481177
source_record_id: DOI:10.1101/2022.02.20.481177
substance_tags: psilocybin
topic_tags: Microdosing,Wellbeing,Creativity
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.02.20.481177
text_rights_status: unverified_not_redistributed
authors:
Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.02.20.481177","source_url":"https://doi.org/10.1101/2022.02.20.481177","doi":"10.1101/2022.02.20.481177","pmid":"","publication_date":"2022-02-21","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359394
source_record_id: https://europepmc.org/article/PMC/PMC12359394
substance_tags: psilocybin
topic_tags: Eating Disorders,Mechanism of Action
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
text_rights_status: not_applicable_no_text
title:
564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359394","source_url":"https://europepmc.org/article/PMC/PMC12359394","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


title: 205. SYNERGISTIC BEHAVIORAL AND NEUROPLASTIC EFFECTS OF PSILOCYBIN-NMDAR MODULATOR ADMINISTRATION
publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359736
source_record_id: https://europepmc.org/article/PMC/PMC12359736
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359736","source_url":"https://europepmc.org/article/PMC/PMC12359736","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


authors: Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F.
journal: bioRxiv
publication_date: 2022-03-01
doi: 10.1101/2022.02.28.482395
source_url: https://doi.org/10.1101/2022.02.28.482395
source_record_id: DOI:10.1101/2022.02.28.482395
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Default Mode Network
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.02.28.482395
text_rights_status: unverified_not_redistributed
title:
Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.02.28.482395","source_url":"https://doi.org/10.1101/2022.02.28.482395","doi":"10.1101/2022.02.28.482395","pmid":"","publication_date":"2022-03-01","importer_version":"2.1.3","text_redistributed":false}


title: Increased low-frequency brain responses to music after psilocybin therapy for depression
authors: Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL.
journal: bioRxiv
publication_date: 2022-02-14
doi: 10.1101/2022.02.13.480302
source_url: https://doi.org/10.1101/2022.02.13.480302
source_record_id: DOI:10.1101/2022.02.13.480302
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Aging,Emotional Processing,Treatment-Resistant Depression
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.02.13.480302
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.02.13.480302","source_url":"https://doi.org/10.1101/2022.02.13.480302","doi":"10.1101/2022.02.13.480302","pmid":"","publication_date":"2022-02-14","importer_version":"2.1.3","text_redistributed":false}


title: Age moderates the relationship between psychedelics use and mental health in naturalistic settings
journal: Research Square
publication_date: 2026-03-09
doi: 10.21203/rs.3.rs-9022170/v1
source_url: https://doi.org/10.21203/rs.3.rs-9022170/v1
source_record_id: DOI:10.21203/rs.3.rs-9022170/v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-9022170/v1
text_rights_status: unverified_not_redistributed
authors:
Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-9022170/v1","source_url":"https://doi.org/10.21203/rs.3.rs-9022170/v1","doi":"10.21203/rs.3.rs-9022170/v1","pmid":"","publication_date":"2026-03-09","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-06-08
source_url: https://osf.io/preprints/psyarxiv/qyce5_v1
source_record_id: https://osf.io/preprints/psyarxiv/qyce5_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/qyce5_v1
text_rights_status: unverified_not_redistributed
title:
Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/qyce5_v1","source_url":"https://osf.io/preprints/psyarxiv/qyce5_v1","doi":"","pmid":"","publication_date":"2023-06-08","importer_version":"2.1.3","text_redistributed":false}


title: Decreased brain modularity after psilocybin therapy for depression.
journal: Research Square
publication_date: 2021-05-19
doi: 10.21203/rs.3.rs-513323/v1
source_url: https://doi.org/10.21203/rs.3.rs-513323/v1
source_record_id: DOI:10.21203/rs.3.rs-513323/v1
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-513323/v1
text_rights_status: unverified_not_redistributed
authors:
Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.

topic_tags:
Depression,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-513323/v1","source_url":"https://doi.org/10.21203/rs.3.rs-513323/v1","doi":"10.21203/rs.3.rs-513323/v1","pmid":"","publication_date":"2021-05-19","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-11-30
source_url: https://europepmc.org/article/PMC/PMC12739712
source_record_id: https://europepmc.org/article/PMC/PMC12739712
substance_tags: psilocybin
topic_tags: Neurogenesis,Inflammation
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
text_rights_status: not_applicable_no_text
title:
Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal Neurogenesis

authors:
Madhu L, Somayaji Y, Kotian S, Attaluri S, Patel J, Panda P, Rao V, Kodali M, Shankar G, Rao S, Weintraub S, Shuai B, Rao X, Shetty A.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12739712","source_url":"https://europepmc.org/article/PMC/PMC12739712","doi":"","pmid":"","publication_date":"2025-11-30","importer_version":"2.1.3","text_redistributed":false}


authors: Coppola M, Bevione F, Mondola R.
journal: Preprints.org
publication_date: 2021-06-27
doi: 10.20944/preprints202106.0682.v1
source_url: https://doi.org/10.20944/preprints202106.0682.v1
source_record_id: DOI:10.20944/preprints202106.0682.v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Spirituality
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.20944/preprints202106.0682.v1
text_rights_status: unverified_not_redistributed
title:
Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202106.0682.v1","source_url":"https://doi.org/10.20944/preprints202106.0682.v1","doi":"10.20944/preprints202106.0682.v1","pmid":"","publication_date":"2021-06-27","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-03-09
source_url: https://osf.io/preprints/psyarxiv/wupvy_v1
source_record_id: https://osf.io/preprints/psyarxiv/wupvy_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/wupvy_v1
text_rights_status: unverified_not_redistributed
title:
Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/wupvy_v1","source_url":"https://osf.io/preprints/psyarxiv/wupvy_v1","doi":"","pmid":"","publication_date":"2023-03-09","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-12-13
source_url: https://osf.io/preprints/psyarxiv/xqzu2_v1
source_record_id: https://osf.io/preprints/psyarxiv/xqzu2_v1
substance_tags: psilocybin
topic_tags: Pharmacology,Mystical Experience,Healthy Volunteers
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/xqzu2_v1
text_rights_status: unverified_not_redistributed
title:
A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/xqzu2_v1","source_url":"https://osf.io/preprints/psyarxiv/xqzu2_v1","doi":"","pmid":"","publication_date":"2021-12-13","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359778
source_record_id: https://europepmc.org/article/PMC/PMC12359778
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:02
text_rights_status: not_applicable_no_text
title:
229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359778","source_url":"https://europepmc.org/article/PMC/PMC12359778","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359530
source_record_id: https://europepmc.org/article/PMC/PMC12359530
substance_tags: psilocybin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:48
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359530","source_url":"https://europepmc.org/article/PMC/PMC12359530","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


title: 694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING
publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359587
source_record_id: https://europepmc.org/article/PMC/PMC12359587
substance_tags: psilocybin
topic_tags: Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359587","source_url":"https://europepmc.org/article/PMC/PMC12359587","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Altered States, Enhanced Potential: Psychedelics and Physical Performance
journal: PsyArXiv
publication_date: 2026-06-11
source_url: https://osf.io/preprints/psyarxiv/txgq2_v2
source_record_id: https://osf.io/preprints/psyarxiv/txgq2_v2
substance_tags: psilocybin
topic_tags: Chronic Pain,Consciousness,Microdosing,Emotional Processing,Safety
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/txgq2_v2
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/txgq2_v2","source_url":"https://osf.io/preprints/psyarxiv/txgq2_v2","doi":"","pmid":"","publication_date":"2026-06-11","importer_version":"2.1.3","text_redistributed":false}


title: Blunted psychedelic drug effects in older adults
journal: PsyArXiv
publication_date: 2025-09-03
source_url: https://osf.io/preprints/psyarxiv/yz4cd_v2
source_record_id: https://osf.io/preprints/psyarxiv/yz4cd_v2
substance_tags: psilocybin
topic_tags: Aging,Longevity,Older Adults,Safety
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/yz4cd_v2
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/yz4cd_v2","source_url":"https://osf.io/preprints/psyarxiv/yz4cd_v2","doi":"","pmid":"","publication_date":"2025-09-03","importer_version":"2.1.3","text_redistributed":false}


authors: McCulloch DE, Olsen AS, Ozenne B, Stenbaek DS, Armand S, Madsen MK, Knudsen GM, Fisher PM.
journal: medRxiv
publication_date: 2023-07-02
doi: 10.1101/2023.07.03.23292164
source_url: https://doi.org/10.1101/2023.07.03.23292164
source_record_id: DOI:10.1101/2023.07.03.23292164
substance_tags: psilocybin
topic_tags: Brain Imaging,Observational Study
study_type: Observational Study
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2023.07.03.23292164
text_rights_status: unverified_not_redistributed
title:
Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2023.07.03.23292164","source_url":"https://doi.org/10.1101/2023.07.03.23292164","doi":"10.1101/2023.07.03.23292164","pmid":"","publication_date":"2023-07-02","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2022-09-29
doi: 10.31234/osf.io/kh3cx
source_url: https://doi.org/10.31234/osf.io/kh3cx
source_record_id: DOI:10.31234/osf.io/kh3cx
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/kh3cx
text_rights_status: unverified_not_redistributed
title:
Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing

authors:
Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/kh3cx","source_url":"https://doi.org/10.31234/osf.io/kh3cx","doi":"10.31234/osf.io/kh3cx","pmid":"","publication_date":"2022-09-29","importer_version":"2.1.3","text_redistributed":false}


authors: Beck SA, Barlow C, Engel L, Barratt MJ.
publication_date: 2025-06-06
doi: 10.1016/j.toxicon.2025.108450
pubmed_id: 40490153
source_url: https://doi.org/10.1016/j.toxicon.2025.108450
source_record_id: PMID:40490153
substance_tags: psilocybin
topic_tags: Observational Study,Adolescents
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.toxicon.2025.108450
text_rights_status: unverified_not_redistributed
title:
"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:40490153","source_url":"https://doi.org/10.1016/j.toxicon.2025.108450","doi":"10.1016/j.toxicon.2025.108450","pmid":"40490153","publication_date":"2025-06-06","importer_version":"2.1.3","text_redistributed":false}


title: EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTS
publication_date: 2025-01-31
source_url: https://europepmc.org/article/PMC/PMC11814656
source_record_id: https://europepmc.org/article/PMC/PMC11814656
substance_tags: psilocybin
topic_tags: Chronic Pain
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11814656","source_url":"https://europepmc.org/article/PMC/PMC11814656","doi":"","pmid":"","publication_date":"2025-01-31","importer_version":"2.1.3","text_redistributed":false}


title: Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network
authors: Lewis-Healey E, Laukkonen RE, van Elk M.
journal: PsyArXiv
publication_date: 2021-05-18
doi: 10.31234/osf.io/q3ymd
source_url: https://doi.org/10.31234/osf.io/q3ymd
source_record_id: DOI:10.31234/osf.io/q3ymd
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Clinical Trial,Drug Interactions
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/q3ymd
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/q3ymd","source_url":"https://doi.org/10.31234/osf.io/q3ymd","doi":"10.31234/osf.io/q3ymd","pmid":"","publication_date":"2021-05-18","importer_version":"2.1.3","text_redistributed":false}


authors: Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA.
journal: bioRxiv
publication_date: 2022-11-14
doi: 10.1101/2022.11.15.516655
source_url: https://doi.org/10.1101/2022.11.15.516655
source_record_id: DOI:10.1101/2022.11.15.516655
substance_tags: psilocin
topic_tags: Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.11.15.516655
text_rights_status: unverified_not_redistributed
title:
Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.11.15.516655","source_url":"https://doi.org/10.1101/2022.11.15.516655","doi":"10.1101/2022.11.15.516655","pmid":"","publication_date":"2022-11-14","importer_version":"2.1.3","text_redistributed":false}


authors: Gallardo LM.
journal: Preprints.org
publication_date: 2026-04-06
doi: 10.20944/preprints202604.0415.v1
source_url: https://doi.org/10.20944/preprints202604.0415.v1
source_record_id: DOI:10.20944/preprints202604.0415.v1
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.20944/preprints202604.0415.v1
text_rights_status: unverified_not_redistributed
title:
Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy

topic_tags:
Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202604.0415.v1","source_url":"https://doi.org/10.20944/preprints202604.0415.v1","doi":"10.20944/preprints202604.0415.v1","pmid":"","publication_date":"2026-04-06","importer_version":"2.1.3","text_redistributed":false}


authors: Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK.
journal: bioRxiv
publication_date: 2025-09-30
doi: 10.1101/2025.09.30.677638
source_url: https://doi.org/10.1101/2025.09.30.677638
source_record_id: DOI:10.1101/2025.09.30.677638
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Biomarkers,Observational Study,Animal Study
study_type: Observational Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2025.09.30.677638
text_rights_status: unverified_not_redistributed
title:
Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2025.09.30.677638","source_url":"https://doi.org/10.1101/2025.09.30.677638","doi":"10.1101/2025.09.30.677638","pmid":"","publication_date":"2025-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin rescues sociability deficits in an animal model of autism
journal: bioRxiv
publication_date: 2020-09-09
doi: 10.1101/2020.09.09.289348
source_url: https://doi.org/10.1101/2020.09.09.289348
source_record_id: DOI:10.1101/2020.09.09.289348
substance_tags: psilocybin
topic_tags: Animal Study,Drug Interactions
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2020.09.09.289348
text_rights_status: unverified_not_redistributed
authors:
Mollinedo-Gajate I, Song C, Sintes-Rodriguez M, Whelan T, Soula A, Selimbeyoglu A, Hurley S, Knöpfel T.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2020.09.09.289348","source_url":"https://doi.org/10.1101/2020.09.09.289348","doi":"10.1101/2020.09.09.289348","pmid":"","publication_date":"2020-09-09","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-11-30
source_url: https://europepmc.org/article/PMC/PMC12740486
source_record_id: https://europepmc.org/article/PMC/PMC12740486
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging,Older Adults,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study

authors:
Bukovsky D, Amaev A, Song J, Torres-Carmona E, Kyte S, Ueno F, Deluca V, Bowie C, Flint A, Husain I, Graff-Guerrero A, Gerretsen P.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12740486","source_url":"https://europepmc.org/article/PMC/PMC12740486","doi":"","pmid":"","publication_date":"2025-11-30","importer_version":"2.1.3","text_redistributed":false}


authors: McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM.
journal: bioRxiv
publication_date: 2021-01-28
doi: 10.1101/2021.01.28.428377
source_url: https://doi.org/10.1101/2021.01.28.428377
source_record_id: DOI:10.1101/2021.01.28.428377
substance_tags: psilocybin
study_type: Observational Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2021.01.28.428377
text_rights_status: unverified_not_redistributed
title:
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals

topic_tags:
Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Wellbeing,Personality Change,Observational Study

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2021.01.28.428377","source_url":"https://doi.org/10.1101/2021.01.28.428377","doi":"10.1101/2021.01.28.428377","pmid":"","publication_date":"2021-01-28","importer_version":"2.1.3","text_redistributed":false}


title: The entropic brain today
authors: Carhart-Harris R.
journal: PsyArXiv
publication_date: 2025-12-11
doi: 10.31234/osf.io/ubzq3_v1
source_url: https://doi.org/10.31234/osf.io/ubzq3_v1
source_record_id: DOI:10.31234/osf.io/ubzq3_v1
substance_tags: psilocybin
topic_tags: Consciousness,Aging,Wellbeing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/ubzq3_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/ubzq3_v1","source_url":"https://doi.org/10.31234/osf.io/ubzq3_v1","doi":"10.31234/osf.io/ubzq3_v1","pmid":"","publication_date":"2025-12-11","importer_version":"2.1.3","text_redistributed":false}


journal: medRxiv
publication_date: 2021-04-06
doi: 10.1101/2021.04.02.21254838
source_url: https://doi.org/10.1101/2021.04.02.21254838
source_record_id: DOI:10.1101/2021.04.02.21254838
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2021.04.02.21254838
text_rights_status: unverified_not_redistributed
title:
Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies

authors:
Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2021.04.02.21254838","source_url":"https://doi.org/10.1101/2021.04.02.21254838","doi":"10.1101/2021.04.02.21254838","pmid":"","publication_date":"2021-04-06","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359596
source_record_id: https://europepmc.org/article/PMC/PMC12359596
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINE

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359596","source_url":"https://europepmc.org/article/PMC/PMC12359596","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359512
source_record_id: https://europepmc.org/article/PMC/PMC12359512
substance_tags: psilocybin
topic_tags: Anxiety,Biomarkers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359512","source_url":"https://europepmc.org/article/PMC/PMC12359512","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Neurocomputational evidence of sustained Self-Other mergence after psychedelics
authors: Mallaroni P, Mason NL, Preller KH, Razi A, Ereira S, Ramaekers JG.
journal: medRxiv
publication_date: 2025-10-07
doi: 10.1101/2025.10.07.25337510
source_url: https://doi.org/10.1101/2025.10.07.25337510
source_record_id: DOI:10.1101/2025.10.07.25337510
substance_tags: psilocybin
topic_tags: Brain Imaging,Wellbeing
study_type: Other
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2025.10.07.25337510
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2025.10.07.25337510","source_url":"https://doi.org/10.1101/2025.10.07.25337510","doi":"10.1101/2025.10.07.25337510","pmid":"","publication_date":"2025-10-07","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
authors: Shao L, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC.
journal: bioRxiv
publication_date: 2021-02-16
doi: 10.1101/2021.02.17.431629
source_url: https://doi.org/10.1101/2021.02.17.431629
source_record_id: DOI:10.1101/2021.02.17.431629
substance_tags: psilocybin
topic_tags: Neuroplasticity,Animal Study
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2021.02.17.431629
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2021.02.17.431629","source_url":"https://doi.org/10.1101/2021.02.17.431629","doi":"10.1101/2021.02.17.431629","pmid":"","publication_date":"2021-02-16","importer_version":"2.1.3","text_redistributed":false}


title: Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST
journal: PsyArXiv
publication_date: 2026-01-14
source_url: https://osf.io/preprints/psyarxiv/6mj8n_v1
source_record_id: https://osf.io/preprints/psyarxiv/6mj8n_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Mechanism of Action,Consciousness,Spirituality,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/6mj8n_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/6mj8n_v1","source_url":"https://osf.io/preprints/psyarxiv/6mj8n_v1","doi":"","pmid":"","publication_date":"2026-01-14","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2025-09-25
source_url: https://osf.io/preprints/psyarxiv/4cn5r_v1
source_record_id: https://osf.io/preprints/psyarxiv/4cn5r_v1
substance_tags: psilocybin
topic_tags: Anxiety,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/4cn5r_v1
text_rights_status: unverified_not_redistributed
title:
“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/4cn5r_v1","source_url":"https://osf.io/preprints/psyarxiv/4cn5r_v1","doi":"","pmid":"","publication_date":"2025-09-25","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359495
source_record_id: https://europepmc.org/article/PMC/PMC12359495
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359495","source_url":"https://europepmc.org/article/PMC/PMC12359495","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359800
source_record_id: https://europepmc.org/article/PMC/PMC12359800
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359800","source_url":"https://europepmc.org/article/PMC/PMC12359800","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359594
source_record_id: https://europepmc.org/article/PMC/PMC12359594
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359594","source_url":"https://europepmc.org/article/PMC/PMC12359594","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


authors: Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI, Wenthur CJ.
journal: bioRxiv
publication_date: 2020-08-13
doi: 10.1101/2020.08.12.248229
source_url: https://doi.org/10.1101/2020.08.12.248229
source_record_id: DOI:10.1101/2020.08.12.248229
substance_tags: psilocybin
topic_tags: Anxiety,Mechanism of Action,Animal Study,Drug Interactions
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2020.08.12.248229
text_rights_status: unverified_not_redistributed
title:
Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2020.08.12.248229","source_url":"https://doi.org/10.1101/2020.08.12.248229","doi":"10.1101/2020.08.12.248229","pmid":"","publication_date":"2020-08-13","importer_version":"2.1.3","text_redistributed":false}


title: A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms
authors: Chue P, Andreiev A, Bucuci E, Els C, Chue J.
publication_date: 2022-08-31
source_url: https://europepmc.org/article/PMC/PMC9568164
source_record_id: https://europepmc.org/article/PMC/PMC9568164
substance_tags: psilocybin,psilocin
topic_tags: Pharmacology,Receptor Pharmacology,Epigenetics,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9568164
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9568164","source_url":"https://europepmc.org/article/PMC/PMC9568164","doi":"","pmid":"","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


title: A virtual clinical trial of psychedelics to treat patients with disorders of consciousness
journal: bioRxiv
publication_date: 2024-08-18
doi: 10.1101/2024.08.16.608251
source_url: https://doi.org/10.1101/2024.08.16.608251
source_record_id: DOI:10.1101/2024.08.16.608251
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness,Aging,Clinical Trial
study_type: Clinical Trial
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.08.16.608251
text_rights_status: unverified_not_redistributed
authors:
Alnagger NL, Cardone P, Martial C, Sanz Perl Y, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason NL, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Nunez P, Annen J.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.08.16.608251","source_url":"https://doi.org/10.1101/2024.08.16.608251","doi":"10.1101/2024.08.16.608251","pmid":"","publication_date":"2024-08-18","importer_version":"2.1.3","text_redistributed":false}


journal: bioRxiv
publication_date: 2021-05-16
doi: 10.1101/2021.05.14.444193
source_url: https://doi.org/10.1101/2021.05.14.444193
source_record_id: DOI:10.1101/2021.05.14.444193
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Aging
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2021.05.14.444193
text_rights_status: unverified_not_redistributed
title:
LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory

authors:
Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2021.05.14.444193","source_url":"https://doi.org/10.1101/2021.05.14.444193","doi":"10.1101/2021.05.14.444193","pmid":"","publication_date":"2021-05-16","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-07-31
source_url: https://europepmc.org/article/PMC/PMC12359785
source_record_id: https://europepmc.org/article/PMC/PMC12359785
substance_tags: psilocybin
topic_tags: Eating Disorders
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359785","source_url":"https://europepmc.org/article/PMC/PMC12359785","doi":"","pmid":"","publication_date":"2025-07-31","importer_version":"2.1.3","text_redistributed":false}


authors: Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM.
journal: Preprints.org
publication_date: 2020-11-29
doi: 10.20944/preprints202011.0742.v1
source_url: https://doi.org/10.20944/preprints202011.0742.v1
source_record_id: DOI:10.20944/preprints202011.0742.v1
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.20944/preprints202011.0742.v1
text_rights_status: unverified_not_redistributed
title:
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202011.0742.v1","source_url":"https://doi.org/10.20944/preprints202011.0742.v1","doi":"10.20944/preprints202011.0742.v1","pmid":"","publication_date":"2020-11-29","importer_version":"2.1.3","text_redistributed":false}


authors: Ben-Zion Z, Simon G, Lazebnik T.
journal: Research Square
publication_date: 2026-02-01
doi: 10.21203/rs.3.rs-8682370/v1
source_url: https://doi.org/10.21203/rs.3.rs-8682370/v1
source_record_id: DOI:10.21203/rs.3.rs-8682370/v1
substance_tags: psilocybin
topic_tags: Consciousness,Mystical Experience,Safety
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-8682370/v1
text_rights_status: unverified_not_redistributed
title:
Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-8682370/v1","source_url":"https://doi.org/10.21203/rs.3.rs-8682370/v1","doi":"10.21203/rs.3.rs-8682370/v1","pmid":"","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}


journal: bioRxiv
publication_date: 2021-12-06
doi: 10.1101/2021.11.30.470657
source_url: https://doi.org/10.1101/2021.11.30.470657
source_record_id: DOI:10.1101/2021.11.30.470657
substance_tags: psilocybin
topic_tags: Brain Imaging,Microdosing,Creativity
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2021.11.30.470657
text_rights_status: unverified_not_redistributed
title:
Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity

authors:
Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2021.11.30.470657","source_url":"https://doi.org/10.1101/2021.11.30.470657","doi":"10.1101/2021.11.30.470657","pmid":"","publication_date":"2021-12-06","importer_version":"2.1.3","text_redistributed":false}


title: Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere
journal: Authorea Preprints
publication_date: 2023-11-16
doi: 10.22541/au.170019739.91075425/v1
source_url: https://doi.org/10.22541/au.170019739.91075425/v1
source_record_id: DOI:10.22541/au.170019739.91075425/v1
substance_tags: psilocybin
topic_tags: Mechanism of Action,Adverse Events,Genomics
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.22541/au.170019739.91075425/v1
text_rights_status: unverified_not_redistributed
authors:
McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording W, Lloyd R, Shuey L, Drenth A, James T.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.22541/au.170019739.91075425/v1","source_url":"https://doi.org/10.22541/au.170019739.91075425/v1","doi":"10.22541/au.170019739.91075425/v1","pmid":"","publication_date":"2023-11-16","importer_version":"2.1.3","text_redistributed":false}


authors: Rahman T.
journal: Preprints.org
publication_date: 2026-05-25
doi: 10.20944/preprints202605.1558.v1
source_url: https://doi.org/10.20944/preprints202605.1558.v1
source_record_id: DOI:10.20944/preprints202605.1558.v1
substance_tags: psilocybin
topic_tags: Drug Interactions
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.20944/preprints202605.1558.v1
text_rights_status: unverified_not_redistributed
title:
Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and Retrieval

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202605.1558.v1","source_url":"https://doi.org/10.20944/preprints202605.1558.v1","doi":"10.20944/preprints202605.1558.v1","pmid":"","publication_date":"2026-05-25","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2020-08-12
source_url: https://osf.io/preprints/psyarxiv/u6v9y_v1
source_record_id: https://osf.io/preprints/psyarxiv/u6v9y_v1
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/u6v9y_v1
text_rights_status: unverified_not_redistributed
title:
The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/u6v9y_v1","source_url":"https://osf.io/preprints/psyarxiv/u6v9y_v1","doi":"","pmid":"","publication_date":"2020-08-12","importer_version":"2.1.3","text_redistributed":false}


authors: Hoyer D.
journal: Authorea Preprints
publication_date: 2024-05-22
doi: 10.22541/au.171648613.31141136/v1
source_url: https://doi.org/10.22541/au.171648613.31141136/v1
source_record_id: DOI:10.22541/au.171648613.31141136/v1
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.22541/au.171648613.31141136/v1
text_rights_status: unverified_not_redistributed
title:
On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.

topic_tags:
Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.22541/au.171648613.31141136/v1","source_url":"https://doi.org/10.22541/au.171648613.31141136/v1","doi":"10.22541/au.171648613.31141136/v1","pmid":"","publication_date":"2024-05-22","importer_version":"2.1.3","text_redistributed":false}


authors: Hirschfeld T, Schmidt TT.
journal: bioRxiv
publication_date: 2020-06-10
doi: 10.1101/2020.06.09.142802
source_url: https://doi.org/10.1101/2020.06.09.142802
source_record_id: DOI:10.1101/2020.06.09.142802
substance_tags: psilocybin
topic_tags: Consciousness,Mystical Experience,Meta-Analysis,Review Article
study_type: Meta-Analysis
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2020.06.09.142802
text_rights_status: unverified_not_redistributed
title:
How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2020.06.09.142802","source_url":"https://doi.org/10.1101/2020.06.09.142802","doi":"10.1101/2020.06.09.142802","pmid":"","publication_date":"2020-06-10","importer_version":"2.1.3","text_redistributed":false}


authors: Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S.
journal: Research Square
publication_date: 2023-07-26
doi: 10.21203/rs.3.rs-3189970/v1
source_url: https://doi.org/10.21203/rs.3.rs-3189970/v1
source_record_id: DOI:10.21203/rs.3.rs-3189970/v1
substance_tags: psilocybin
topic_tags: Eating Disorders,Aging,Safety
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-3189970/v1
text_rights_status: unverified_not_redistributed
title:
“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-3189970/v1","source_url":"https://doi.org/10.21203/rs.3.rs-3189970/v1","doi":"10.21203/rs.3.rs-3189970/v1","pmid":"","publication_date":"2023-07-26","importer_version":"2.1.3","text_redistributed":false}


journal: Research Square
publication_date: 2024-02-21
doi: 10.21203/rs.3.rs-3905152/v1
source_url: https://doi.org/10.21203/rs.3.rs-3905152/v1
source_record_id: DOI:10.21203/rs.3.rs-3905152/v1
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-3905152/v1
text_rights_status: unverified_not_redistributed
title:
Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction

authors:
Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-3905152/v1","source_url":"https://doi.org/10.21203/rs.3.rs-3905152/v1","doi":"10.21203/rs.3.rs-3905152/v1","pmid":"","publication_date":"2024-02-21","importer_version":"2.1.3","text_redistributed":false}


authors: Martin HM, Cofre R, Destexhe A.
journal: bioRxiv
publication_date: 2025-10-19
doi: 10.1101/2025.10.20.683366
source_url: https://doi.org/10.1101/2025.10.20.683366
source_record_id: DOI:10.1101/2025.10.20.683366
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2025.10.20.683366
text_rights_status: unverified_not_redistributed
title:
Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2025.10.20.683366","source_url":"https://doi.org/10.1101/2025.10.20.683366","doi":"10.1101/2025.10.20.683366","pmid":"","publication_date":"2025-10-19","importer_version":"2.1.3","text_redistributed":false}


authors: Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL.
journal: Research Square
publication_date: 2024-02-22
doi: 10.21203/rs.3.rs-3941205/v1
source_url: https://doi.org/10.21203/rs.3.rs-3941205/v1
source_record_id: DOI:10.21203/rs.3.rs-3941205/v1
substance_tags: psilocybin
topic_tags: Consciousness,Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-3941205/v1
text_rights_status: unverified_not_redistributed
title:
The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-3941205/v1","source_url":"https://doi.org/10.21203/rs.3.rs-3941205/v1","doi":"10.21203/rs.3.rs-3941205/v1","pmid":"","publication_date":"2024-02-22","importer_version":"2.1.3","text_redistributed":false}


title: Molecular, haemodynamic and functional effects of LSD in the human brain
journal: medRxiv
publication_date: 2025-06-17
doi: 10.1101/2025.06.17.25329677
source_url: https://doi.org/10.1101/2025.06.17.25329677
source_record_id: DOI:10.1101/2025.06.17.25329677
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Healthy Volunteers
study_type: Other
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2025.06.17.25329677
text_rights_status: unverified_not_redistributed
authors:
McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM.

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2025.06.17.25329677","source_url":"https://doi.org/10.1101/2025.06.17.25329677","doi":"10.1101/2025.06.17.25329677","pmid":"","publication_date":"2025-06-17","importer_version":"2.1.3","text_redistributed":false}


title: Unsupervised Extractive Summarization of Psychedelic User Experience Reports
authors: Islam S, Salam S, Hasan MN.
journal: medRxiv
publication_date: 2025-08-26
doi: 10.1101/2025.08.22.25334176
source_url: https://doi.org/10.1101/2025.08.22.25334176
source_record_id: DOI:10.1101/2025.08.22.25334176
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2025.08.22.25334176
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2025.08.22.25334176","source_url":"https://doi.org/10.1101/2025.08.22.25334176","doi":"10.1101/2025.08.22.25334176","pmid":"","publication_date":"2025-08-26","importer_version":"2.1.3","text_redistributed":false}


title: Mapping Psilocybin-Assisted Therapies: A Scoping Review
authors: Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.
journal: medRxiv
publication_date: 2019-12-11
doi: 10.1101/2019.12.04.19013896
source_url: https://doi.org/10.1101/2019.12.04.19013896
source_record_id: DOI:10.1101/2019.12.04.19013896
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2019.12.04.19013896
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2019.12.04.19013896","source_url":"https://doi.org/10.1101/2019.12.04.19013896","doi":"10.1101/2019.12.04.19013896","pmid":"","publication_date":"2019-12-11","importer_version":"2.1.3","text_redistributed":false}


authors: Wang Y, Li T, Reynolds E, Wang Z, Torrens-Spence M, Weng J.
journal: Research Square
publication_date: 2025-04-27
doi: 10.21203/rs.3.rs-6329392/v1
source_url: https://doi.org/10.21203/rs.3.rs-6329392/v1
source_record_id: DOI:10.21203/rs.3.rs-6329392/v1
substance_tags: psilocybin
topic_tags: End-of-Life Distress,In Vitro Study
study_type: In Vitro Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-6329392/v1
text_rights_status: unverified_not_redistributed
title:
Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-6329392/v1","source_url":"https://doi.org/10.21203/rs.3.rs-6329392/v1","doi":"10.21203/rs.3.rs-6329392/v1","pmid":"","publication_date":"2025-04-27","importer_version":"2.1.3","text_redistributed":false}


authors: Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M.
journal: bioRxiv
publication_date: 2019-08-31
doi: 10.1101/751255
source_url: https://doi.org/10.1101/751255
source_record_id: DOI:10.1101/751255
substance_tags: psilocybin
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/751255
text_rights_status: unverified_not_redistributed
title:
Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice

topic_tags:
Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Animal Study,Drug Interactions

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/751255","source_url":"https://doi.org/10.1101/751255","doi":"10.1101/751255","pmid":"","publication_date":"2019-08-31","importer_version":"2.1.3","text_redistributed":false}


title: Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice
authors: Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM.
journal: bioRxiv
publication_date: 2025-04-13
doi: 10.1101/2025.04.08.647757
source_url: https://doi.org/10.1101/2025.04.08.647757
source_record_id: DOI:10.1101/2025.04.08.647757
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Microdosing,Emotional Processing,Animal Study,Safety
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2025.04.08.647757
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2025.04.08.647757","source_url":"https://doi.org/10.1101/2025.04.08.647757","doi":"10.1101/2025.04.08.647757","pmid":"","publication_date":"2025-04-13","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2025-12-30
source_url: https://osf.io/preprints/psyarxiv/6jf49_v1
source_record_id: https://osf.io/preprints/psyarxiv/6jf49_v1
substance_tags: psilocybin
topic_tags: Consciousness,Wellbeing,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:49
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/6jf49_v1
text_rights_status: unverified_not_redistributed
title:
Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/6jf49_v1","source_url":"https://osf.io/preprints/psyarxiv/6jf49_v1","doi":"","pmid":"","publication_date":"2025-12-30","importer_version":"2.1.3","text_redistributed":false}


title: Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms
authors: Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT.
journal: bioRxiv
publication_date: 2018-07-24
doi: 10.1101/374199
source_url: https://doi.org/10.1101/374199
source_record_id: DOI:10.1101/374199
substance_tags: psilocybin
topic_tags: Depression,Addiction,End-of-Life Distress,Genomics,Transcriptomics
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:03
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/374199
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/374199","source_url":"https://doi.org/10.1101/374199","doi":"10.1101/374199","pmid":"","publication_date":"2018-07-24","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-01-31
source_url: https://europepmc.org/article/PMC/PMC11814992
source_record_id: https://europepmc.org/article/PMC/PMC11814992
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11814992","source_url":"https://europepmc.org/article/PMC/PMC11814992","doi":"","pmid":"","publication_date":"2025-01-31","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-01-31
source_url: https://europepmc.org/article/PMC/PMC11815225
source_record_id: https://europepmc.org/article/PMC/PMC11815225
substance_tags: psilocybin
topic_tags: Depression,Metabolomics
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:03
text_rights_status: not_applicable_no_text
title:
BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11815225","source_url":"https://europepmc.org/article/PMC/PMC11815225","doi":"","pmid":"","publication_date":"2025-01-31","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-12-25
source_url: https://osf.io/preprints/psyarxiv/byms6_v1
source_record_id: https://osf.io/preprints/psyarxiv/byms6_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/byms6_v1
text_rights_status: unverified_not_redistributed
title:
Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/byms6_v1","source_url":"https://osf.io/preprints/psyarxiv/byms6_v1","doi":"","pmid":"","publication_date":"2023-12-25","importer_version":"2.1.3","text_redistributed":false}


authors: Biba B, O'Shea B.
journal: PsyArXiv
publication_date: 2025-03-06
doi: 10.31234/osf.io/6xgu8_v2
source_url: https://doi.org/10.31234/osf.io/6xgu8_v2
source_record_id: DOI:10.31234/osf.io/6xgu8_v2
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/6xgu8_v2
text_rights_status: unverified_not_redistributed
title:
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/6xgu8_v2","source_url":"https://doi.org/10.31234/osf.io/6xgu8_v2","doi":"10.31234/osf.io/6xgu8_v2","pmid":"","publication_date":"2025-03-06","importer_version":"2.1.3","text_redistributed":false}


title: Horizontal gene cluster transfer increased hallucinogenic mushroom diversity
authors: Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC.
journal: bioRxiv
publication_date: 2017-08-14
doi: 10.1101/176347
source_url: https://doi.org/10.1101/176347
source_record_id: DOI:10.1101/176347
substance_tags: psilocybin,psilocin
topic_tags: Receptor Pharmacology,Consciousness,Drug Interactions,Genomics
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/176347
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/176347","source_url":"https://doi.org/10.1101/176347","doi":"10.1101/176347","pmid":"","publication_date":"2017-08-14","importer_version":"2.1.3","text_redistributed":false}


title: Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report
authors: Shah S, Morrin H.
journal: Research Square
publication_date: 2026-03-07
doi: 10.21203/rs.3.rs-8919841/v1
source_url: https://doi.org/10.21203/rs.3.rs-8919841/v1
source_record_id: DOI:10.21203/rs.3.rs-8919841/v1
substance_tags: psilocybin
topic_tags: Addiction,Spirituality,Case Report,Healthcare Workers,Safety,Drug Interactions
study_type: Case Report
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-8919841/v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-8919841/v1","source_url":"https://doi.org/10.21203/rs.3.rs-8919841/v1","doi":"10.21203/rs.3.rs-8919841/v1","pmid":"","publication_date":"2026-03-07","importer_version":"2.1.3","text_redistributed":false}


title: Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders
authors: Valdez T, Patel V, Senesombath D, Hatahet-Donovan Z, Hornick MG.
journal: Preprints.org
publication_date: 2024-10-16
doi: 10.20944/preprints202410.1406.v1
source_url: https://doi.org/10.20944/preprints202410.1406.v1
source_record_id: DOI:10.20944/preprints202410.1406.v1
substance_tags: psilocybin
topic_tags: Addiction,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.20944/preprints202410.1406.v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202410.1406.v1","source_url":"https://doi.org/10.20944/preprints202410.1406.v1","doi":"10.20944/preprints202410.1406.v1","pmid":"","publication_date":"2024-10-16","importer_version":"2.1.3","text_redistributed":false}


journal: bioRxiv
publication_date: 2024-12-21
doi: 10.1101/2024.12.21.629922
source_url: https://doi.org/10.1101/2024.12.21.629922
source_record_id: DOI:10.1101/2024.12.21.629922
substance_tags: psilocybin
topic_tags: Consciousness,Drug Interactions
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.12.21.629922
text_rights_status: unverified_not_redistributed
title:
Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity

authors:
Vohryzek J, Garcia Guzman E, Kringelbach ML, Lopez-Sola E, Timmermann C, Roseman L, Tagliazucchi E, Ruffini G, Carhart-Harris R, Deco G, Sanz Perl Y.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.12.21.629922","source_url":"https://doi.org/10.1101/2024.12.21.629922","doi":"10.1101/2024.12.21.629922","pmid":"","publication_date":"2024-12-21","importer_version":"2.1.3","text_redistributed":false}


authors: Jylkkä J.
journal: PsyArXiv
publication_date: 2025-06-05
doi: 10.31234/osf.io/ugr69_v2
source_url: https://doi.org/10.31234/osf.io/ugr69_v2
source_record_id: DOI:10.31234/osf.io/ugr69_v2
substance_tags: psilocybin
topic_tags: Wellbeing,Mystical Experience
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/ugr69_v2
text_rights_status: unverified_not_redistributed
title:
Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/ugr69_v2","source_url":"https://doi.org/10.31234/osf.io/ugr69_v2","doi":"10.31234/osf.io/ugr69_v2","pmid":"","publication_date":"2025-06-05","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin kann offenbar Depressionen lindern
authors: Thomas Müller
journal: MMW - Fortschritte der Medizin
publication_date: 2023-09-26
doi: 10.1007/s15006-023-3025-6
pubmed_id: 37758991
source_url: http://dx.doi.org/10.1007/s15006-023-3025-6
source_record_id: PMID:37758991
substance_tags: psilocybin
topic_tags: Depression,Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-04 07:00:36
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:37758991","source_url":"http://dx.doi.org/10.1007/s15006-023-3025-6","doi":"10.1007/s15006-023-3025-6","pmid":"37758991","publication_date":"2023-09-26","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and autobiographical memory - Six open questions
authors: Kangaslampi S, Lietz MP.
journal: PsyArXiv
publication_date: 2025-03-10
doi: 10.31234/osf.io/su7ch_v2
source_url: https://doi.org/10.31234/osf.io/su7ch_v2
source_record_id: DOI:10.31234/osf.io/su7ch_v2
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/su7ch_v2
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/su7ch_v2","source_url":"https://doi.org/10.31234/osf.io/su7ch_v2","doi":"10.31234/osf.io/su7ch_v2","pmid":"","publication_date":"2025-03-10","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-01-31
source_url: https://europepmc.org/article/PMC/PMC11815219
source_record_id: https://europepmc.org/article/PMC/PMC11815219
substance_tags: psilocybin
topic_tags: Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
title:
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11815219","source_url":"https://europepmc.org/article/PMC/PMC11815219","doi":"","pmid":"","publication_date":"2025-01-31","importer_version":"2.1.3","text_redistributed":false}


authors: Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Spreng RN.
journal: bioRxiv
publication_date: 2020-05-02
doi: 10.1101/2020.05.01.072314
source_url: https://doi.org/10.1101/2020.05.01.072314
source_record_id: DOI:10.1101/2020.05.01.072314
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2020.05.01.072314
text_rights_status: unverified_not_redistributed
title:
Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2020.05.01.072314","source_url":"https://doi.org/10.1101/2020.05.01.072314","doi":"10.1101/2020.05.01.072314","pmid":"","publication_date":"2020-05-02","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-11-21
source_url: https://osf.io/preprints/psyarxiv/9ev27_v1
source_record_id: https://osf.io/preprints/psyarxiv/9ev27_v1
substance_tags: psilocybin
topic_tags: Consciousness,Safety
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/9ev27_v1
text_rights_status: unverified_not_redistributed
title:
Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/9ev27_v1","source_url":"https://osf.io/preprints/psyarxiv/9ev27_v1","doi":"","pmid":"","publication_date":"2023-11-21","importer_version":"2.1.3","text_redistributed":false}


title: Understanding psychedelic 'mystical experience'-A case example
journal: PsyArXiv
publication_date: 2023-03-09
source_url: https://osf.io/preprints/psyarxiv/dh92g_v1
source_record_id: https://osf.io/preprints/psyarxiv/dh92g_v1
substance_tags: psilocybin
topic_tags: Anxiety,PTSD,Wellbeing,Personality Change,Mystical Experience,Clinical Trial,Healthcare Workers
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/dh92g_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/dh92g_v1","source_url":"https://osf.io/preprints/psyarxiv/dh92g_v1","doi":"","pmid":"","publication_date":"2023-03-09","importer_version":"2.1.3","text_redistributed":false}


title: Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
journal: PsyArXiv
publication_date: 2025-07-14
doi: 10.31234/osf.io/7x8q4_v3
source_url: https://doi.org/10.31234/osf.io/7x8q4_v3
source_record_id: DOI:10.31234/osf.io/7x8q4_v3
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Animal Study
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/7x8q4_v3
text_rights_status: unverified_not_redistributed
authors:
Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/7x8q4_v3","source_url":"https://doi.org/10.31234/osf.io/7x8q4_v3","doi":"10.31234/osf.io/7x8q4_v3","pmid":"","publication_date":"2025-07-14","importer_version":"2.1.3","text_redistributed":false}


authors: Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE.
journal: Research Square
publication_date: 2025-08-18
doi: 10.21203/rs.3.rs-6941009/v1
source_url: https://doi.org/10.21203/rs.3.rs-6941009/v1
source_record_id: DOI:10.21203/rs.3.rs-6941009/v1
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Observational Study,Cancer Patients,Safety
study_type: Observational Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-6941009/v1
text_rights_status: unverified_not_redistributed
title:
Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-6941009/v1","source_url":"https://doi.org/10.21203/rs.3.rs-6941009/v1","doi":"10.21203/rs.3.rs-6941009/v1","pmid":"","publication_date":"2025-08-18","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2025-03-26
source_url: https://osf.io/preprints/psyarxiv/mzkyv_v1
source_record_id: https://osf.io/preprints/psyarxiv/mzkyv_v1
substance_tags: psilocybin
topic_tags: Depression,PTSD,Personality Change,Emotional Processing,Spirituality
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/mzkyv_v1
text_rights_status: unverified_not_redistributed
title:
Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/mzkyv_v1","source_url":"https://osf.io/preprints/psyarxiv/mzkyv_v1","doi":"","pmid":"","publication_date":"2025-03-26","importer_version":"2.1.3","text_redistributed":false}


title: A systematic review to assess the use of psilocybin in the treatment of headaches
authors: Bhanot S, Lin M, Bains S, Monroe A, Tsang V.
publication_date: 2023-07-18
source_url: https://europepmc.org/article/PMC/PMC10660046
source_record_id: https://europepmc.org/article/PMC/PMC10660046
substance_tags: psilocybin
topic_tags: Headache / Migraine,Systematic Review,Review Article
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC10660046","source_url":"https://europepmc.org/article/PMC/PMC10660046","doi":"","pmid":"","publication_date":"2023-07-18","importer_version":"2.1.3","text_redistributed":false}


title: The therapeutic potential of psilocybin in depression resistant to psychotropic drugs
authors: Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E.
publication_date: 2023-07-18
source_url: https://europepmc.org/article/PMC/PMC10479004
source_record_id: https://europepmc.org/article/PMC/PMC10479004
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC10479004","source_url":"https://europepmc.org/article/PMC/PMC10479004","doi":"","pmid":"","publication_date":"2023-07-18","importer_version":"2.1.3","text_redistributed":false}


authors: Olami A, Peled-Avron L.
journal: bioRxiv
publication_date: 2024-05-04
doi: 10.1101/2024.05.02.592231
source_url: https://doi.org/10.1101/2024.05.02.592231
source_record_id: DOI:10.1101/2024.05.02.592231
substance_tags: psilocybin
topic_tags: Emotional Processing,Meta-Analysis,Review Article,Drug Interactions
study_type: Meta-Analysis
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.05.02.592231
text_rights_status: unverified_not_redistributed
title:
Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.05.02.592231","source_url":"https://doi.org/10.1101/2024.05.02.592231","doi":"10.1101/2024.05.02.592231","pmid":"","publication_date":"2024-05-04","importer_version":"2.1.3","text_redistributed":false}


authors: Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M.
journal: medRxiv
publication_date: 2025-07-29
doi: 10.1101/2025.07.30.25332422
source_url: https://doi.org/10.1101/2025.07.30.25332422
source_record_id: DOI:10.1101/2025.07.30.25332422
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Wellbeing,Emotional Processing,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2025.07.30.25332422
text_rights_status: unverified_not_redistributed
title:
Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2025.07.30.25332422","source_url":"https://doi.org/10.1101/2025.07.30.25332422","doi":"10.1101/2025.07.30.25332422","pmid":"","publication_date":"2025-07-29","importer_version":"2.1.3","text_redistributed":false}


journal: Wellcome Open Research
publication_date: 2025-07-07
doi: 10.12688/wellcomeopenres.24181.1
source_url: https://doi.org/10.12688/wellcomeopenres.24181.1
source_record_id: DOI:10.12688/wellcomeopenres.24181.1
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-04 07:00:33
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.12688/wellcomeopenres.24181.1
text_rights_status: unverified_not_redistributed
title:
Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies

authors:
Khaleel Rajwani, Melanie Almonte, F. Feroz, Jamila Hokanson, Edward Jacobs, Julian Savulescu, Ilina Singh, David B. Yaden, Brian D. Earp

topic_tags:
Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Adolescents

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.12688/wellcomeopenres.24181.1","source_url":"https://doi.org/10.12688/wellcomeopenres.24181.1","doi":"10.12688/wellcomeopenres.24181.1","pmid":"","publication_date":"2025-07-07","importer_version":"2.1.3","text_redistributed":false}


title: 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
journal: bioRxiv
publication_date: 2022-11-02
doi: 10.1101/2022.11.03.515044
source_url: https://doi.org/10.1101/2022.11.03.515044
source_record_id: DOI:10.1101/2022.11.03.515044
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Neuroplasticity,Mechanism of Action,Animal Study
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.11.03.515044
text_rights_status: unverified_not_redistributed
authors:
Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.11.03.515044","source_url":"https://doi.org/10.1101/2022.11.03.515044","doi":"10.1101/2022.11.03.515044","pmid":"","publication_date":"2022-11-02","importer_version":"2.1.3","text_redistributed":false}


authors: Varley T, Carhart-Harris R, Roseman L, Menon DK, Stamatakis E.
journal: bioRxiv
publication_date: 2019-01-10
doi: 10.1101/517847
source_url: https://doi.org/10.1101/517847
source_record_id: DOI:10.1101/517847
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/517847
text_rights_status: unverified_not_redistributed
title:
Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal Domains

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/517847","source_url":"https://doi.org/10.1101/517847","doi":"10.1101/517847","pmid":"","publication_date":"2019-01-10","importer_version":"2.1.3","text_redistributed":false}


journal: Research Square
publication_date: 2025-07-26
doi: 10.21203/rs.3.rs-7099164/v1
source_url: https://doi.org/10.21203/rs.3.rs-7099164/v1
source_record_id: DOI:10.21203/rs.3.rs-7099164/v1
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Healthy Volunteers
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-7099164/v1
text_rights_status: unverified_not_redistributed
title:
Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study

authors:
Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-7099164/v1","source_url":"https://doi.org/10.21203/rs.3.rs-7099164/v1","doi":"10.21203/rs.3.rs-7099164/v1","pmid":"","publication_date":"2025-07-26","importer_version":"2.1.3","text_redistributed":false}


authors: Barnett BS.
journal: medRxiv
publication_date: 2024-10-12
doi: 10.1101/2024.10.12.24315367
source_url: https://doi.org/10.1101/2024.10.12.24315367
source_record_id: DOI:10.1101/2024.10.12.24315367
substance_tags: psilocybin
topic_tags: Observational Study
study_type: Observational Study
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2024.10.12.24315367
text_rights_status: unverified_not_redistributed
title:
A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelics

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2024.10.12.24315367","source_url":"https://doi.org/10.1101/2024.10.12.24315367","doi":"10.1101/2024.10.12.24315367","pmid":"","publication_date":"2024-10-12","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin zeigt Wirkung bei Depression.
authors: Julia Mertens L.
publication_date: 2023-03-31
doi: 10.1007/s15006-023-2540-9
pubmed_id: 37016226
source_url: https://doi.org/10.1007/s15006-023-2540-9
source_record_id: PMID:37016226
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37016226","source_url":"https://doi.org/10.1007/s15006-023-2540-9","doi":"10.1007/s15006-023-2540-9","pmid":"37016226","publication_date":"2023-03-31","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2024-10-17
source_url: https://osf.io/preprints/psyarxiv/u9yeg_v1
source_record_id: https://osf.io/preprints/psyarxiv/u9yeg_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Pharmacology,Emotional Processing,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/u9yeg_v1
text_rights_status: unverified_not_redistributed
title:
Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/u9yeg_v1","source_url":"https://osf.io/preprints/psyarxiv/u9yeg_v1","doi":"","pmid":"","publication_date":"2024-10-17","importer_version":"2.1.3","text_redistributed":false}


authors: Hooper J, Gyongyosi E, Hutchison K, Mueller R.
journal: PsyArXiv
publication_date: 2024-10-17
doi: 10.31234/osf.io/u9yeg
source_url: https://doi.org/10.31234/osf.io/u9yeg
source_record_id: DOI:10.31234/osf.io/u9yeg
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/u9yeg
text_rights_status: unverified_not_redistributed
title:
Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/u9yeg","source_url":"https://doi.org/10.31234/osf.io/u9yeg","doi":"10.31234/osf.io/u9yeg","pmid":"","publication_date":"2024-10-17","importer_version":"2.1.3","text_redistributed":false}


title: Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
journal: PsyArXiv
publication_date: 2025-03-28
doi: 10.31234/osf.io/7x8q4_v2
source_url: https://doi.org/10.31234/osf.io/7x8q4_v2
source_record_id: DOI:10.31234/osf.io/7x8q4_v2
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Animal Study
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/7x8q4_v2
text_rights_status: unverified_not_redistributed
authors:
Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/7x8q4_v2","source_url":"https://doi.org/10.31234/osf.io/7x8q4_v2","doi":"10.31234/osf.io/7x8q4_v2","pmid":"","publication_date":"2025-03-28","importer_version":"2.1.3","text_redistributed":false}


title: Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study
authors: Véliz-García O, Domic M.
journal: Research Square
publication_date: 2024-07-31
doi: 10.21203/rs.3.rs-4706910/v1
source_url: https://doi.org/10.21203/rs.3.rs-4706910/v1
source_record_id: DOI:10.21203/rs.3.rs-4706910/v1
substance_tags: psilocybin
topic_tags: Wellbeing,Spirituality,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-4706910/v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-4706910/v1","source_url":"https://doi.org/10.21203/rs.3.rs-4706910/v1","doi":"10.21203/rs.3.rs-4706910/v1","pmid":"","publication_date":"2024-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment
authors: Sousa R, Costa L, Brás J, Vaz R, Martins J, Abreu J, Almeida E, Castro N, Andrade R, Cunha N.
publication_date: 2023-07-18
source_url: https://europepmc.org/article/PMC/PMC10596667
source_record_id: https://europepmc.org/article/PMC/PMC10596667
substance_tags: psilocybin
topic_tags: Addiction
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC10596667","source_url":"https://europepmc.org/article/PMC/PMC10596667","doi":"","pmid":"","publication_date":"2023-07-18","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2022-07-06
source_url: https://osf.io/preprints/psyarxiv/w8j6t_v1
source_record_id: https://osf.io/preprints/psyarxiv/w8j6t_v1
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Mechanism of Action,Wellbeing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/w8j6t_v1
text_rights_status: unverified_not_redistributed
title:
From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/w8j6t_v1","source_url":"https://osf.io/preprints/psyarxiv/w8j6t_v1","doi":"","pmid":"","publication_date":"2022-07-06","importer_version":"2.1.3","text_redistributed":false}


title: Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review
authors: Halman A, Kong G, Sarris J, Perkins D.
journal: medRxiv
publication_date: 2023-05-31
doi: 10.1101/2023.06.01.23290811
source_url: https://doi.org/10.1101/2023.06.01.23290811
source_record_id: DOI:10.1101/2023.06.01.23290811
substance_tags: psilocybin
topic_tags: Mechanism of Action,Systematic Review,Review Article,Case Report,Drug Interactions
study_type: Systematic Review
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2023.06.01.23290811
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2023.06.01.23290811","source_url":"https://doi.org/10.1101/2023.06.01.23290811","doi":"10.1101/2023.06.01.23290811","pmid":"","publication_date":"2023-05-31","importer_version":"2.1.3","text_redistributed":false}


title: The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance
authors: Yoo M, Sakopoulos S.
journal: Authorea Preprints
publication_date: 2024-08-28
doi: 10.22541/au.172496618.87990987/v1
source_url: https://doi.org/10.22541/au.172496618.87990987/v1
source_record_id: DOI:10.22541/au.172496618.87990987/v1
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.22541/au.172496618.87990987/v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.22541/au.172496618.87990987/v1","source_url":"https://doi.org/10.22541/au.172496618.87990987/v1","doi":"10.22541/au.172496618.87990987/v1","pmid":"","publication_date":"2024-08-28","importer_version":"2.1.3","text_redistributed":false}


title: Neural mechanisms of psychedelic visual imagery
authors: Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A.
journal: medRxiv
publication_date: 2022-09-08
doi: 10.1101/2022.09.07.22279700
source_url: https://doi.org/10.1101/2022.09.07.22279700
source_record_id: DOI:10.1101/2022.09.07.22279700
substance_tags: psilocybin
topic_tags: Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2022.09.07.22279700
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2022.09.07.22279700","source_url":"https://doi.org/10.1101/2022.09.07.22279700","doi":"10.1101/2022.09.07.22279700","pmid":"","publication_date":"2022-09-08","importer_version":"2.1.3","text_redistributed":false}


title: Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
journal: PsyArXiv
publication_date: 2025-02-12
doi: 10.31234/osf.io/7x8q4_v1
source_url: https://doi.org/10.31234/osf.io/7x8q4_v1
source_record_id: DOI:10.31234/osf.io/7x8q4_v1
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Animal Study
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/7x8q4_v1
text_rights_status: unverified_not_redistributed
authors:
Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/7x8q4_v1","source_url":"https://doi.org/10.31234/osf.io/7x8q4_v1","doi":"10.31234/osf.io/7x8q4_v1","pmid":"","publication_date":"2025-02-12","importer_version":"2.1.3","text_redistributed":false}


authors: Tsang V.
publication_date: 2024-08-26
source_url: https://europepmc.org/article/PMC/PMC11860442
source_record_id: https://europepmc.org/article/PMC/PMC11860442
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Case Report,Observational Study
study_type: Case Report
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
title:
A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11860442","source_url":"https://europepmc.org/article/PMC/PMC11860442","doi":"","pmid":"","publication_date":"2024-08-26","importer_version":"2.1.3","text_redistributed":false}


authors: Schenberg EE.
journal: PsyArXiv
publication_date: 2024-09-30
doi: 10.31234/osf.io/uxhv7_v1
source_url: https://doi.org/10.31234/osf.io/uxhv7_v1
source_record_id: DOI:10.31234/osf.io/uxhv7_v1
substance_tags: psilocybin
topic_tags: Depression,PTSD,Randomized Controlled Trial,Review Article
study_type: Randomized Controlled Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/uxhv7_v1
text_rights_status: unverified_not_redistributed
title:
From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/uxhv7_v1","source_url":"https://doi.org/10.31234/osf.io/uxhv7_v1","doi":"10.31234/osf.io/uxhv7_v1","pmid":"","publication_date":"2024-09-30","importer_version":"2.1.3","text_redistributed":false}


title: A dual-receptor model of serotonergic psychedelics
authors: Juliani A, Chelu V, Graesser L, Safron A.
journal: bioRxiv
publication_date: 2024-04-14
doi: 10.1101/2024.04.12.589282
source_url: https://doi.org/10.1101/2024.04.12.589282
source_record_id: DOI:10.1101/2024.04.12.589282
substance_tags: psilocybin
topic_tags: Anxiety,Mechanism of Action,Receptor Pharmacology
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.04.12.589282
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.04.12.589282","source_url":"https://doi.org/10.1101/2024.04.12.589282","doi":"10.1101/2024.04.12.589282","pmid":"","publication_date":"2024-04-14","importer_version":"2.1.3","text_redistributed":false}


authors: Schenberg EE.
journal: PsyArXiv
publication_date: 2024-09-30
doi: 10.31234/osf.io/uxhv7
source_url: https://doi.org/10.31234/osf.io/uxhv7
source_record_id: DOI:10.31234/osf.io/uxhv7
substance_tags: psilocybin
topic_tags: Depression,PTSD,Randomized Controlled Trial,Review Article
study_type: Randomized Controlled Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:50
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/uxhv7
text_rights_status: unverified_not_redistributed
title:
From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/uxhv7","source_url":"https://doi.org/10.31234/osf.io/uxhv7","doi":"10.31234/osf.io/uxhv7","pmid":"","publication_date":"2024-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Majic T, Schmidt TT, Gröticke A, Gasser P, Richards WA, Riemer TG, Evens R.
journal: PsyArXiv
publication_date: 2024-10-21
doi: 10.31234/osf.io/s6bzc
source_url: https://doi.org/10.31234/osf.io/s6bzc
source_record_id: DOI:10.31234/osf.io/s6bzc
substance_tags: psilocybin
topic_tags: Creativity,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/s6bzc
text_rights_status: unverified_not_redistributed
title:
The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/s6bzc","source_url":"https://doi.org/10.31234/osf.io/s6bzc","doi":"10.31234/osf.io/s6bzc","pmid":"","publication_date":"2024-10-21","importer_version":"2.1.3","text_redistributed":false}


authors: Pagni B, Petridis P, Podrebarac S, Grinband J, Claus E, Bogenschutz M.
publication_date: 2024-04-23
source_url: https://europepmc.org/article/PMC/PMC11033768
source_record_id: https://europepmc.org/article/PMC/PMC11033768
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Emotional Processing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
title:
300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11033768","source_url":"https://europepmc.org/article/PMC/PMC11033768","doi":"","pmid":"","publication_date":"2024-04-23","importer_version":"2.1.3","text_redistributed":false}


authors: Weleff J, Akiki TJ, Barnett BS.
journal: medRxiv
publication_date: 2021-11-23
doi: 10.1101/2021.11.22.21266718
source_url: https://doi.org/10.1101/2021.11.22.21266718
source_record_id: DOI:10.1101/2021.11.22.21266718
substance_tags: psilocybin
topic_tags: Addiction,Safety
study_type: Other
source_name: medRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: medRxiv
abstract_source_url: https://doi.org/10.1101/2021.11.22.21266718
text_rights_status: unverified_not_redistributed
title:
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies

source_provenance_json:
{"source_name":"medRxiv","source_record_id":"DOI:10.1101/2021.11.22.21266718","source_url":"https://doi.org/10.1101/2021.11.22.21266718","doi":"10.1101/2021.11.22.21266718","pmid":"","publication_date":"2021-11-23","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Assisted Therapy for Major Depressive Disorder: A Review
journal: PsyArXiv
publication_date: 2021-06-26
source_url: https://osf.io/preprints/psyarxiv/9kuhs_v1
source_record_id: https://osf.io/preprints/psyarxiv/9kuhs_v1
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/9kuhs_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/9kuhs_v1","source_url":"https://osf.io/preprints/psyarxiv/9kuhs_v1","doi":"","pmid":"","publication_date":"2021-06-26","importer_version":"2.1.3","text_redistributed":false}


authors: Holas P, Kaminska J.
journal: Research Square
publication_date: 2024-08-14
doi: 10.21203/rs.3.rs-4860906/v1
source_url: https://doi.org/10.21203/rs.3.rs-4860906/v1
source_record_id: DOI:10.21203/rs.3.rs-4860906/v1
substance_tags: psilocybin
topic_tags: Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-4860906/v1
text_rights_status: unverified_not_redistributed
title:
Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish Adults

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-4860906/v1","source_url":"https://doi.org/10.21203/rs.3.rs-4860906/v1","doi":"10.21203/rs.3.rs-4860906/v1","pmid":"","publication_date":"2024-08-14","importer_version":"2.1.3","text_redistributed":false}


authors: Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T.
journal: bioRxiv
publication_date: 2024-06-15
doi: 10.1101/2024.06.13.594677
source_url: https://doi.org/10.1101/2024.06.13.594677
source_record_id: DOI:10.1101/2024.06.13.594677
substance_tags: psilocin
topic_tags: Mechanism of Action,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.06.13.594677
text_rights_status: unverified_not_redistributed
title:
Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.06.13.594677","source_url":"https://doi.org/10.1101/2024.06.13.594677","doi":"10.1101/2024.06.13.594677","pmid":"","publication_date":"2024-06-15","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics: A new era of treatment?
authors: Torres S.
publication_date: 2021-08-12
source_url: https://europepmc.org/article/PMC/PMC9475866
source_record_id: https://europepmc.org/article/PMC/PMC9475866
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9475866
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9475866","source_url":"https://europepmc.org/article/PMC/PMC9475866","doi":"","pmid":"","publication_date":"2021-08-12","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2024-06-06
source_url: https://osf.io/preprints/psyarxiv/bvk2f_v1
source_record_id: https://osf.io/preprints/psyarxiv/bvk2f_v1
substance_tags: psilocybin
topic_tags: PTSD,Personality Change,Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/bvk2f_v1
text_rights_status: unverified_not_redistributed
title:
5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/bvk2f_v1","source_url":"https://osf.io/preprints/psyarxiv/bvk2f_v1","doi":"","pmid":"","publication_date":"2024-06-06","importer_version":"2.1.3","text_redistributed":false}


authors: Calder A, Hasler G.
journal: PsyArXiv
publication_date: 2024-06-06
doi: 10.31234/osf.io/um2cy
source_url: https://doi.org/10.31234/osf.io/um2cy
source_record_id: DOI:10.31234/osf.io/um2cy
substance_tags: psilocybin
topic_tags: Safety,Adverse Events
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/um2cy
text_rights_status: unverified_not_redistributed
title:
Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/um2cy","source_url":"https://doi.org/10.31234/osf.io/um2cy","doi":"10.31234/osf.io/um2cy","pmid":"","publication_date":"2024-06-06","importer_version":"2.1.3","text_redistributed":false}


title: Statistical diversity distinguishes global states of consciousness
authors: Starkey J, Carhart-Harris RL, Pigorini A, Nobili L, Barrett AB.
journal: bioRxiv
publication_date: 2023-12-06
doi: 10.1101/2023.12.05.570101
source_url: https://doi.org/10.1101/2023.12.05.570101
source_record_id: DOI:10.1101/2023.12.05.570101
substance_tags: psilocybin
topic_tags: Consciousness,Drug Interactions
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2023.12.05.570101
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2023.12.05.570101","source_url":"https://doi.org/10.1101/2023.12.05.570101","doi":"10.1101/2023.12.05.570101","pmid":"","publication_date":"2023-12-06","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2024-05-25
source_url: https://osf.io/preprints/psyarxiv/y8sb7_v1
source_record_id: https://osf.io/preprints/psyarxiv/y8sb7_v1
substance_tags: psilocybin
topic_tags: Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/y8sb7_v1
text_rights_status: unverified_not_redistributed
title:
Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/y8sb7_v1","source_url":"https://osf.io/preprints/psyarxiv/y8sb7_v1","doi":"","pmid":"","publication_date":"2024-05-25","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2025-01-31
source_url: https://europepmc.org/article/PMC/PMC11814968
source_record_id: https://europepmc.org/article/PMC/PMC11814968
substance_tags: psilocybin
topic_tags: Mechanism of Action
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
text_rights_status: not_applicable_no_text
title:
PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11814968","source_url":"https://europepmc.org/article/PMC/PMC11814968","doi":"","pmid":"","publication_date":"2025-01-31","importer_version":"2.1.3","text_redistributed":false}


authors: Ahuja S, Zaher F, Palaniyappan L.
journal: Research Square
publication_date: 2024-07-09
doi: 10.21203/rs.3.rs-4534997/v1
source_url: https://doi.org/10.21203/rs.3.rs-4534997/v1
source_record_id: DOI:10.21203/rs.3.rs-4534997/v1
substance_tags: psilocybin
study_type: Meta-Analysis
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-4534997/v1
text_rights_status: unverified_not_redistributed
title:
Quantitative Natural Language Processing Markers of Psychoactive Drug Effects: A Pre-Registered Systematic Review

topic_tags:
Addiction,Pharmacology,Biomarkers,Emotional Processing,Meta-Analysis,Systematic Review,Review Article

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-4534997/v1","source_url":"https://doi.org/10.21203/rs.3.rs-4534997/v1","doi":"10.21203/rs.3.rs-4534997/v1","pmid":"","publication_date":"2024-07-09","importer_version":"2.1.3","text_redistributed":false}


title: Treating addiction with psychedelics - are we waking up?
authors: Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A.
publication_date: 2021-08-12
source_url: https://europepmc.org/article/PMC/PMC9480123
source_record_id: https://europepmc.org/article/PMC/PMC9480123
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9480123
text_rights_status: unverified_not_redistributed
topic_tags:
Addiction,Receptor Pharmacology,Mystical Experience,Review Article,Cancer Patients,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9480123","source_url":"https://europepmc.org/article/PMC/PMC9480123","doi":"","pmid":"","publication_date":"2021-08-12","importer_version":"2.1.3","text_redistributed":false}


title: Altered trajectories in the dynamical repertoire of functional network states under psilocybin
journal: bioRxiv
publication_date: 2018-07-24
doi: 10.1101/376491
source_url: https://doi.org/10.1101/376491
source_record_id: DOI:10.1101/376491
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness,Healthy Volunteers
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/376491
text_rights_status: unverified_not_redistributed
authors:
Lord L, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/376491","source_url":"https://doi.org/10.1101/376491","doi":"10.1101/376491","pmid":"","publication_date":"2018-07-24","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-06-29
source_url: https://osf.io/preprints/psyarxiv/8ncj6_v1
source_record_id: https://osf.io/preprints/psyarxiv/8ncj6_v1
substance_tags: psilocybin
topic_tags: Consciousness,Mystical Experience
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/8ncj6_v1
text_rights_status: unverified_not_redistributed
title:
Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/8ncj6_v1","source_url":"https://osf.io/preprints/psyarxiv/8ncj6_v1","doi":"","pmid":"","publication_date":"2023-06-29","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics for depression: from neurobiology to treatment
authors: Kuypers K.
publication_date: 2023-07-18
source_url: https://europepmc.org/article/PMC/PMC10417770
source_record_id: https://europepmc.org/article/PMC/PMC10417770
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC10417770
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC10417770","source_url":"https://europepmc.org/article/PMC/PMC10417770","doi":"","pmid":"","publication_date":"2023-07-18","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics Use and the Risk of Reduced Formal Mental Health Care
authors: Viña S.
journal: Research Square
publication_date: 2024-05-12
doi: 10.21203/rs.3.rs-4378944/v1
source_url: https://doi.org/10.21203/rs.3.rs-4378944/v1
source_record_id: DOI:10.21203/rs.3.rs-4378944/v1
substance_tags: psilocybin
topic_tags: Observational Study,Safety,Drug Interactions
study_type: Observational Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-4378944/v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-4378944/v1","source_url":"https://doi.org/10.21203/rs.3.rs-4378944/v1","doi":"10.21203/rs.3.rs-4378944/v1","pmid":"","publication_date":"2024-05-12","importer_version":"2.1.3","text_redistributed":false}


title: The entropic heart: Tracking the psychedelic state via heart rate dynamics
journal: bioRxiv
publication_date: 2023-11-08
doi: 10.1101/2023.11.07.566008
source_url: https://doi.org/10.1101/2023.11.07.566008
source_record_id: DOI:10.1101/2023.11.07.566008
substance_tags: psilocybin
topic_tags: Biomarkers
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2023.11.07.566008
text_rights_status: unverified_not_redistributed
authors:
Rosas FE, Mediano PA, Timmermann C, Luppi AI, Candia-Rivera D, Abbasi-Asl R, Gazzaley A, Kringelbach ML, Muthukumaraswamy S, Bor D, Garfinkel S, Carhart-Harris RL.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2023.11.07.566008","source_url":"https://doi.org/10.1101/2023.11.07.566008","doi":"10.1101/2023.11.07.566008","pmid":"","publication_date":"2023-11-08","importer_version":"2.1.3","text_redistributed":false}


title: Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy
authors: Strickland JC, Garcia-Romeu A, Johnson M.
journal: PsyArXiv
publication_date: 2020-12-28
doi: 10.31234/osf.io/f5dmt
source_url: https://doi.org/10.31234/osf.io/f5dmt
source_record_id: DOI:10.31234/osf.io/f5dmt
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,Mystical Experience
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/f5dmt
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/f5dmt","source_url":"https://doi.org/10.31234/osf.io/f5dmt","doi":"10.31234/osf.io/f5dmt","pmid":"","publication_date":"2020-12-28","importer_version":"2.1.3","text_redistributed":false}


journal: bioRxiv
publication_date: 2024-06-24
doi: 10.1101/2024.06.20.599885
source_url: https://doi.org/10.1101/2024.06.20.599885
source_record_id: DOI:10.1101/2024.06.20.599885
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.06.20.599885
text_rights_status: unverified_not_redistributed
title:
Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation

authors:
Van Maldegem M, Vohryzek J, Atasoy S, Alnagger N, Cardone P, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Kringelbach ML, Stamatakis EA, Luppi AI.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.06.20.599885","source_url":"https://doi.org/10.1101/2024.06.20.599885","doi":"10.1101/2024.06.20.599885","pmid":"","publication_date":"2024-06-24","importer_version":"2.1.3","text_redistributed":false}


title: Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst
journal: PsyArXiv
publication_date: 2023-01-03
source_url: https://osf.io/preprints/psyarxiv/f26ce_v1
source_record_id: https://osf.io/preprints/psyarxiv/f26ce_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Pharmacology,Personality Change,Systematic Review,Review Article
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/f26ce_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/f26ce_v1","source_url":"https://osf.io/preprints/psyarxiv/f26ce_v1","doi":"","pmid":"","publication_date":"2023-01-03","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2024-06-09
source_url: https://osf.io/preprints/psyarxiv/adnpg_v1
source_record_id: https://osf.io/preprints/psyarxiv/adnpg_v1
substance_tags: psilocybin
topic_tags: Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/adnpg_v1
text_rights_status: unverified_not_redistributed
title:
Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/adnpg_v1","source_url":"https://osf.io/preprints/psyarxiv/adnpg_v1","doi":"","pmid":"","publication_date":"2024-06-09","importer_version":"2.1.3","text_redistributed":false}


title: Is Microdosing a Placebo?
journal: PsyArXiv
publication_date: 2023-06-03
source_url: https://osf.io/preprints/psyarxiv/3ykst_v1
source_record_id: https://osf.io/preprints/psyarxiv/3ykst_v1
substance_tags: psilocybin
topic_tags: Microdosing,Personality Change
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/3ykst_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/3ykst_v1","source_url":"https://osf.io/preprints/psyarxiv/3ykst_v1","doi":"","pmid":"","publication_date":"2023-06-03","importer_version":"2.1.3","text_redistributed":false}


title: Is Microdosing a Placebo?
authors: Polito V, Liknaitzky P.
journal: PsyArXiv
publication_date: 2023-06-03
doi: 10.31234/osf.io/3ykst
source_url: https://doi.org/10.31234/osf.io/3ykst
source_record_id: DOI:10.31234/osf.io/3ykst
substance_tags: psilocybin
topic_tags: Microdosing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/3ykst
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/3ykst","source_url":"https://doi.org/10.31234/osf.io/3ykst","doi":"10.31234/osf.io/3ykst","pmid":"","publication_date":"2023-06-03","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-06-08
source_url: https://osf.io/preprints/psyarxiv/auycp_v1
source_record_id: https://osf.io/preprints/psyarxiv/auycp_v1
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/auycp_v1
text_rights_status: unverified_not_redistributed
title:
Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/auycp_v1","source_url":"https://osf.io/preprints/psyarxiv/auycp_v1","doi":"","pmid":"","publication_date":"2023-06-08","importer_version":"2.1.3","text_redistributed":false}


authors: Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB.
journal: PsyArXiv
publication_date: 2023-06-08
doi: 10.31234/osf.io/auycp_v1
source_url: https://doi.org/10.31234/osf.io/auycp_v1
source_record_id: DOI:10.31234/osf.io/auycp_v1
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/auycp_v1
text_rights_status: unverified_not_redistributed
title:
Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/auycp_v1","source_url":"https://doi.org/10.31234/osf.io/auycp_v1","doi":"10.31234/osf.io/auycp_v1","pmid":"","publication_date":"2023-06-08","importer_version":"2.1.3","text_redistributed":false}


title: Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine
journal: PsyArXiv
publication_date: 2022-11-14
source_url: https://osf.io/preprints/psyarxiv/r96tc_v1
source_record_id: https://osf.io/preprints/psyarxiv/r96tc_v1
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/r96tc_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/r96tc_v1","source_url":"https://osf.io/preprints/psyarxiv/r96tc_v1","doi":"","pmid":"","publication_date":"2022-11-14","importer_version":"2.1.3","text_redistributed":false}


authors: Husain M, Blumberger D, Castle D, Kloiber S, Ortiz A, Rosenblat J, Mulsant B.
publication_date: 2023-07-18
source_url: https://europepmc.org/article/PMC/PMC10660879
source_record_id: https://europepmc.org/article/PMC/PMC10660879
substance_tags: psilocybin
topic_tags: Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
text_rights_status: not_applicable_no_text
title:
A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC10660879","source_url":"https://europepmc.org/article/PMC/PMC10660879","doi":"","pmid":"","publication_date":"2023-07-18","importer_version":"2.1.3","text_redistributed":false}


title: Do undergraduates’ views of psychedelics relate to the context for psychedelic use?
authors: Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK.
journal: PsyArXiv
publication_date: 2024-04-23
doi: 10.31234/osf.io/xnu5c
source_url: https://doi.org/10.31234/osf.io/xnu5c
source_record_id: DOI:10.31234/osf.io/xnu5c
substance_tags: psilocybin
topic_tags: Microdosing,Observational Study,Safety
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/xnu5c
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/xnu5c","source_url":"https://doi.org/10.31234/osf.io/xnu5c","doi":"10.31234/osf.io/xnu5c","pmid":"","publication_date":"2024-04-23","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2024-07-27
source_url: https://osf.io/preprints/psyarxiv/tmeb3_v1
source_record_id: https://osf.io/preprints/psyarxiv/tmeb3_v1
substance_tags: psilocybin
topic_tags: Anxiety,Mechanism of Action,Aging,Personality Change,Veterans
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/tmeb3_v1
text_rights_status: unverified_not_redistributed
title:
Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/tmeb3_v1","source_url":"https://osf.io/preprints/psyarxiv/tmeb3_v1","doi":"","pmid":"","publication_date":"2024-07-27","importer_version":"2.1.3","text_redistributed":false}


title: Aesthetic Chills Mitigate Maladaptive Cognition In Depression
authors: Schoeller F, Jain A, Adrien V, Maes P, Reggente N.
journal: Research Square
publication_date: 2023-11-13
doi: 10.21203/rs.3.rs-3582420/v1
source_url: https://doi.org/10.21203/rs.3.rs-3582420/v1
source_record_id: DOI:10.21203/rs.3.rs-3582420/v1
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Consciousness,Emotional Processing,Safety
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-3582420/v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-3582420/v1","source_url":"https://doi.org/10.21203/rs.3.rs-3582420/v1","doi":"10.21203/rs.3.rs-3582420/v1","pmid":"","publication_date":"2023-11-13","importer_version":"2.1.3","text_redistributed":false}


title: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds
journal: PsyArXiv
publication_date: 2022-04-27
source_url: https://osf.io/preprints/psyarxiv/a25wb_v1
source_record_id: https://osf.io/preprints/psyarxiv/a25wb_v1
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/a25wb_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/a25wb_v1","source_url":"https://osf.io/preprints/psyarxiv/a25wb_v1","doi":"","pmid":"","publication_date":"2022-04-27","importer_version":"2.1.3","text_redistributed":false}


journal: bioRxiv
publication_date: 2024-04-21
doi: 10.1101/2024.04.19.590212
source_url: https://doi.org/10.1101/2024.04.19.590212
source_record_id: DOI:10.1101/2024.04.19.590212
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Clinical Trial,Animal Study
study_type: Clinical Trial
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2024.04.19.590212
text_rights_status: unverified_not_redistributed
title:
The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

authors:
Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2024.04.19.590212","source_url":"https://doi.org/10.1101/2024.04.19.590212","doi":"10.1101/2024.04.19.590212","pmid":"","publication_date":"2024-04-21","importer_version":"2.1.3","text_redistributed":false}


authors: Carter D, Reardon I, Swain J, Vando L.
journal: Research Square
publication_date: 2026-06-01
doi: 10.21203/rs.3.rs-9839240/v1
source_url: https://doi.org/10.21203/rs.3.rs-9839240/v1
source_record_id: DOI:10.21203/rs.3.rs-9839240/v1
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-9839240/v1
text_rights_status: unverified_not_redistributed
title:
Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults

topic_tags:
Depression,Chronic Pain,Emotional Processing,Randomized Controlled Trial,Observational Study,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-9839240/v1","source_url":"https://doi.org/10.21203/rs.3.rs-9839240/v1","doi":"10.21203/rs.3.rs-9839240/v1","pmid":"","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-06-03
source_url: https://osf.io/preprints/psyarxiv/45z7w_v1
source_record_id: https://osf.io/preprints/psyarxiv/45z7w_v1
substance_tags: psilocybin
topic_tags: Consciousness,Aging
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/45z7w_v1
text_rights_status: unverified_not_redistributed
title:
The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/45z7w_v1","source_url":"https://osf.io/preprints/psyarxiv/45z7w_v1","doi":"","pmid":"","publication_date":"2023-06-03","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-10-26
source_url: https://osf.io/preprints/psyarxiv/4gfyd_v1
source_record_id: https://osf.io/preprints/psyarxiv/4gfyd_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/4gfyd_v1
text_rights_status: unverified_not_redistributed
title:
A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/4gfyd_v1","source_url":"https://osf.io/preprints/psyarxiv/4gfyd_v1","doi":"","pmid":"","publication_date":"2023-10-26","importer_version":"2.1.3","text_redistributed":false}


authors: Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.
journal: PsyArXiv
publication_date: 2021-02-23
doi: 10.31234/osf.io/r726d
source_url: https://doi.org/10.31234/osf.io/r726d
source_record_id: DOI:10.31234/osf.io/r726d
substance_tags: psilocybin
topic_tags: Depression,Safety
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/r726d
text_rights_status: unverified_not_redistributed
title:
Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/r726d","source_url":"https://doi.org/10.31234/osf.io/r726d","doi":"10.31234/osf.io/r726d","pmid":"","publication_date":"2021-02-23","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and psychiatric disorders: A emerging role
authors: Peixoto C, Santos F, Rego D, Medeiros H.
publication_date: 2021-08-12
source_url: https://europepmc.org/article/PMC/PMC9470409
source_record_id: https://europepmc.org/article/PMC/PMC9470409
substance_tags: psilocybin
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9470409
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9470409","source_url":"https://europepmc.org/article/PMC/PMC9470409","doi":"","pmid":"","publication_date":"2021-08-12","importer_version":"2.1.3","text_redistributed":false}


journal: bioRxiv
publication_date: 2022-07-12
doi: 10.1101/2022.07.12.499688
source_url: https://doi.org/10.1101/2022.07.12.499688
source_record_id: DOI:10.1101/2022.07.12.499688
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Aging
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.07.12.499688
text_rights_status: unverified_not_redistributed
title:
Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

authors:
Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NL, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.07.12.499688","source_url":"https://doi.org/10.1101/2022.07.12.499688","doi":"10.1101/2022.07.12.499688","pmid":"","publication_date":"2022-07-12","importer_version":"2.1.3","text_redistributed":false}


title: Global species diversity and distribution of the psychedelic fungal genus Panaeolus
authors: Strauss D, Ghosh S, Murray Z, Gryzenhout M.
publication_date: 2023-05-31
source_url: https://europepmc.org/article/AGR/IND608043020
source_record_id: https://europepmc.org/article/AGR/IND608043020
substance_tags: psilocybin
topic_tags: Clinical Trial,Review Article
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/AGR/IND608043020
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/AGR/IND608043020","source_url":"https://europepmc.org/article/AGR/IND608043020","doi":"","pmid":"","publication_date":"2023-05-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)
journal: PsyArXiv
publication_date: 2021-03-23
source_url: https://osf.io/preprints/psyarxiv/8vks6_v1
source_record_id: https://osf.io/preprints/psyarxiv/8vks6_v1
substance_tags: psilocybin
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/8vks6_v1
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/8vks6_v1","source_url":"https://osf.io/preprints/psyarxiv/8vks6_v1","doi":"","pmid":"","publication_date":"2021-03-23","importer_version":"2.1.3","text_redistributed":false}


title: Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’
authors: McAlpine R, Blackburne G, Kamboj S.
journal: PsyArXiv
publication_date: 2023-04-27
doi: 10.31234/osf.io/gw9jp
source_url: https://doi.org/10.31234/osf.io/gw9jp
source_record_id: DOI:10.31234/osf.io/gw9jp
substance_tags: psilocybin
topic_tags: Wellbeing,Healthcare Workers
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:51
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/gw9jp
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/gw9jp","source_url":"https://doi.org/10.31234/osf.io/gw9jp","doi":"10.31234/osf.io/gw9jp","pmid":"","publication_date":"2023-04-27","importer_version":"2.1.3","text_redistributed":false}


journal: National Academies Press (US), Washington (DC)
publication_date: 2022-08-31
pubmed_id: 36049038
source_url: https://europepmc.org/article/MED/36049038
source_record_id: PMID:36049038
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Healthcare Workers,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/MED/36049038
text_rights_status: unverified_not_redistributed
title:
Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop

authors:
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36049038","source_url":"https://europepmc.org/article/MED/36049038","doi":"","pmid":"36049038","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


authors: Girala N.
publication_date: 2022-08-31
source_url: https://europepmc.org/article/PMC/PMC9567945
source_record_id: https://europepmc.org/article/PMC/PMC9567945
substance_tags: psilocybin
topic_tags: Depression,Addiction,Emotional Processing,Mystical Experience,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9567945
text_rights_status: unverified_not_redistributed
title:
Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9567945","source_url":"https://europepmc.org/article/PMC/PMC9567945","doi":"","pmid":"","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-04-01
source_url: https://osf.io/preprints/psyarxiv/kxmgq_v1
source_record_id: https://osf.io/preprints/psyarxiv/kxmgq_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Consciousness,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/kxmgq_v1
text_rights_status: unverified_not_redistributed
title:
Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/kxmgq_v1","source_url":"https://osf.io/preprints/psyarxiv/kxmgq_v1","doi":"","pmid":"","publication_date":"2021-04-01","importer_version":"2.1.3","text_redistributed":false}


title: Pharmacotherapy for the Secondary Prevention of Suicide: Leads from the Social Pain Hypothesis
authors: Rajkumar RP.
journal: Preprints.org
publication_date: 2022-07-04
doi: 10.20944/preprints202207.0064.v1
source_url: https://doi.org/10.20944/preprints202207.0064.v1
source_record_id: DOI:10.20944/preprints202207.0064.v1
substance_tags: psilocybin
topic_tags: Chronic Pain,Safety
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.20944/preprints202207.0064.v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202207.0064.v1","source_url":"https://doi.org/10.20944/preprints202207.0064.v1","doi":"10.20944/preprints202207.0064.v1","pmid":"","publication_date":"2022-07-04","importer_version":"2.1.3","text_redistributed":false}


authors: Brennan B, Kelman A, Belser AB.
journal: PsyArXiv
publication_date: 2023-07-17
doi: 10.31234/osf.io/2ab59
source_url: https://doi.org/10.31234/osf.io/2ab59
source_record_id: DOI:10.31234/osf.io/2ab59
substance_tags: psilocybin
topic_tags: Clinical Trial,Systematic Review,Review Article,Safety
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:05
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/2ab59
text_rights_status: unverified_not_redistributed
title:
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/2ab59","source_url":"https://doi.org/10.31234/osf.io/2ab59","doi":"10.31234/osf.io/2ab59","pmid":"","publication_date":"2023-07-17","importer_version":"2.1.3","text_redistributed":false}


title: Neuroimaging in psychedelic drug development: Past, present, and future
authors: Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D.
journal: PsyArXiv
publication_date: 2022-06-29
doi: 10.31234/osf.io/xwu4j
source_url: https://doi.org/10.31234/osf.io/xwu4j
source_record_id: DOI:10.31234/osf.io/xwu4j
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Aging
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/xwu4j
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/xwu4j","source_url":"https://doi.org/10.31234/osf.io/xwu4j","doi":"10.31234/osf.io/xwu4j","pmid":"","publication_date":"2022-06-29","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2023-07-18
source_url: https://europepmc.org/article/PMC/PMC10595939
source_record_id: https://europepmc.org/article/PMC/PMC10595939
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
text_rights_status: not_applicable_no_text
title:
Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression

authors:
Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC10595939","source_url":"https://europepmc.org/article/PMC/PMC10595939","doi":"","pmid":"","publication_date":"2023-07-18","importer_version":"2.1.3","text_redistributed":false}


authors: Rodrigues J, Nombora O, Ribeiro L.
publication_date: 2022-08-31
source_url: https://europepmc.org/article/PMC/PMC9567436
source_record_id: https://europepmc.org/article/PMC/PMC9567436
substance_tags: psilocybin
topic_tags: OCD,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Safety
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9567436
text_rights_status: unverified_not_redistributed
title:
Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9567436","source_url":"https://europepmc.org/article/PMC/PMC9567436","doi":"","pmid":"","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


authors: Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL.
journal: bioRxiv
publication_date: 2022-07-02
doi: 10.1101/2022.06.29.498015
source_url: https://doi.org/10.1101/2022.06.29.498015
source_record_id: DOI:10.1101/2022.06.29.498015
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Mechanism of Action
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.06.29.498015
text_rights_status: unverified_not_redistributed
title:
Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.06.29.498015","source_url":"https://doi.org/10.1101/2022.06.29.498015","doi":"10.1101/2022.06.29.498015","pmid":"","publication_date":"2022-07-02","importer_version":"2.1.3","text_redistributed":false}


authors: Chao YS, Horton J.
journal: Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)
publication_date: 2021-05-31
pubmed_id: 36170470
source_url: https://europepmc.org/article/MED/36170470
source_record_id: PMID:36170470
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/MED/36170470
text_rights_status: unverified_not_redistributed
title:
Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders

topic_tags:
Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36170470","source_url":"https://europepmc.org/article/MED/36170470","doi":"","pmid":"36170470","publication_date":"2021-05-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens
journal: bioRxiv
publication_date: 2018-07-23
doi: 10.1101/375105
source_url: https://doi.org/10.1101/375105
source_record_id: DOI:10.1101/375105
substance_tags: psilocybin
topic_tags: Mechanism of Action,Transcriptomics,Metabolomics
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/375105
text_rights_status: unverified_not_redistributed
authors:
Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT.

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/375105","source_url":"https://doi.org/10.1101/375105","doi":"10.1101/375105","pmid":"","publication_date":"2018-07-23","importer_version":"2.1.3","text_redistributed":false}


title: The treatment of abandonment anxiety with MDMA and LSD
journal: PsyArXiv
publication_date: 2023-06-08
source_url: https://osf.io/preprints/psyarxiv/pw2tf_v1
source_record_id: https://osf.io/preprints/psyarxiv/pw2tf_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/pw2tf_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/pw2tf_v1","source_url":"https://osf.io/preprints/psyarxiv/pw2tf_v1","doi":"","pmid":"","publication_date":"2023-06-08","importer_version":"2.1.3","text_redistributed":false}


title: Naturalistic Entheogenics: Précis of Philosophy of Psychedelics
journal: PsyArXiv
publication_date: 2021-07-07
source_url: https://osf.io/preprints/psyarxiv/ztewb_v1
source_record_id: https://osf.io/preprints/psyarxiv/ztewb_v1
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/ztewb_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/ztewb_v1","source_url":"https://osf.io/preprints/psyarxiv/ztewb_v1","doi":"","pmid":"","publication_date":"2021-07-07","importer_version":"2.1.3","text_redistributed":false}


title: Global Drug Survey
journal: PsyArXiv
publication_date: 2020-04-11
source_url: https://osf.io/preprints/psyarxiv/xb8ve_v1
source_record_id: https://osf.io/preprints/psyarxiv/xb8ve_v1
substance_tags: psilocybin
topic_tags: Microdosing,Creativity,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/xb8ve_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/xb8ve_v1","source_url":"https://osf.io/preprints/psyarxiv/xb8ve_v1","doi":"","pmid":"","publication_date":"2020-04-11","importer_version":"2.1.3","text_redistributed":false}


title: Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials
journal: PsyArXiv
publication_date: 2021-03-07
source_url: https://osf.io/preprints/psyarxiv/q2hzm_v1
source_record_id: https://osf.io/preprints/psyarxiv/q2hzm_v1
substance_tags: psilocybin
topic_tags: Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article
study_type: Randomized Controlled Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/q2hzm_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/q2hzm_v1","source_url":"https://osf.io/preprints/psyarxiv/q2hzm_v1","doi":"","pmid":"","publication_date":"2021-03-07","importer_version":"2.1.3","text_redistributed":false}


title: Predictors of Psychedelic Experience: A Thematic Analysis
authors: McCartney A, McGovern H, De Foe A.
journal: PsyArXiv
publication_date: 2021-12-20
doi: 10.31234/osf.io/5d7fc
source_url: https://doi.org/10.31234/osf.io/5d7fc
source_record_id: DOI:10.31234/osf.io/5d7fc
substance_tags: psilocybin
topic_tags: Mechanism of Action
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/5d7fc
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/5d7fc","source_url":"https://doi.org/10.31234/osf.io/5d7fc","doi":"10.31234/osf.io/5d7fc","pmid":"","publication_date":"2021-12-20","importer_version":"2.1.3","text_redistributed":false}


authors: Golden C.
journal: Imperial College London
publication_date: 2016-12-31
doi: 10.25560/45527
source_url: https://doi.org/10.25560/45527
source_record_id: DOI:10.25560/45527
substance_tags: psilocybin
topic_tags: Mechanism of Action,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.25560/45527
text_rights_status: unverified_not_redistributed
title:
Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.25560/45527","source_url":"https://doi.org/10.25560/45527","doi":"10.25560/45527","pmid":"","publication_date":"2016-12-31","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-05-04
source_url: https://osf.io/preprints/psyarxiv/2489x_v1
source_record_id: https://osf.io/preprints/psyarxiv/2489x_v1
substance_tags: psilocybin
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/2489x_v1
text_rights_status: unverified_not_redistributed
title:
New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review

topic_tags:
Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Wellbeing,Personality Change,Creativity,Review Article

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/2489x_v1","source_url":"https://osf.io/preprints/psyarxiv/2489x_v1","doi":"","pmid":"","publication_date":"2021-05-04","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis
journal: PsyArXiv
publication_date: 2021-10-10
source_url: https://osf.io/preprints/psyarxiv/yu7jf_v1
source_record_id: https://osf.io/preprints/psyarxiv/yu7jf_v1
substance_tags: psilocybin
topic_tags: Pharmacology,Meta-Analysis,Systematic Review,Review Article
study_type: Meta-Analysis
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/yu7jf_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/yu7jf_v1","source_url":"https://osf.io/preprints/psyarxiv/yu7jf_v1","doi":"","pmid":"","publication_date":"2021-10-10","importer_version":"2.1.3","text_redistributed":false}


title: Therapeutic interventions for PTSD - current evidence on the the role of psychedelics
authors: Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J.
publication_date: 2021-08-12
source_url: https://europepmc.org/article/PMC/PMC9475922
source_record_id: https://europepmc.org/article/PMC/PMC9475922
substance_tags: psilocybin
topic_tags: PTSD,Mechanism of Action,Review Article,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/PMC/PMC9475922
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC9475922","source_url":"https://europepmc.org/article/PMC/PMC9475922","doi":"","pmid":"","publication_date":"2021-08-12","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2020-08-06
source_url: https://osf.io/preprints/psyarxiv/b7mnz_v1
source_record_id: https://osf.io/preprints/psyarxiv/b7mnz_v1
substance_tags: psilocybin
topic_tags: PTSD,Addiction,Chronic Pain,Consciousness,Emotional Processing,Creativity,Mystical Experience
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/b7mnz_v1
text_rights_status: unverified_not_redistributed
title:
Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/b7mnz_v1","source_url":"https://osf.io/preprints/psyarxiv/b7mnz_v1","doi":"","pmid":"","publication_date":"2020-08-06","importer_version":"2.1.3","text_redistributed":false}


authors: Al-Matrouk A, Al-Hasan M, Naqi HA, Al-Abkal N, Mohammed H, Haider M, Al-Shammeri D, Bojbarah H.
journal: Research Square
publication_date: 2020-11-17
doi: 10.21203/rs.3.rs-33143/v2
source_url: https://doi.org/10.21203/rs.3.rs-33143/v2
source_record_id: DOI:10.21203/rs.3.rs-33143/v2
substance_tags: psilocin
topic_tags: Addiction,Review Article,Toxicity
study_type: Review Article
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-33143/v2
text_rights_status: unverified_not_redistributed
title:
Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-33143/v2","source_url":"https://doi.org/10.21203/rs.3.rs-33143/v2","doi":"10.21203/rs.3.rs-33143/v2","pmid":"","publication_date":"2020-11-17","importer_version":"2.1.3","text_redistributed":false}


authors: Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD.
journal: bioRxiv
publication_date: 2022-05-23
doi: 10.1101/2022.05.20.492842
source_url: https://doi.org/10.1101/2022.05.20.492842
source_record_id: DOI:10.1101/2022.05.20.492842
substance_tags: psilocybin
topic_tags: Pharmacology,Mechanism of Action,Consciousness,Systematic Review,Review Article
study_type: Systematic Review
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/2022.05.20.492842
text_rights_status: unverified_not_redistributed
title:
Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory

source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/2022.05.20.492842","source_url":"https://doi.org/10.1101/2022.05.20.492842","doi":"10.1101/2022.05.20.492842","pmid":"","publication_date":"2022-05-23","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-05-30
source_url: https://osf.io/preprints/psyarxiv/8aeyf_v1
source_record_id: https://osf.io/preprints/psyarxiv/8aeyf_v1
substance_tags: psilocybin
topic_tags: Consciousness,Wellbeing,Personality Change,Spirituality,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/8aeyf_v1
text_rights_status: unverified_not_redistributed
title:
Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/8aeyf_v1","source_url":"https://osf.io/preprints/psyarxiv/8aeyf_v1","doi":"","pmid":"","publication_date":"2021-05-30","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-06-09
doi: 10.31234/osf.io/64kyg
source_url: https://doi.org/10.31234/osf.io/64kyg
source_record_id: DOI:10.31234/osf.io/64kyg
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/64kyg
text_rights_status: unverified_not_redistributed
title:
Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses

authors:
McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/64kyg","source_url":"https://doi.org/10.31234/osf.io/64kyg","doi":"10.31234/osf.io/64kyg","pmid":"","publication_date":"2021-06-09","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-06-13
source_url: https://osf.io/preprints/psyarxiv/emcxw_v1
source_record_id: https://osf.io/preprints/psyarxiv/emcxw_v1
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Microdosing,Creativity
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/emcxw_v1
text_rights_status: unverified_not_redistributed
title:
Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/emcxw_v1","source_url":"https://osf.io/preprints/psyarxiv/emcxw_v1","doi":"","pmid":"","publication_date":"2021-06-13","importer_version":"2.1.3","text_redistributed":false}


title: A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
authors: Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL.
journal: PsyArXiv
publication_date: 2020-10-27
doi: 10.31234/osf.io/nhbjk
source_url: https://doi.org/10.31234/osf.io/nhbjk
source_record_id: DOI:10.31234/osf.io/nhbjk
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis
study_type: Meta-Analysis
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/nhbjk
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/nhbjk","source_url":"https://doi.org/10.31234/osf.io/nhbjk","doi":"10.31234/osf.io/nhbjk","pmid":"","publication_date":"2020-10-27","importer_version":"2.1.3","text_redistributed":false}


authors: Siegel V, Emmert-Aronson B.
journal: F1000Res
publication_date: 2021-07-21
doi: 10.12688/f1000research.53496.1
source_url: https://doi.org/10.12688/f1000research.53496.1
source_record_id: DOI:10.12688/f1000research.53496.1
substance_tags: psilocybin
topic_tags: Spirituality,Mystical Experience
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.12688/f1000research.53496.1
text_rights_status: unverified_not_redistributed
title:
Both partners practicing orgasmic meditation report having a mystical-type experience: results using the Mystical Experience Questionnaire

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.12688/f1000research.53496.1","source_url":"https://doi.org/10.12688/f1000research.53496.1","doi":"10.12688/f1000research.53496.1","pmid":"","publication_date":"2021-07-21","importer_version":"2.1.3","text_redistributed":false}


title: A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
authors: Luoma JB.
journal: PsyArXiv
publication_date: 2020-06-11
doi: 10.31234/osf.io/sgujx
source_url: https://doi.org/10.31234/osf.io/sgujx
source_record_id: DOI:10.31234/osf.io/sgujx
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis
study_type: Meta-Analysis
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/sgujx
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/sgujx","source_url":"https://doi.org/10.31234/osf.io/sgujx","doi":"10.31234/osf.io/sgujx","pmid":"","publication_date":"2020-06-11","importer_version":"2.1.3","text_redistributed":false}


title: Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers
authors: Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS.
journal: PsyArXiv
publication_date: 2018-11-01
doi: 10.31234/osf.io/gk4jd
source_url: https://doi.org/10.31234/osf.io/gk4jd
source_record_id: DOI:10.31234/osf.io/gk4jd
substance_tags: psilocybin
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/gk4jd
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/gk4jd","source_url":"https://doi.org/10.31234/osf.io/gk4jd","doi":"10.31234/osf.io/gk4jd","pmid":"","publication_date":"2018-11-01","importer_version":"2.1.3","text_redistributed":false}


title: Decreased Directed Functional Connectivity in the Psychedelic State
authors: Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK.
journal: bioRxiv
publication_date: 2019-07-15
doi: 10.1101/703660
source_url: https://doi.org/10.1101/703660
source_record_id: DOI:10.1101/703660
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Aging
study_type: Other
source_name: bioRxiv
publication_status: preprint
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: bioRxiv
abstract_source_url: https://doi.org/10.1101/703660
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"bioRxiv","source_record_id":"DOI:10.1101/703660","source_url":"https://doi.org/10.1101/703660","doi":"10.1101/703660","pmid":"","publication_date":"2019-07-15","importer_version":"2.1.3","text_redistributed":false}


title: Towards a molecular approach for the identification of fungal taxa that contain psilocybin
authors: Lee JC.
journal: University of Strathclyde
publication_date: 2000-12-31
doi: 10.48730/zty1-g223
source_url: https://doi.org/10.48730/zty1-g223
source_record_id: DOI:10.48730/zty1-g223
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.48730/zty1-g223
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.48730/zty1-g223","source_url":"https://doi.org/10.48730/zty1-g223","doi":"10.48730/zty1-g223","pmid":"","publication_date":"2000-12-31","importer_version":"2.1.3","text_redistributed":false}


title: PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report
authors: Palenicek T, Tyls F, Viktorinova M, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J.
publication_date: 2016-05-26
source_url: https://europepmc.org/article/PMC/PMC5616436
source_record_id: https://europepmc.org/article/PMC/PMC5616436
substance_tags: psilocybin
topic_tags: Brain Imaging,Healthy Volunteers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC5616436","source_url":"https://europepmc.org/article/PMC/PMC5616436","doi":"","pmid":"","publication_date":"2016-05-26","importer_version":"2.1.3","text_redistributed":false}


authors: Lord L.
journal: University of Oxford
publication_date: 2017-12-31
source_url: https://europepmc.org/article/ETH/770691
source_record_id: https://europepmc.org/article/ETH/770691
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:52
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/ETH/770691
text_rights_status: unverified_not_redistributed
title:
Integration and segregation in whole-brain networks: implications for altered states of consciousness

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/ETH/770691","source_url":"https://europepmc.org/article/ETH/770691","doi":"","pmid":"","publication_date":"2017-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J.
publication_date: 2016-05-26
source_url: https://europepmc.org/article/PMC/PMC5616440
source_record_id: https://europepmc.org/article/PMC/PMC5616440
substance_tags: psilocybin
topic_tags: Brain Imaging,Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:06
text_rights_status: not_applicable_no_text
title:
PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC5616440","source_url":"https://europepmc.org/article/PMC/PMC5616440","doi":"","pmid":"","publication_date":"2016-05-26","importer_version":"2.1.3","text_redistributed":false}


title: METHOD FOR DETECTING IMMUNOCHROMATOGRAPHY OF PSILOCIN BY COMPETITION METHOD, AND TEST KIT
authors: NANBA YASUHARU, MOCHIZUKI TAKESHI, OZAKI KEIKO, HOJO HIROSHI, YAMAGUCHI MITSUMINE.
publication_date: 2003-07-10
source_url: https://europepmc.org/article/PAT/JP2005031029
source_record_id: https://europepmc.org/article/PAT/JP2005031029
substance_tags: psilocin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PAT/JP2005031029","source_url":"https://europepmc.org/article/PAT/JP2005031029","doi":"","pmid":"","publication_date":"2003-07-10","importer_version":"2.1.3","text_redistributed":false}


title: [Polymorphe forms of psilocine and psilocybine].
authors: Kuhnert-Brandstätter M, Heindl W.
publication_date: 1976-07-31
doi: 10.1002/ardp.19763090804
pubmed_id: 971051
source_url: https://doi.org/10.1002/ardp.19763090804
source_record_id: PMID:971051
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:971051","source_url":"https://doi.org/10.1002/ardp.19763090804","doi":"10.1002/ardp.19763090804","pmid":"971051","publication_date":"1976-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Study on the biological characteristics and cultivation of panaeolus bisporus
authors: He Xinsheng.
publication_date: 2004-12-31
source_url: https://europepmc.org/article/CBA/602890
source_record_id: https://europepmc.org/article/CBA/602890
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/CBA/602890
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/CBA/602890","source_url":"https://europepmc.org/article/CBA/602890","doi":"","pmid":"","publication_date":"2004-12-31","importer_version":"2.1.3","text_redistributed":false}


title: [A caution for psilocybine in wild mushrooms. A young addict acquired acute delirium].
authors: Bergman B, Karlsson AC.
publication_date: 1995-09-30
pubmed_id: 7564628
source_url: https://europepmc.org/article/MED/7564628
source_record_id: PMID:7564628
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:7564628","source_url":"https://europepmc.org/article/MED/7564628","doi":"","pmid":"7564628","publication_date":"1995-09-30","importer_version":"2.1.3","text_redistributed":false}


title: [Chromosome defects in patients treated with Psilocybine].
authors: Eberle P, Leuner H.
publication_date: 1969-12-31
doi: 10.1007/bf00286993
pubmed_id: 5449943
source_url: https://doi.org/10.1007/bf00286993
source_record_id: PMID:5449943
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:5449943","source_url":"https://doi.org/10.1007/bf00286993","doi":"10.1007/bf00286993","pmid":"5449943","publication_date":"1969-12-31","importer_version":"2.1.3","text_redistributed":false}


title: [Psilocybine induced changes in extraoptical perception].
authors: Dubanský B, Vyhnánsková M, Setlík L.
publication_date: 1967-10-31
pubmed_id: 5612948
source_url: https://europepmc.org/article/MED/5612948
source_record_id: PMID:5612948
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:5612948","source_url":"https://europepmc.org/article/MED/5612948","doi":"","pmid":"5612948","publication_date":"1967-10-31","importer_version":"2.1.3","text_redistributed":false}


title: [The association of proprioceptive sensations and neurologic symptoms after psilocybine].
authors: Dubanský B, Vyhnánková M, Setlík L.
publication_date: 1967-10-31
pubmed_id: 5612947
source_url: https://europepmc.org/article/MED/5612947
source_record_id: PMID:5612947
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:5612947","source_url":"https://europepmc.org/article/MED/5612947","doi":"","pmid":"5612947","publication_date":"1967-10-31","importer_version":"2.1.3","text_redistributed":false}


authors: Dubanský B, Vyhmánková M.
publication_date: 1967-10-31
pubmed_id: 5612963
source_url: https://europepmc.org/article/MED/5612963
source_record_id: PMID:5612963
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:03:53
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
title:
[Psilocybine in brain injured subjects and its different effects in relation to the localization of the lesion].

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:5612963","source_url":"https://europepmc.org/article/MED/5612963","doi":"","pmid":"5612963","publication_date":"1967-10-31","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2026-03-10
doi: 10.1080/02791072.2025.2454474.
source_url: https://osf.io/preprints/psyarxiv/4jm2n_v1
source_record_id: DOI:10.1080/02791072.2025.2454474.
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality,Review Article,Observational Study
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:04:23
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/4jm2n_v1
text_rights_status: unverified_not_redistributed
title:
Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.1080/02791072.2025.2454474.","source_url":"https://osf.io/preprints/psyarxiv/4jm2n_v1","doi":"10.1080/02791072.2025.2454474.","pmid":"","publication_date":"2026-03-10","importer_version":"2.1.3","text_redistributed":false}


title: Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network
journal: PsyArXiv
publication_date: 2021-05-18
doi: 10.1037/pne0000290
source_url: https://osf.io/preprints/psyarxiv/q3ymd_v1
source_record_id: DOI:10.1037/pne0000290
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Clinical Trial,Drug Interactions
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:04:24
last_checked: 2026-07-04 07:00:37
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/q3ymd_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.1037/pne0000290","source_url":"https://osf.io/preprints/psyarxiv/q3ymd_v1","doi":"10.1037/pne0000290","pmid":"","publication_date":"2021-05-18","importer_version":"2.1.3","text_redistributed":false}


title: Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
journal: PsyArXiv
publication_date: 2025-03-28
doi: 10.1093/schbul/sbaf068
source_url: https://osf.io/preprints/psyarxiv/7x8q4_v2
source_record_id: DOI:10.1093/schbul/sbaf068
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Animal Study
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:04:24
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/7x8q4_v2
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.1093/schbul/sbaf068","source_url":"https://osf.io/preprints/psyarxiv/7x8q4_v2","doi":"10.1093/schbul/sbaf068","pmid":"","publication_date":"2025-03-28","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2023-07-17
doi: 10.1089/psymed.2023.00071
source_url: https://osf.io/preprints/psyarxiv/2ab59_v1
source_record_id: DOI:10.1089/psymed.2023.00071
substance_tags: psilocybin
topic_tags: Clinical Trial,Systematic Review,Review Article,Safety
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:04:24
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/2ab59_v1
text_rights_status: unverified_not_redistributed
title:
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.1089/psymed.2023.00071","source_url":"https://osf.io/preprints/psyarxiv/2ab59_v1","doi":"10.1089/psymed.2023.00071","pmid":"","publication_date":"2023-07-17","importer_version":"2.1.3","text_redistributed":false}


title: Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial
journal: PsyArXiv
publication_date: 2022-10-18
source_url: https://osf.io/preprints/psyarxiv/s4qhf_v1
source_record_id: https://osf.io/preprints/psyarxiv/s4qhf_v1
substance_tags: psilocybin
topic_tags: Microdosing,Wellbeing,Creativity
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:04:24
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/s4qhf_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/s4qhf_v1","source_url":"https://osf.io/preprints/psyarxiv/s4qhf_v1","doi":"","pmid":"","publication_date":"2022-10-18","importer_version":"2.1.3","text_redistributed":false}


authors: King's College London
journal: ClinicalTrials.gov
publication_date: 2025-07-27
source_url: https://clinicaltrials.gov/study/NCT05651126
source_record_id: https://clinicaltrials.gov/study/NCT05651126
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05651126
text_rights_status: unverified_not_redistributed
title:
Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05651126","source_url":"https://clinicaltrials.gov/study/NCT05651126","doi":"","pmid":"","publication_date":"2025-07-27","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-02-12
source_url: https://clinicaltrials.gov/study/NCT07053917
source_record_id: https://clinicaltrials.gov/study/NCT07053917
substance_tags: psilocybin
topic_tags: Clinical Trial,Animal Study,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07053917
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07053917","source_url":"https://clinicaltrials.gov/study/NCT07053917","doi":"","pmid":"","publication_date":"2026-02-12","importer_version":"2.1.3","text_redistributed":false}


authors: Queen's University
journal: ClinicalTrials.gov
publication_date: 2025-05-12
source_url: https://clinicaltrials.gov/study/NCT06969170
source_record_id: https://clinicaltrials.gov/study/NCT06969170
substance_tags: psilocybin
topic_tags: Anxiety,Brain Imaging,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06969170
text_rights_status: unverified_not_redistributed
title:
A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06969170","source_url":"https://clinicaltrials.gov/study/NCT06969170","doi":"","pmid":"","publication_date":"2025-05-12","importer_version":"2.1.3","text_redistributed":false}


title: Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase
authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2025-05-15
source_url: https://clinicaltrials.gov/study/NCT05592379
source_record_id: https://clinicaltrials.gov/study/NCT05592379
substance_tags: psilocybin
topic_tags: Consciousness,Wellbeing
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05592379
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05592379","source_url":"https://clinicaltrials.gov/study/NCT05592379","doi":"","pmid":"","publication_date":"2025-05-15","importer_version":"2.1.3","text_redistributed":false}


authors: Clairvoyant Therapeutics
journal: ClinicalTrials.gov
publication_date: 2024-08-14
source_url: https://clinicaltrials.gov/study/NCT05646303
source_record_id: https://clinicaltrials.gov/study/NCT05646303
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05646303
text_rights_status: unverified_not_redistributed
title:
A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05646303","source_url":"https://clinicaltrials.gov/study/NCT05646303","doi":"","pmid":"","publication_date":"2024-08-14","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients
authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2020-10-19
source_url: https://clinicaltrials.gov/study/NCT00957359
source_record_id: https://clinicaltrials.gov/study/NCT00957359
substance_tags: psilocybin
study_type: Review Article
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT00957359
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Review Article,Cancer Patients,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT00957359","source_url":"https://clinicaltrials.gov/study/NCT00957359","doi":"","pmid":"","publication_date":"2020-10-19","importer_version":"2.1.3","text_redistributed":false}


authors: University of Utah
journal: ClinicalTrials.gov
publication_date: 2024-11-11
source_url: https://clinicaltrials.gov/study/NCT05557643
source_record_id: https://clinicaltrials.gov/study/NCT05557643
substance_tags: psilocybin
topic_tags: Depression
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05557643
text_rights_status: unverified_not_redistributed
title:
PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05557643","source_url":"https://clinicaltrials.gov/study/NCT05557643","doi":"","pmid":"","publication_date":"2024-11-11","importer_version":"2.1.3","text_redistributed":false}


authors: University of Pennsylvania
journal: ClinicalTrials.gov
publication_date: 2026-07-08
source_url: https://clinicaltrials.gov/study/NCT06810310
source_record_id: https://clinicaltrials.gov/study/NCT06810310
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Mechanism of Action
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-15 01:27:00
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06810310
text_rights_status: unverified_not_redistributed
title:
Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06810310","source_url":"https://clinicaltrials.gov/study/NCT06810310","doi":"","pmid":"","publication_date":"2026-07-08","importer_version":"2.1.3","text_redistributed":false}


authors: University of California, Berkeley
journal: ClinicalTrials.gov
publication_date: 2026-07-09
source_url: https://clinicaltrials.gov/study/NCT05265546
source_record_id: https://clinicaltrials.gov/study/NCT05265546
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-16 01:24:50
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05265546
text_rights_status: unverified_not_redistributed
title:
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05265546","source_url":"https://clinicaltrials.gov/study/NCT05265546","doi":"","pmid":"","publication_date":"2026-07-09","importer_version":"2.1.3","text_redistributed":false}


authors: Optimi Health Corporation
journal: ClinicalTrials.gov
publication_date: 2023-03-19
source_url: https://clinicaltrials.gov/study/NCT05252598
source_record_id: https://clinicaltrials.gov/study/NCT05252598
substance_tags: psilocybin,psilocin
topic_tags: Depression,Anxiety,Microdosing,Wellbeing,Safety,Toxicity
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05252598
text_rights_status: unverified_not_redistributed
title:
Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05252598","source_url":"https://clinicaltrials.gov/study/NCT05252598","doi":"","pmid":"","publication_date":"2023-03-19","importer_version":"2.1.3","text_redistributed":false}


authors: Section for Affective Disorders; Northern Stockholm Psychiatry
journal: ClinicalTrials.gov
publication_date: 2024-04-18
source_url: https://clinicaltrials.gov/study/NCT04630964
source_record_id: https://clinicaltrials.gov/study/NCT04630964
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04630964
text_rights_status: unverified_not_redistributed
title:
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04630964","source_url":"https://clinicaltrials.gov/study/NCT04630964","doi":"","pmid":"","publication_date":"2024-04-18","importer_version":"2.1.3","text_redistributed":false}


title: The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.
authors: Maastricht University
journal: ClinicalTrials.gov
publication_date: 2025-09-14
source_url: https://clinicaltrials.gov/study/NCT06368492
source_record_id: https://clinicaltrials.gov/study/NCT06368492
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06368492
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,Chronic Pain,Headache / Migraine,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06368492","source_url":"https://clinicaltrials.gov/study/NCT06368492","doi":"","pmid":"","publication_date":"2025-09-14","importer_version":"2.1.3","text_redistributed":false}


authors: University of Colorado, Denver
journal: ClinicalTrials.gov
publication_date: 2026-04-20
source_url: https://clinicaltrials.gov/study/NCT06430541
source_record_id: https://clinicaltrials.gov/study/NCT06430541
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Observational Study
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06430541
text_rights_status: unverified_not_redistributed
title:
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06430541","source_url":"https://clinicaltrials.gov/study/NCT06430541","doi":"","pmid":"","publication_date":"2026-04-20","importer_version":"2.1.3","text_redistributed":false}


authors: Yvan Beaussant, MD, MSci
journal: ClinicalTrials.gov
publication_date: 2025-12-15
source_url: https://clinicaltrials.gov/study/NCT06001749
source_record_id: https://clinicaltrials.gov/study/NCT06001749
substance_tags: psilocybin
topic_tags: Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06001749
text_rights_status: unverified_not_redistributed
title:
Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06001749","source_url":"https://clinicaltrials.gov/study/NCT06001749","doi":"","pmid":"","publication_date":"2025-12-15","importer_version":"2.1.3","text_redistributed":false}


authors: Brugmann University Hospital
journal: ClinicalTrials.gov
publication_date: 2024-08-06
source_url: https://clinicaltrials.gov/study/NCT06160232
source_record_id: https://clinicaltrials.gov/study/NCT06160232
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06160232
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06160232","source_url":"https://clinicaltrials.gov/study/NCT06160232","doi":"","pmid":"","publication_date":"2024-08-06","importer_version":"2.1.3","text_redistributed":false}


authors: Gabriella Gobbi
journal: ClinicalTrials.gov
publication_date: 2026-02-24
source_url: https://clinicaltrials.gov/study/NCT07433452
source_record_id: https://clinicaltrials.gov/study/NCT07433452
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Receptor Pharmacology,Biomarkers,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07433452
text_rights_status: unverified_not_redistributed
title:
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07433452","source_url":"https://clinicaltrials.gov/study/NCT07433452","doi":"","pmid":"","publication_date":"2026-02-24","importer_version":"2.1.3","text_redistributed":false}


authors: Brigham and Women's Hospital
journal: ClinicalTrials.gov
publication_date: 2026-06-14
source_url: https://clinicaltrials.gov/study/NCT07296094
source_record_id: https://clinicaltrials.gov/study/NCT07296094
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07296094
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial

topic_tags:
Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07296094","source_url":"https://clinicaltrials.gov/study/NCT07296094","doi":"","pmid":"","publication_date":"2026-06-14","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2021-04-26
source_url: https://clinicaltrials.gov/study/NCT03604744
source_record_id: https://clinicaltrials.gov/study/NCT03604744
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Receptor Pharmacology,Consciousness,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03604744
text_rights_status: unverified_not_redistributed
title:
Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03604744","source_url":"https://clinicaltrials.gov/study/NCT03604744","doi":"","pmid":"","publication_date":"2021-04-26","importer_version":"2.1.3","text_redistributed":false}


title: A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2022-11-07
source_url: https://clinicaltrials.gov/study/NCT02061293
source_record_id: https://clinicaltrials.gov/study/NCT02061293
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Spirituality,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02061293
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02061293","source_url":"https://clinicaltrials.gov/study/NCT02061293","doi":"","pmid":"","publication_date":"2022-11-07","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
authors: Peggy C Nopoulos
journal: ClinicalTrials.gov
publication_date: 2025-11-16
source_url: https://clinicaltrials.gov/study/NCT05421065
source_record_id: https://clinicaltrials.gov/study/NCT05421065
substance_tags: psilocybin
topic_tags: Addiction
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05421065
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05421065","source_url":"https://clinicaltrials.gov/study/NCT05421065","doi":"","pmid":"","publication_date":"2025-11-16","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin vs Ketamine for Alcohol Use Disorder
authors: University of Iowa
journal: ClinicalTrials.gov
publication_date: 2025-11-27
source_url: https://clinicaltrials.gov/study/NCT06405607
source_record_id: https://clinicaltrials.gov/study/NCT06405607
substance_tags: psilocybin
topic_tags: Addiction
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06405607
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06405607","source_url":"https://clinicaltrials.gov/study/NCT06405607","doi":"","pmid":"","publication_date":"2025-11-27","importer_version":"2.1.3","text_redistributed":false}


authors: University of Sydney
journal: ClinicalTrials.gov
publication_date: 2024-06-09
source_url: https://clinicaltrials.gov/study/NCT06444243
source_record_id: https://clinicaltrials.gov/study/NCT06444243
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06444243
text_rights_status: unverified_not_redistributed
title:
A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06444243","source_url":"https://clinicaltrials.gov/study/NCT06444243","doi":"","pmid":"","publication_date":"2024-06-09","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-assisted Interpersonal Therapy for Depression
authors: University of Otago
journal: ClinicalTrials.gov
publication_date: 2025-04-08
source_url: https://clinicaltrials.gov/study/NCT05581797
source_record_id: https://clinicaltrials.gov/study/NCT05581797
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05581797
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05581797","source_url":"https://clinicaltrials.gov/study/NCT05581797","doi":"","pmid":"","publication_date":"2025-04-08","importer_version":"2.1.3","text_redistributed":false}


authors: Medical University of Vienna
journal: ClinicalTrials.gov
publication_date: 2026-03-23
source_url: https://clinicaltrials.gov/study/NCT07490353
source_record_id: https://clinicaltrials.gov/study/NCT07490353
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07490353
text_rights_status: unverified_not_redistributed
title:
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial

topic_tags:
Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Wellbeing,Clinical Trial,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07490353","source_url":"https://clinicaltrials.gov/study/NCT07490353","doi":"","pmid":"","publication_date":"2026-03-23","importer_version":"2.1.3","text_redistributed":false}


title: Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
authors: University of Zurich
journal: ClinicalTrials.gov
publication_date: 2020-11-03
source_url: https://clinicaltrials.gov/study/NCT03736980
source_record_id: https://clinicaltrials.gov/study/NCT03736980
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Aging,Mystical Experience,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03736980
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03736980","source_url":"https://clinicaltrials.gov/study/NCT03736980","doi":"","pmid":"","publication_date":"2020-11-03","importer_version":"2.1.3","text_redistributed":false}


authors: Cybin Therapeutics Inc.
journal: ClinicalTrials.gov
publication_date: 2023-07-05
source_url: https://clinicaltrials.gov/study/NCT05594667
source_record_id: https://clinicaltrials.gov/study/NCT05594667
substance_tags: psilocybin
topic_tags: Depression,Receptor Pharmacology
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05594667
text_rights_status: unverified_not_redistributed
title:
Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05594667","source_url":"https://clinicaltrials.gov/study/NCT05594667","doi":"","pmid":"","publication_date":"2023-07-05","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for the Treatment of Major Depressive Disorder
authors: Washington University School of Medicine
journal: ClinicalTrials.gov
publication_date: 2024-07-24
source_url: https://clinicaltrials.gov/study/NCT05675800
source_record_id: https://clinicaltrials.gov/study/NCT05675800
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05675800
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05675800","source_url":"https://clinicaltrials.gov/study/NCT05675800","doi":"","pmid":"","publication_date":"2024-07-24","importer_version":"2.1.3","text_redistributed":false}


title: Pharmacokinetics of Psilocybin in Normal Adult Volunteers
authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2020-04-14
source_url: https://clinicaltrials.gov/study/NCT02163707
source_record_id: https://clinicaltrials.gov/study/NCT02163707
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02163707
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02163707","source_url":"https://clinicaltrials.gov/study/NCT02163707","doi":"","pmid":"","publication_date":"2020-04-14","importer_version":"2.1.3","text_redistributed":false}


authors: Jennifer Mitchell
journal: ClinicalTrials.gov
publication_date: 2026-06-07
source_url: https://clinicaltrials.gov/study/NCT07386730
source_record_id: https://clinicaltrials.gov/study/NCT07386730
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07386730
text_rights_status: unverified_not_redistributed
title:
A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease

topic_tags:
Brain Imaging,Mechanism of Action,Biomarkers,Aging,Wellbeing,Animal Study,Healthy Volunteers,Older Adults,Safety,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07386730","source_url":"https://clinicaltrials.gov/study/NCT07386730","doi":"","pmid":"","publication_date":"2026-06-07","importer_version":"2.1.3","text_redistributed":false}


authors: University Health Network, Toronto
journal: ClinicalTrials.gov
publication_date: 2024-10-17
source_url: https://clinicaltrials.gov/study/NCT06506019
source_record_id: https://clinicaltrials.gov/study/NCT06506019
substance_tags: psilocybin,psilocin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06506019
text_rights_status: unverified_not_redistributed
title:
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study

topic_tags:
Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06506019","source_url":"https://clinicaltrials.gov/study/NCT06506019","doi":"","pmid":"","publication_date":"2024-10-17","importer_version":"2.1.3","text_redistributed":false}


authors: Beersheva Mental Health Center
journal: ClinicalTrials.gov
publication_date: 2025-11-18
source_url: https://clinicaltrials.gov/study/NCT04882839
source_record_id: https://clinicaltrials.gov/study/NCT04882839
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04882839
text_rights_status: unverified_not_redistributed
title:
Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.

topic_tags:
Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04882839","source_url":"https://clinicaltrials.gov/study/NCT04882839","doi":"","pmid":"","publication_date":"2025-11-18","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
authors: Oregon Health and Science University
journal: ClinicalTrials.gov
publication_date: 2025-10-09
source_url: https://clinicaltrials.gov/study/NCT06988319
source_record_id: https://clinicaltrials.gov/study/NCT06988319
substance_tags: psilocybin
topic_tags: Chronic Pain,Safety,Adverse Events
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06988319
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06988319","source_url":"https://clinicaltrials.gov/study/NCT06988319","doi":"","pmid":"","publication_date":"2025-10-09","importer_version":"2.1.3","text_redistributed":false}


authors: Anders Fink-Jensen, MD, DMSci
journal: ClinicalTrials.gov
publication_date: 2026-03-23
source_url: https://clinicaltrials.gov/study/NCT05416229
source_record_id: https://clinicaltrials.gov/study/NCT05416229
substance_tags: psilocybin,psilocin
topic_tags: Addiction,Brain Imaging,Biomarkers,Aging,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05416229
text_rights_status: unverified_not_redistributed
title:
The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05416229","source_url":"https://clinicaltrials.gov/study/NCT05416229","doi":"","pmid":"","publication_date":"2026-03-23","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin in Alcohol Use Disorder With Comorbid Depression
authors: Centre Hospitalier Universitaire de Nīmes
journal: ClinicalTrials.gov
publication_date: 2025-03-18
source_url: https://clinicaltrials.gov/study/NCT06235411
source_record_id: https://clinicaltrials.gov/study/NCT06235411
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06235411
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06235411","source_url":"https://clinicaltrials.gov/study/NCT06235411","doi":"","pmid":"","publication_date":"2025-03-18","importer_version":"2.1.3","text_redistributed":false}


title: Study of Psilocybin for Anorexia in Young Adults
authors: Marissa Raymond-Flesch, MD, MPH
journal: ClinicalTrials.gov
publication_date: 2026-03-02
source_url: https://clinicaltrials.gov/study/NCT06399263
source_record_id: https://clinicaltrials.gov/study/NCT06399263
substance_tags: psilocybin
topic_tags: Eating Disorders
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06399263
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06399263","source_url":"https://clinicaltrials.gov/study/NCT06399263","doi":"","pmid":"","publication_date":"2026-03-02","importer_version":"2.1.3","text_redistributed":false}


title: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
authors: Maryland Oncology Hematology, PA
journal: ClinicalTrials.gov
publication_date: 2021-10-14
source_url: https://clinicaltrials.gov/study/NCT04593563
source_record_id: https://clinicaltrials.gov/study/NCT04593563
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Cancer Patients,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04593563
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04593563","source_url":"https://clinicaltrials.gov/study/NCT04593563","doi":"","pmid":"","publication_date":"2021-10-14","importer_version":"2.1.3","text_redistributed":false}


authors: University Health Network, Toronto
journal: ClinicalTrials.gov
publication_date: 2026-06-21
source_url: https://clinicaltrials.gov/study/NCT06416085
source_record_id: https://clinicaltrials.gov/study/NCT06416085
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06416085
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06416085","source_url":"https://clinicaltrials.gov/study/NCT06416085","doi":"","pmid":"","publication_date":"2026-06-21","importer_version":"2.1.3","text_redistributed":false}


authors: Sheppard Pratt Health System
journal: ClinicalTrials.gov
publication_date: 2022-10-24
source_url: https://clinicaltrials.gov/study/NCT04433845
source_record_id: https://clinicaltrials.gov/study/NCT04433845
substance_tags: psilocybin
topic_tags: Depression,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04433845
text_rights_status: unverified_not_redistributed
title:
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04433845","source_url":"https://clinicaltrials.gov/study/NCT04433845","doi":"","pmid":"","publication_date":"2022-10-24","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
authors: Imperial College London
journal: ClinicalTrials.gov
publication_date: 2024-06-16
source_url: https://clinicaltrials.gov/study/NCT04505189
source_record_id: https://clinicaltrials.gov/study/NCT04505189
substance_tags: psilocybin
topic_tags: Eating Disorders,Brain Imaging,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04505189
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04505189","source_url":"https://clinicaltrials.gov/study/NCT04505189","doi":"","pmid":"","publication_date":"2024-06-16","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin in Anorexia Nervosa
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2023-05-05
source_url: https://clinicaltrials.gov/study/NCT04052568
source_record_id: https://clinicaltrials.gov/study/NCT04052568
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Eating Disorders,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04052568
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04052568","source_url":"https://clinicaltrials.gov/study/NCT04052568","doi":"","pmid":"","publication_date":"2023-05-05","importer_version":"2.1.3","text_redistributed":false}


title: Microdosing Psychedelics to Improve Mood
authors: Rotem Petranker
journal: ClinicalTrials.gov
publication_date: 2025-12-29
source_url: https://clinicaltrials.gov/study/NCT05259943
source_record_id: https://clinicaltrials.gov/study/NCT05259943
substance_tags: psilocybin
topic_tags: Depression,Microdosing,Clinical Trial,Observational Study,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05259943
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05259943","source_url":"https://clinicaltrials.gov/study/NCT05259943","doi":"","pmid":"","publication_date":"2025-12-29","importer_version":"2.1.3","text_redistributed":false}


authors: Kevin Boehnke
journal: ClinicalTrials.gov
publication_date: 2025-04-15
source_url: https://clinicaltrials.gov/study/NCT05128162
source_record_id: https://clinicaltrials.gov/study/NCT05128162
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05128162
text_rights_status: unverified_not_redistributed
title:
A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia

topic_tags:
Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05128162","source_url":"https://clinicaltrials.gov/study/NCT05128162","doi":"","pmid":"","publication_date":"2025-04-15","importer_version":"2.1.3","text_redistributed":false}


authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2025-08-18
source_url: https://clinicaltrials.gov/study/NCT05733546
source_record_id: https://clinicaltrials.gov/study/NCT05733546
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05733546
text_rights_status: unverified_not_redistributed
title:
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05733546","source_url":"https://clinicaltrials.gov/study/NCT05733546","doi":"","pmid":"","publication_date":"2025-08-18","importer_version":"2.1.3","text_redistributed":false}


authors: Ottawa Hospital Research Institute
journal: ClinicalTrials.gov
publication_date: 2026-07-09
source_url: https://clinicaltrials.gov/study/NCT04754061
source_record_id: https://clinicaltrials.gov/study/NCT04754061
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-16 01:24:51
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04754061
text_rights_status: unverified_not_redistributed
title:
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial

topic_tags:
Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04754061","source_url":"https://clinicaltrials.gov/study/NCT04754061","doi":"","pmid":"","publication_date":"2026-07-09","importer_version":"2.1.3","text_redistributed":false}


title: Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2023-03-28
source_url: https://clinicaltrials.gov/study/NCT04849013
source_record_id: https://clinicaltrials.gov/study/NCT04849013
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Consciousness,Spirituality,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04849013
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04849013","source_url":"https://clinicaltrials.gov/study/NCT04849013","doi":"","pmid":"","publication_date":"2023-03-28","importer_version":"2.1.3","text_redistributed":false}


authors: MycoMedica Life Sciences PBC
journal: ClinicalTrials.gov
publication_date: 2024-10-08
source_url: https://clinicaltrials.gov/study/NCT06326606
source_record_id: https://clinicaltrials.gov/study/NCT06326606
substance_tags: psilocybin
topic_tags: Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06326606
text_rights_status: unverified_not_redistributed
title:
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06326606","source_url":"https://clinicaltrials.gov/study/NCT06326606","doi":"","pmid":"","publication_date":"2024-10-08","importer_version":"2.1.3","text_redistributed":false}


authors: The Roots to Thrive Society for Psychedelic Therapy
journal: ClinicalTrials.gov
publication_date: 2023-07-24
source_url: https://clinicaltrials.gov/study/NCT05958758
source_record_id: https://clinicaltrials.gov/study/NCT05958758
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Wellbeing,Resilience,Observational Study,Safety,Adverse Events
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05958758
text_rights_status: unverified_not_redistributed
title:
An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05958758","source_url":"https://clinicaltrials.gov/study/NCT05958758","doi":"","pmid":"","publication_date":"2023-07-24","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-06-21
source_url: https://clinicaltrials.gov/study/NCT06407635
source_record_id: https://clinicaltrials.gov/study/NCT06407635
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06407635
text_rights_status: unverified_not_redistributed
topic_tags:
PTSD,Receptor Pharmacology,Consciousness,Wellbeing,Mystical Experience,Randomized Controlled Trial,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06407635","source_url":"https://clinicaltrials.gov/study/NCT06407635","doi":"","pmid":"","publication_date":"2026-06-21","importer_version":"2.1.3","text_redistributed":false}


authors: VA Office of Research and Development
journal: ClinicalTrials.gov
publication_date: 2026-06-04
source_url: https://clinicaltrials.gov/study/NCT07226232
source_record_id: https://clinicaltrials.gov/study/NCT07226232
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07226232
text_rights_status: unverified_not_redistributed
title:
A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans

topic_tags:
Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07226232","source_url":"https://clinicaltrials.gov/study/NCT07226232","doi":"","pmid":"","publication_date":"2026-06-04","importer_version":"2.1.3","text_redistributed":false}


authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-03-10
source_url: https://clinicaltrials.gov/study/NCT06442423
source_record_id: https://clinicaltrials.gov/study/NCT06442423
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06442423
text_rights_status: unverified_not_redistributed
title:
Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06442423","source_url":"https://clinicaltrials.gov/study/NCT06442423","doi":"","pmid":"","publication_date":"2026-03-10","importer_version":"2.1.3","text_redistributed":false}


authors: Joshua Woolley, MD, PhD
journal: ClinicalTrials.gov
publication_date: 2026-04-28
source_url: https://clinicaltrials.gov/study/NCT05351541
source_record_id: https://clinicaltrials.gov/study/NCT05351541
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Emotional Processing
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05351541
text_rights_status: unverified_not_redistributed
title:
A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05351541","source_url":"https://clinicaltrials.gov/study/NCT05351541","doi":"","pmid":"","publication_date":"2026-04-28","importer_version":"2.1.3","text_redistributed":false}


authors: Combat Stress
journal: ClinicalTrials.gov
publication_date: 2023-05-24
source_url: https://clinicaltrials.gov/study/NCT05876481
source_record_id: https://clinicaltrials.gov/study/NCT05876481
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Treatment-Resistant Depression,Veterans,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05876481
text_rights_status: unverified_not_redistributed
title:
Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05876481","source_url":"https://clinicaltrials.gov/study/NCT05876481","doi":"","pmid":"","publication_date":"2023-05-24","importer_version":"2.1.3","text_redistributed":false}


title: Molecular Imaging Study of Harmine/DMT: a Basic Research Approach
authors: Insel Gruppe AG, University Hospital Bern
journal: ClinicalTrials.gov
publication_date: 2025-03-18
source_url: https://clinicaltrials.gov/study/NCT06252506
source_record_id: https://clinicaltrials.gov/study/NCT06252506
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Aging,Animal Study,Healthy Volunteers
study_type: Animal Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06252506
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06252506","source_url":"https://clinicaltrials.gov/study/NCT06252506","doi":"","pmid":"","publication_date":"2025-03-18","importer_version":"2.1.3","text_redistributed":false}


authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2022-09-21
source_url: https://clinicaltrials.gov/study/NCT04519957
source_record_id: https://clinicaltrials.gov/study/NCT04519957
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04519957
text_rights_status: unverified_not_redistributed
title:
Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP001 And COMP003 Trials (P-TRD LTFU)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04519957","source_url":"https://clinicaltrials.gov/study/NCT04519957","doi":"","pmid":"","publication_date":"2022-09-21","importer_version":"2.1.3","text_redistributed":false}


authors: Indiana University
journal: ClinicalTrials.gov
publication_date: 2026-03-29
source_url: https://clinicaltrials.gov/study/NCT07499583
source_record_id: https://clinicaltrials.gov/study/NCT07499583
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07499583
text_rights_status: unverified_not_redistributed
title:
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder

topic_tags:
Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07499583","source_url":"https://clinicaltrials.gov/study/NCT07499583","doi":"","pmid":"","publication_date":"2026-03-29","importer_version":"2.1.3","text_redistributed":false}


authors: University of Calgary
journal: ClinicalTrials.gov
publication_date: 2025-12-29
source_url: https://clinicaltrials.gov/study/NCT06615908
source_record_id: https://clinicaltrials.gov/study/NCT06615908
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06615908
text_rights_status: unverified_not_redistributed
title:
A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial

topic_tags:
Anxiety,PTSD,Headache / Migraine,Emotional Processing,Randomized Controlled Trial,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06615908","source_url":"https://clinicaltrials.gov/study/NCT06615908","doi":"","pmid":"","publication_date":"2025-12-29","importer_version":"2.1.3","text_redistributed":false}


title: Optimizing Microdosing and Meditation
authors: National University of Natural Medicine
journal: ClinicalTrials.gov
publication_date: 2025-06-04
source_url: https://clinicaltrials.gov/study/NCT06560658
source_record_id: https://clinicaltrials.gov/study/NCT06560658
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06560658
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06560658","source_url":"https://clinicaltrials.gov/study/NCT06560658","doi":"","pmid":"","publication_date":"2025-06-04","importer_version":"2.1.3","text_redistributed":false}


authors: King's College London
journal: ClinicalTrials.gov
publication_date: 2021-07-21
source_url: https://clinicaltrials.gov/study/NCT04959253
source_record_id: https://clinicaltrials.gov/study/NCT04959253
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04959253
text_rights_status: unverified_not_redistributed
title:
A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04959253","source_url":"https://clinicaltrials.gov/study/NCT04959253","doi":"","pmid":"","publication_date":"2021-07-21","importer_version":"2.1.3","text_redistributed":false}


title: The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2025-06-12
source_url: https://clinicaltrials.gov/study/NCT05312151
source_record_id: https://clinicaltrials.gov/study/NCT05312151
substance_tags: psilocybin
topic_tags: PTSD,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05312151
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05312151","source_url":"https://clinicaltrials.gov/study/NCT05312151","doi":"","pmid":"","publication_date":"2025-06-12","importer_version":"2.1.3","text_redistributed":false}


authors: Robin Carhart-Harris, PhD, MA
journal: ClinicalTrials.gov
publication_date: 2026-06-03
source_url: https://clinicaltrials.gov/study/NCT06626139
source_record_id: https://clinicaltrials.gov/study/NCT06626139
substance_tags: psilocybin
topic_tags: Neuroplasticity,Wellbeing,Emotional Processing,Healthy Volunteers,Drug Interactions
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06626139
text_rights_status: unverified_not_redistributed
title:
2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy Volunteers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06626139","source_url":"https://clinicaltrials.gov/study/NCT06626139","doi":"","pmid":"","publication_date":"2026-06-03","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2014-05-19
source_url: https://clinicaltrials.gov/study/NCT01988311
source_record_id: https://clinicaltrials.gov/study/NCT01988311
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT01988311
text_rights_status: unverified_not_redistributed
title:
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT01988311","source_url":"https://clinicaltrials.gov/study/NCT01988311","doi":"","pmid":"","publication_date":"2014-05-19","importer_version":"2.1.3","text_redistributed":false}


authors: Nathan Brashares Sackett
journal: ClinicalTrials.gov
publication_date: 2025-08-27
source_url: https://clinicaltrials.gov/study/NCT06853912
source_record_id: https://clinicaltrials.gov/study/NCT06853912
substance_tags: psilocybin
topic_tags: PTSD,Addiction,Clinical Trial,Veterans,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06853912
text_rights_status: unverified_not_redistributed
title:
A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06853912","source_url":"https://clinicaltrials.gov/study/NCT06853912","doi":"","pmid":"","publication_date":"2025-08-27","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study
authors: Nantes University Hospital
journal: ClinicalTrials.gov
publication_date: 2026-02-04
source_url: https://clinicaltrials.gov/study/NCT07391332
source_record_id: https://clinicaltrials.gov/study/NCT07391332
substance_tags: psilocybin
topic_tags: Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07391332
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07391332","source_url":"https://clinicaltrials.gov/study/NCT07391332","doi":"","pmid":"","publication_date":"2026-02-04","importer_version":"2.1.3","text_redistributed":false}


title: Characterization of Altered Waking States of Consciousness in Healthy Humans
authors: University of Zurich
journal: ClinicalTrials.gov
publication_date: 2021-04-28
source_url: https://clinicaltrials.gov/study/NCT03853577
source_record_id: https://clinicaltrials.gov/study/NCT03853577
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03853577
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Brain Imaging,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03853577","source_url":"https://clinicaltrials.gov/study/NCT03853577","doi":"","pmid":"","publication_date":"2021-04-28","importer_version":"2.1.3","text_redistributed":false}


authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2024-11-19
source_url: https://clinicaltrials.gov/study/NCT03356483
source_record_id: https://clinicaltrials.gov/study/NCT03356483
substance_tags: psilocybin
topic_tags: OCD,Brain Imaging,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03356483
text_rights_status: unverified_not_redistributed
title:
Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03356483","source_url":"https://clinicaltrials.gov/study/NCT03356483","doi":"","pmid":"","publication_date":"2024-11-19","importer_version":"2.1.3","text_redistributed":false}


authors: University of Washington
journal: ClinicalTrials.gov
publication_date: 2025-11-04
source_url: https://clinicaltrials.gov/study/NCT05847686
source_record_id: https://clinicaltrials.gov/study/NCT05847686
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05847686
text_rights_status: unverified_not_redistributed
title:
A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05847686","source_url":"https://clinicaltrials.gov/study/NCT05847686","doi":"","pmid":"","publication_date":"2025-11-04","importer_version":"2.1.3","text_redistributed":false}


authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2026-05-11
source_url: https://clinicaltrials.gov/study/NCT07570654
source_record_id: https://clinicaltrials.gov/study/NCT07570654
substance_tags: psilocybin
topic_tags: PTSD,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07570654
text_rights_status: unverified_not_redistributed
title:
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07570654","source_url":"https://clinicaltrials.gov/study/NCT07570654","doi":"","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2020-11-30
source_url: https://clinicaltrials.gov/study/NCT03912974
source_record_id: https://clinicaltrials.gov/study/NCT03912974
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03912974
text_rights_status: unverified_not_redistributed
title:
Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03912974","source_url":"https://clinicaltrials.gov/study/NCT03912974","doi":"","pmid":"","publication_date":"2020-11-30","importer_version":"2.1.3","text_redistributed":false}


title: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
authors: Massachusetts General Hospital
journal: ClinicalTrials.gov
publication_date: 2024-01-23
source_url: https://clinicaltrials.gov/study/NCT05381974
source_record_id: https://clinicaltrials.gov/study/NCT05381974
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05381974
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05381974","source_url":"https://clinicaltrials.gov/study/NCT05381974","doi":"","pmid":"","publication_date":"2024-01-23","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-03-12
source_url: https://clinicaltrials.gov/study/NCT04620759
source_record_id: https://clinicaltrials.gov/study/NCT04620759
substance_tags: psilocybin
topic_tags: Depression,Addiction,Healthcare Workers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04620759
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04620759","source_url":"https://clinicaltrials.gov/study/NCT04620759","doi":"","pmid":"","publication_date":"2026-03-12","importer_version":"2.1.3","text_redistributed":false}


title: 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-06-28
source_url: https://clinicaltrials.gov/study/NCT05452772
source_record_id: https://clinicaltrials.gov/study/NCT05452772
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-05 01:22:40
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05452772
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05452772","source_url":"https://clinicaltrials.gov/study/NCT05452772","doi":"","pmid":"","publication_date":"2026-06-28","importer_version":"2.1.3","text_redistributed":false}


title: A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
authors: University of Colorado, Denver
journal: ClinicalTrials.gov
publication_date: 2026-07-05
source_url: https://clinicaltrials.gov/study/NCT07516405
source_record_id: https://clinicaltrials.gov/study/NCT07516405
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-12 01:23:47
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07516405
text_rights_status: unverified_not_redistributed
topic_tags:
Pharmacology,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Older Adults,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07516405","source_url":"https://clinicaltrials.gov/study/NCT07516405","doi":"","pmid":"","publication_date":"2026-07-05","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-05-06
source_url: https://clinicaltrials.gov/study/NCT05710237
source_record_id: https://clinicaltrials.gov/study/NCT05710237
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05710237
text_rights_status: unverified_not_redistributed
title:
Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial

topic_tags:
Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05710237","source_url":"https://clinicaltrials.gov/study/NCT05710237","doi":"","pmid":"","publication_date":"2026-05-06","importer_version":"2.1.3","text_redistributed":false}


authors: Ohio State University
journal: ClinicalTrials.gov
publication_date: 2026-03-03
source_url: https://clinicaltrials.gov/study/NCT05554094
source_record_id: https://clinicaltrials.gov/study/NCT05554094
substance_tags: psilocybin
topic_tags: PTSD,Veterans,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05554094
text_rights_status: unverified_not_redistributed
title:
Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05554094","source_url":"https://clinicaltrials.gov/study/NCT05554094","doi":"","pmid":"","publication_date":"2026-03-03","importer_version":"2.1.3","text_redistributed":false}


title: Repeat Dosing of Psilocybin in Headache Disorders
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2024-02-08
source_url: https://clinicaltrials.gov/study/NCT04218539
source_record_id: https://clinicaltrials.gov/study/NCT04218539
substance_tags: psilocybin
topic_tags: Headache / Migraine,Biomarkers,Inflammation
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04218539
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04218539","source_url":"https://clinicaltrials.gov/study/NCT04218539","doi":"","pmid":"","publication_date":"2024-02-08","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
authors: Imperial College London
journal: ClinicalTrials.gov
publication_date: 2024-01-18
source_url: https://clinicaltrials.gov/study/NCT05548075
source_record_id: https://clinicaltrials.gov/study/NCT05548075
substance_tags: psilocybin
topic_tags: Neuroplasticity,Brain Imaging,Biomarkers,Observational Study
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05548075
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05548075","source_url":"https://clinicaltrials.gov/study/NCT05548075","doi":"","pmid":"","publication_date":"2024-01-18","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin in Major Depressive Disorder
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2021-12-14
source_url: https://clinicaltrials.gov/study/NCT03181529
source_record_id: https://clinicaltrials.gov/study/NCT03181529
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03181529
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03181529","source_url":"https://clinicaltrials.gov/study/NCT03181529","doi":"","pmid":"","publication_date":"2021-12-14","importer_version":"2.1.3","text_redistributed":false}


authors: University of Nebraska
journal: ClinicalTrials.gov
publication_date: 2026-05-05
source_url: https://clinicaltrials.gov/study/NCT05220046
source_record_id: https://clinicaltrials.gov/study/NCT05220046
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Wellbeing,Observational Study
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05220046
text_rights_status: unverified_not_redistributed
title:
An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal Cancers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05220046","source_url":"https://clinicaltrials.gov/study/NCT05220046","doi":"","pmid":"","publication_date":"2026-05-05","importer_version":"2.1.3","text_redistributed":false}


authors: Bruyère Health Research Institute.
journal: ClinicalTrials.gov
publication_date: 2026-07-09
source_url: https://clinicaltrials.gov/study/NCT07063862
source_record_id: https://clinicaltrials.gov/study/NCT07063862
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-16 01:24:50
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07063862
text_rights_status: unverified_not_redistributed
title:
PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial

topic_tags:
Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07063862","source_url":"https://clinicaltrials.gov/study/NCT07063862","doi":"","pmid":"","publication_date":"2026-07-09","importer_version":"2.1.3","text_redistributed":false}


title: Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin
authors: Washington University School of Medicine
journal: ClinicalTrials.gov
publication_date: 2025-10-30
source_url: https://clinicaltrials.gov/study/NCT04501653
source_record_id: https://clinicaltrials.gov/study/NCT04501653
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04501653
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04501653","source_url":"https://clinicaltrials.gov/study/NCT04501653","doi":"","pmid":"","publication_date":"2025-10-30","importer_version":"2.1.3","text_redistributed":false}


title: Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2019-09-09
source_url: https://clinicaltrials.gov/study/NCT02971605
source_record_id: https://clinicaltrials.gov/study/NCT02971605
substance_tags: psilocybin
topic_tags: Mechanism of Action,Emotional Processing,Abuse Liability
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02971605
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02971605","source_url":"https://clinicaltrials.gov/study/NCT02971605","doi":"","pmid":"","publication_date":"2019-09-09","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin in Post-Treatment Lyme Disease
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2025-08-19
source_url: https://clinicaltrials.gov/study/NCT05305105
source_record_id: https://clinicaltrials.gov/study/NCT05305105
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05305105
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05305105","source_url":"https://clinicaltrials.gov/study/NCT05305105","doi":"","pmid":"","publication_date":"2025-08-19","importer_version":"2.1.3","text_redistributed":false}


authors: University of Chicago
journal: ClinicalTrials.gov
publication_date: 2025-12-22
source_url: https://clinicaltrials.gov/study/NCT05399498
source_record_id: https://clinicaltrials.gov/study/NCT05399498
substance_tags: psilocybin
topic_tags: Depression,Personality Change,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05399498
text_rights_status: unverified_not_redistributed
title:
An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05399498","source_url":"https://clinicaltrials.gov/study/NCT05399498","doi":"","pmid":"","publication_date":"2025-12-22","importer_version":"2.1.3","text_redistributed":false}


authors: University of Southern California
journal: ClinicalTrials.gov
publication_date: 2025-09-25
source_url: https://clinicaltrials.gov/study/NCT06233344
source_record_id: https://clinicaltrials.gov/study/NCT06233344
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06233344
text_rights_status: unverified_not_redistributed
title:
An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy

topic_tags:
Brain Imaging,Mechanism of Action,Biomarkers,Spirituality,Clinical Trial,Observational Study,Safety,Adverse Events,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06233344","source_url":"https://clinicaltrials.gov/study/NCT06233344","doi":"","pmid":"","publication_date":"2025-09-25","importer_version":"2.1.3","text_redistributed":false}


authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2022-02-13
source_url: https://clinicaltrials.gov/study/NCT02421263
source_record_id: https://clinicaltrials.gov/study/NCT02421263
substance_tags: psilocybin
topic_tags: Wellbeing,Spirituality,Mystical Experience,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02421263
text_rights_status: unverified_not_redistributed
title:
A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02421263","source_url":"https://clinicaltrials.gov/study/NCT02421263","doi":"","pmid":"","publication_date":"2022-02-13","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2026-04-28
source_url: https://clinicaltrials.gov/study/NCT05883540
source_record_id: https://clinicaltrials.gov/study/NCT05883540
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05883540
text_rights_status: unverified_not_redistributed
title:
Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05883540","source_url":"https://clinicaltrials.gov/study/NCT05883540","doi":"","pmid":"","publication_date":"2026-04-28","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2025-11-04
source_url: https://clinicaltrials.gov/study/NCT03554174
source_record_id: https://clinicaltrials.gov/study/NCT03554174
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03554174
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03554174","source_url":"https://clinicaltrials.gov/study/NCT03554174","doi":"","pmid":"","publication_date":"2025-11-04","importer_version":"2.1.3","text_redistributed":false}


authors: University of Calgary
journal: ClinicalTrials.gov
publication_date: 2026-05-13
source_url: https://clinicaltrials.gov/study/NCT06885996
source_record_id: https://clinicaltrials.gov/study/NCT06885996
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06885996
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence

topic_tags:
Depression,Anxiety,PTSD,Mechanism of Action,Biomarkers,Oxidative Stress,Emotional Processing,Randomized Controlled Trial,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06885996","source_url":"https://clinicaltrials.gov/study/NCT06885996","doi":"","pmid":"","publication_date":"2026-05-13","importer_version":"2.1.3","text_redistributed":false}


authors: TRYP Therapeutics
journal: ClinicalTrials.gov
publication_date: 2024-11-18
source_url: https://clinicaltrials.gov/study/NCT05035927
source_record_id: https://clinicaltrials.gov/study/NCT05035927
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05035927
text_rights_status: unverified_not_redistributed
title:
A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder

topic_tags:
Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05035927","source_url":"https://clinicaltrials.gov/study/NCT05035927","doi":"","pmid":"","publication_date":"2024-11-18","importer_version":"2.1.3","text_redistributed":false}


authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2025-12-03
source_url: https://clinicaltrials.gov/study/NCT05398484
source_record_id: https://clinicaltrials.gov/study/NCT05398484
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05398484
text_rights_status: unverified_not_redistributed
title:
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05398484","source_url":"https://clinicaltrials.gov/study/NCT05398484","doi":"","pmid":"","publication_date":"2025-12-03","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-assisted Cognitive Behavioral Therapy for Depression
authors: University of California, Los Angeles
journal: ClinicalTrials.gov
publication_date: 2026-05-18
source_url: https://clinicaltrials.gov/study/NCT05227612
source_record_id: https://clinicaltrials.gov/study/NCT05227612
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05227612
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05227612","source_url":"https://clinicaltrials.gov/study/NCT05227612","doi":"","pmid":"","publication_date":"2026-05-18","importer_version":"2.1.3","text_redistributed":false}


authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-07-15
source_url: https://clinicaltrials.gov/study/NCT07306364
source_record_id: https://clinicaltrials.gov/study/NCT07306364
substance_tags: psilocybin
topic_tags: Addiction,Chronic Pain,Mechanism of Action,Animal Study
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-22 01:27:46
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07306364
text_rights_status: unverified_not_redistributed
title:
Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07306364","source_url":"https://clinicaltrials.gov/study/NCT07306364","doi":"","pmid":"","publication_date":"2026-07-15","importer_version":"2.1.3","text_redistributed":false}


title: Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder
authors: University of California, Los Angeles
journal: ClinicalTrials.gov
publication_date: 2026-05-03
source_url: https://clinicaltrials.gov/study/NCT07566104
source_record_id: https://clinicaltrials.gov/study/NCT07566104
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07566104
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07566104","source_url":"https://clinicaltrials.gov/study/NCT07566104","doi":"","pmid":"","publication_date":"2026-05-03","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-facilitated Treatment for Chronic Pain
authors: University of Alabama at Birmingham
journal: ClinicalTrials.gov
publication_date: 2026-03-10
source_url: https://clinicaltrials.gov/study/NCT05068791
source_record_id: https://clinicaltrials.gov/study/NCT05068791
substance_tags: psilocybin
topic_tags: Chronic Pain,Personality Change,Emotional Processing,Mystical Experience,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05068791
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05068791","source_url":"https://clinicaltrials.gov/study/NCT05068791","doi":"","pmid":"","publication_date":"2026-03-10","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2024-02-01
source_url: https://clinicaltrials.gov/study/NCT05242029
source_record_id: https://clinicaltrials.gov/study/NCT05242029
substance_tags: psilocybin
topic_tags: Addiction,Chronic Pain,Toxicity
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05242029
text_rights_status: unverified_not_redistributed
title:
A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05242029","source_url":"https://clinicaltrials.gov/study/NCT05242029","doi":"","pmid":"","publication_date":"2024-02-01","importer_version":"2.1.3","text_redistributed":false}


authors: Brain and Cognition Discovery Foundation
journal: ClinicalTrials.gov
publication_date: 2023-07-26
source_url: https://clinicaltrials.gov/study/NCT05029466
source_record_id: https://clinicaltrials.gov/study/NCT05029466
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05029466
text_rights_status: unverified_not_redistributed
title:
The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05029466","source_url":"https://clinicaltrials.gov/study/NCT05029466","doi":"","pmid":"","publication_date":"2023-07-26","importer_version":"2.1.3","text_redistributed":false}


authors: Yvan Beaussant, MD, MSci
journal: ClinicalTrials.gov
publication_date: 2026-02-16
source_url: https://clinicaltrials.gov/study/NCT04950608
source_record_id: https://clinicaltrials.gov/study/NCT04950608
substance_tags: psilocybin
topic_tags: Depression,End-of-Life Distress,Cancer Patients,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04950608
text_rights_status: unverified_not_redistributed
title:
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04950608","source_url":"https://clinicaltrials.gov/study/NCT04950608","doi":"","pmid":"","publication_date":"2026-02-16","importer_version":"2.1.3","text_redistributed":false}


authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2025-12-17
source_url: https://clinicaltrials.gov/study/NCT05624268
source_record_id: https://clinicaltrials.gov/study/NCT05624268
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05624268
text_rights_status: unverified_not_redistributed
title:
A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05624268","source_url":"https://clinicaltrials.gov/study/NCT05624268","doi":"","pmid":"","publication_date":"2025-12-17","importer_version":"2.1.3","text_redistributed":false}


authors: University of California, San Diego
journal: ClinicalTrials.gov
publication_date: 2026-07-20
source_url: https://clinicaltrials.gov/study/NCT06814522
source_record_id: https://clinicaltrials.gov/study/NCT06814522
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-22 01:27:46
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06814522
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]

topic_tags:
Depression,Addiction,Brain Imaging,Biomarkers,Wellbeing,Emotional Processing,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06814522","source_url":"https://clinicaltrials.gov/study/NCT06814522","doi":"","pmid":"","publication_date":"2026-07-20","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-01-11
source_url: https://clinicaltrials.gov/study/NCT06656702
source_record_id: https://clinicaltrials.gov/study/NCT06656702
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06656702
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06656702","source_url":"https://clinicaltrials.gov/study/NCT06656702","doi":"","pmid":"","publication_date":"2026-01-11","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
authors: New York State Psychiatric Institute
journal: ClinicalTrials.gov
publication_date: 2023-03-12
source_url: https://clinicaltrials.gov/study/NCT04656301
source_record_id: https://clinicaltrials.gov/study/NCT04656301
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Receptor Pharmacology,Aging,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04656301
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04656301","source_url":"https://clinicaltrials.gov/study/NCT04656301","doi":"","pmid":"","publication_date":"2023-03-12","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin Administration With 5-HT1a Blockade
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-06-24
source_url: https://clinicaltrials.gov/study/NCT07565493
source_record_id: https://clinicaltrials.gov/study/NCT07565493
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Consciousness,Observational Study,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 23:13:10
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07565493
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07565493","source_url":"https://clinicaltrials.gov/study/NCT07565493","doi":"","pmid":"","publication_date":"2026-06-24","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2021-12-21
source_url: https://clinicaltrials.gov/study/NCT03153579
source_record_id: https://clinicaltrials.gov/study/NCT03153579
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03153579
text_rights_status: unverified_not_redistributed
title:
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03153579","source_url":"https://clinicaltrials.gov/study/NCT03153579","doi":"","pmid":"","publication_date":"2021-12-21","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample
authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2026-05-11
source_url: https://clinicaltrials.gov/study/NCT05322954
source_record_id: https://clinicaltrials.gov/study/NCT05322954
substance_tags: psilocybin
topic_tags: Addiction,Observational Study,Safety
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05322954
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05322954","source_url":"https://clinicaltrials.gov/study/NCT05322954","doi":"","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Ghent
journal: ClinicalTrials.gov
publication_date: 2024-09-18
source_url: https://clinicaltrials.gov/study/NCT06378229
source_record_id: https://clinicaltrials.gov/study/NCT06378229
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Brain Imaging,Observational Study,Treatment-Resistant Depression,Safety,Toxicity
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06378229
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06378229","source_url":"https://clinicaltrials.gov/study/NCT06378229","doi":"","pmid":"","publication_date":"2024-09-18","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-05-17
source_url: https://clinicaltrials.gov/study/NCT06299319
source_record_id: https://clinicaltrials.gov/study/NCT06299319
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06299319
text_rights_status: unverified_not_redistributed
title:
Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial

topic_tags:
Addiction,OCD,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Case Report,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06299319","source_url":"https://clinicaltrials.gov/study/NCT06299319","doi":"","pmid":"","publication_date":"2026-05-17","importer_version":"2.1.3","text_redistributed":false}


authors: University of Washington
journal: ClinicalTrials.gov
publication_date: 2025-03-17
source_url: https://clinicaltrials.gov/study/NCT05163496
source_record_id: https://clinicaltrials.gov/study/NCT05163496
substance_tags: psilocybin
topic_tags: Depression,Healthcare Workers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05163496
text_rights_status: unverified_not_redistributed
title:
A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05163496","source_url":"https://clinicaltrials.gov/study/NCT05163496","doi":"","pmid":"","publication_date":"2025-03-17","importer_version":"2.1.3","text_redistributed":false}


authors: James J. Peters Veterans Affairs Medical Center
journal: ClinicalTrials.gov
publication_date: 2026-05-03
source_url: https://clinicaltrials.gov/study/NCT07251491
source_record_id: https://clinicaltrials.gov/study/NCT07251491
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07251491
text_rights_status: unverified_not_redistributed
title:
Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury

topic_tags:
Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Wellbeing,Veterans,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07251491","source_url":"https://clinicaltrials.gov/study/NCT07251491","doi":"","pmid":"","publication_date":"2026-05-03","importer_version":"2.1.3","text_redistributed":false}


authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2026-01-11
source_url: https://clinicaltrials.gov/study/NCT05711940
source_record_id: https://clinicaltrials.gov/study/NCT05711940
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05711940
text_rights_status: unverified_not_redistributed
title:
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05711940","source_url":"https://clinicaltrials.gov/study/NCT05711940","doi":"","pmid":"","publication_date":"2026-01-11","importer_version":"2.1.3","text_redistributed":false}


title: Open Label Psilocybin Brain Stimulation and Imaging Pilot Study
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-04-19
source_url: https://clinicaltrials.gov/study/NCT06835699
source_record_id: https://clinicaltrials.gov/study/NCT06835699
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06835699
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06835699","source_url":"https://clinicaltrials.gov/study/NCT06835699","doi":"","pmid":"","publication_date":"2026-04-19","importer_version":"2.1.3","text_redistributed":false}


authors: Nova Mentis Life Science Corp
journal: ClinicalTrials.gov
publication_date: 2024-05-07
source_url: https://clinicaltrials.gov/study/NCT05832255
source_record_id: https://clinicaltrials.gov/study/NCT05832255
substance_tags: psilocybin
study_type: Review Article
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05832255
text_rights_status: unverified_not_redistributed
title:
An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients

topic_tags:
Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Microdosing,Review Article,Healthcare Workers,Toxicity,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05832255","source_url":"https://clinicaltrials.gov/study/NCT05832255","doi":"","pmid":"","publication_date":"2024-05-07","importer_version":"2.1.3","text_redistributed":false}


authors: Empower Research Inc
journal: ClinicalTrials.gov
publication_date: 2024-06-23
source_url: https://clinicaltrials.gov/study/NCT06471959
source_record_id: https://clinicaltrials.gov/study/NCT06471959
substance_tags: psilocybin,psilocin
topic_tags: Resilience,Healthcare Workers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06471959
text_rights_status: unverified_not_redistributed
title:
Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06471959","source_url":"https://clinicaltrials.gov/study/NCT06471959","doi":"","pmid":"","publication_date":"2024-06-23","importer_version":"2.1.3","text_redistributed":false}


authors: Stanford University
journal: ClinicalTrials.gov
publication_date: 2026-05-05
source_url: https://clinicaltrials.gov/study/NCT07479550
source_record_id: https://clinicaltrials.gov/study/NCT07479550
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:27
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07479550
text_rights_status: unverified_not_redistributed
title:
A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07479550","source_url":"https://clinicaltrials.gov/study/NCT07479550","doi":"","pmid":"","publication_date":"2026-05-05","importer_version":"2.1.3","text_redistributed":false}


authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-07-08
source_url: https://clinicaltrials.gov/study/NCT06624137
source_record_id: https://clinicaltrials.gov/study/NCT06624137
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-15 01:27:00
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06624137
text_rights_status: unverified_not_redistributed
title:
Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects

topic_tags:
Depression,PTSD,Addiction,OCD,Headache / Migraine,Brain Imaging,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06624137","source_url":"https://clinicaltrials.gov/study/NCT06624137","doi":"","pmid":"","publication_date":"2026-07-08","importer_version":"2.1.3","text_redistributed":false}


authors: Halucenex Life Sciences Inc.
journal: ClinicalTrials.gov
publication_date: 2023-06-28
source_url: https://clinicaltrials.gov/study/NCT05243329
source_record_id: https://clinicaltrials.gov/study/NCT05243329
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05243329
text_rights_status: unverified_not_redistributed
title:
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

topic_tags:
Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05243329","source_url":"https://clinicaltrials.gov/study/NCT05243329","doi":"","pmid":"","publication_date":"2023-06-28","importer_version":"2.1.3","text_redistributed":false}


title: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
authors: Sharmin Ghaznavi
journal: ClinicalTrials.gov
publication_date: 2026-07-16
source_url: https://clinicaltrials.gov/study/NCT06247839
source_record_id: https://clinicaltrials.gov/study/NCT06247839
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-22 01:27:46
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06247839
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06247839","source_url":"https://clinicaltrials.gov/study/NCT06247839","doi":"","pmid":"","publication_date":"2026-07-16","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-03-17
source_url: https://clinicaltrials.gov/study/NCT07211438
source_record_id: https://clinicaltrials.gov/study/NCT07211438
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07211438
text_rights_status: unverified_not_redistributed
title:
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07211438","source_url":"https://clinicaltrials.gov/study/NCT07211438","doi":"","pmid":"","publication_date":"2026-03-17","importer_version":"2.1.3","text_redistributed":false}


authors: MycoMedica Life Sciences PBC
journal: ClinicalTrials.gov
publication_date: 2026-02-12
source_url: https://clinicaltrials.gov/study/NCT07050368
source_record_id: https://clinicaltrials.gov/study/NCT07050368
substance_tags: psilocybin
topic_tags: Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07050368
text_rights_status: unverified_not_redistributed
title:
A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07050368","source_url":"https://clinicaltrials.gov/study/NCT07050368","doi":"","pmid":"","publication_date":"2026-02-12","importer_version":"2.1.3","text_redistributed":false}


title: Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin
authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2026-04-02
source_url: https://clinicaltrials.gov/study/NCT05866471
source_record_id: https://clinicaltrials.gov/study/NCT05866471
substance_tags: psilocybin
topic_tags: Neuroplasticity,Wellbeing,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05866471
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05866471","source_url":"https://clinicaltrials.gov/study/NCT05866471","doi":"","pmid":"","publication_date":"2026-04-02","importer_version":"2.1.3","text_redistributed":false}


authors: Lobe Sciences Ltd.
journal: ClinicalTrials.gov
publication_date: 2023-09-12
source_url: https://clinicaltrials.gov/study/NCT06035900
source_record_id: https://clinicaltrials.gov/study/NCT06035900
substance_tags: psilocybin,psilocin
topic_tags: Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06035900
text_rights_status: unverified_not_redistributed
title:
Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06035900","source_url":"https://clinicaltrials.gov/study/NCT06035900","doi":"","pmid":"","publication_date":"2023-09-12","importer_version":"2.1.3","text_redistributed":false}


authors: McMaster University
journal: ClinicalTrials.gov
publication_date: 2025-03-18
source_url: https://clinicaltrials.gov/study/NCT06225232
source_record_id: https://clinicaltrials.gov/study/NCT06225232
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06225232
text_rights_status: unverified_not_redistributed
title:
An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06225232","source_url":"https://clinicaltrials.gov/study/NCT06225232","doi":"","pmid":"","publication_date":"2025-03-18","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2024-06-17
source_url: https://clinicaltrials.gov/study/NCT02243813
source_record_id: https://clinicaltrials.gov/study/NCT02243813
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02243813
text_rights_status: unverified_not_redistributed
title:
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02243813","source_url":"https://clinicaltrials.gov/study/NCT02243813","doi":"","pmid":"","publication_date":"2024-06-17","importer_version":"2.1.3","text_redistributed":false}


title: The Effects of Psilocybin on Shared Experience in Film Processing
authors: Western University, Canada
journal: ClinicalTrials.gov
publication_date: 2024-09-26
source_url: https://clinicaltrials.gov/study/NCT06529939
source_record_id: https://clinicaltrials.gov/study/NCT06529939
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness,Aging,Clinical Trial,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06529939
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06529939","source_url":"https://clinicaltrials.gov/study/NCT06529939","doi":"","pmid":"","publication_date":"2024-09-26","importer_version":"2.1.3","text_redistributed":false}


authors: Sunstone Medical
journal: ClinicalTrials.gov
publication_date: 2026-06-30
source_url: https://clinicaltrials.gov/study/NCT06902974
source_record_id: https://clinicaltrials.gov/study/NCT06902974
substance_tags: psilocybin
topic_tags: PTSD,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-07 01:23:04
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06902974
text_rights_status: unverified_not_redistributed
title:
A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06902974","source_url":"https://clinicaltrials.gov/study/NCT06902974","doi":"","pmid":"","publication_date":"2026-06-30","importer_version":"2.1.3","text_redistributed":false}


authors: Beersheva Mental Health Center
journal: ClinicalTrials.gov
publication_date: 2025-11-18
source_url: https://clinicaltrials.gov/study/NCT07183748
source_record_id: https://clinicaltrials.gov/study/NCT07183748
substance_tags: psilocybin
topic_tags: Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07183748
text_rights_status: unverified_not_redistributed
title:
A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07183748","source_url":"https://clinicaltrials.gov/study/NCT07183748","doi":"","pmid":"","publication_date":"2025-11-18","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2023-12-14
source_url: https://clinicaltrials.gov/study/NCT02981173
source_record_id: https://clinicaltrials.gov/study/NCT02981173
substance_tags: psilocybin
topic_tags: Headache / Migraine,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02981173
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02981173","source_url":"https://clinicaltrials.gov/study/NCT02981173","doi":"","pmid":"","publication_date":"2023-12-14","importer_version":"2.1.3","text_redistributed":false}


authors: TRYP Therapeutics
journal: ClinicalTrials.gov
publication_date: 2026-02-04
source_url: https://clinicaltrials.gov/study/NCT06206265
source_record_id: https://clinicaltrials.gov/study/NCT06206265
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06206265
text_rights_status: unverified_not_redistributed
title:
A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06206265","source_url":"https://clinicaltrials.gov/study/NCT06206265","doi":"","pmid":"","publication_date":"2026-02-04","importer_version":"2.1.3","text_redistributed":false}


title: Investigation of Psychedelic Effects in Psychoactive Substances
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-02-22
source_url: https://clinicaltrials.gov/study/NCT06772753
source_record_id: https://clinicaltrials.gov/study/NCT06772753
substance_tags: psilocybin
topic_tags: Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06772753
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06772753","source_url":"https://clinicaltrials.gov/study/NCT06772753","doi":"","pmid":"","publication_date":"2026-02-22","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2025-09-30
source_url: https://clinicaltrials.gov/study/NCT06989957
source_record_id: https://clinicaltrials.gov/study/NCT06989957
substance_tags: psilocybin
topic_tags: PTSD,Veterans,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06989957
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06989957","source_url":"https://clinicaltrials.gov/study/NCT06989957","doi":"","pmid":"","publication_date":"2025-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychopharmacology of Psilocybin in Cancer Patients
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2018-07-18
source_url: https://clinicaltrials.gov/study/NCT00465595
source_record_id: https://clinicaltrials.gov/study/NCT00465595
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Pharmacology,Consciousness,Spirituality,Healthy Volunteers,Cancer Patients
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT00465595
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT00465595","source_url":"https://clinicaltrials.gov/study/NCT00465595","doi":"","pmid":"","publication_date":"2018-07-18","importer_version":"2.1.3","text_redistributed":false}


authors: Gitte Moos Knudsen
journal: ClinicalTrials.gov
publication_date: 2022-08-09
source_url: https://clinicaltrials.gov/study/NCT04280055
source_record_id: https://clinicaltrials.gov/study/NCT04280055
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04280055
text_rights_status: unverified_not_redistributed
title:
Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study

topic_tags:
Chronic Pain,Headache / Migraine,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04280055","source_url":"https://clinicaltrials.gov/study/NCT04280055","doi":"","pmid":"","publication_date":"2022-08-09","importer_version":"2.1.3","text_redistributed":false}


title: NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
authors: M.D. Anderson Cancer Center
journal: ClinicalTrials.gov
publication_date: 2026-06-23
source_url: https://clinicaltrials.gov/study/NCT07227909
source_record_id: https://clinicaltrials.gov/study/NCT07227909
substance_tags: psilocybin
topic_tags: Chronic Pain,Wellbeing,Mystical Experience,Healthcare Workers,Toxicity
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07227909
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07227909","source_url":"https://clinicaltrials.gov/study/NCT07227909","doi":"","pmid":"","publication_date":"2026-06-23","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
authors: Joshua Woolley
journal: ClinicalTrials.gov
publication_date: 2021-01-06
source_url: https://clinicaltrials.gov/study/NCT02950467
source_record_id: https://clinicaltrials.gov/study/NCT02950467
substance_tags: psilocybin
topic_tags: Depression,End-of-Life Distress
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02950467
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02950467","source_url":"https://clinicaltrials.gov/study/NCT02950467","doi":"","pmid":"","publication_date":"2021-01-06","importer_version":"2.1.3","text_redistributed":false}


authors: Centre Hospitalier Universitaire de Nīmes
journal: ClinicalTrials.gov
publication_date: 2025-08-19
source_url: https://clinicaltrials.gov/study/NCT06650800
source_record_id: https://clinicaltrials.gov/study/NCT06650800
substance_tags: psilocybin,psilocin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06650800
text_rights_status: unverified_not_redistributed
title:
Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study

topic_tags:
Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06650800","source_url":"https://clinicaltrials.gov/study/NCT06650800","doi":"","pmid":"","publication_date":"2025-08-19","importer_version":"2.1.3","text_redistributed":false}


authors: University of Calgary
journal: ClinicalTrials.gov
publication_date: 2026-06-01
source_url: https://clinicaltrials.gov/study/NCT06768944
source_record_id: https://clinicaltrials.gov/study/NCT06768944
substance_tags: psilocybin
topic_tags: Anxiety,Biomarkers,Wellbeing,Personality Change,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06768944
text_rights_status: unverified_not_redistributed
title:
The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06768944","source_url":"https://clinicaltrials.gov/study/NCT06768944","doi":"","pmid":"","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}


authors: University of Washington
journal: ClinicalTrials.gov
publication_date: 2026-05-03
source_url: https://clinicaltrials.gov/study/NCT07565909
source_record_id: https://clinicaltrials.gov/study/NCT07565909
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07565909
text_rights_status: unverified_not_redistributed
title:
A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07565909","source_url":"https://clinicaltrials.gov/study/NCT07565909","doi":"","pmid":"","publication_date":"2026-05-03","importer_version":"2.1.3","text_redistributed":false}


authors: Anthony P King
journal: ClinicalTrials.gov
publication_date: 2026-06-24
source_url: https://clinicaltrials.gov/study/NCT07104916
source_record_id: https://clinicaltrials.gov/study/NCT07104916
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 23:13:10
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07104916
text_rights_status: unverified_not_redistributed
title:
A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)

topic_tags:
Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial,Healthcare Workers,Drug Interactions

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07104916","source_url":"https://clinicaltrials.gov/study/NCT07104916","doi":"","pmid":"","publication_date":"2026-06-24","importer_version":"2.1.3","text_redistributed":false}


title: The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-07-19
source_url: https://clinicaltrials.gov/study/NCT07610369
source_record_id: https://clinicaltrials.gov/study/NCT07610369
substance_tags: psilocybin
topic_tags: Depression,Microdosing,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-22 01:27:46
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07610369
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07610369","source_url":"https://clinicaltrials.gov/study/NCT07610369","doi":"","pmid":"","publication_date":"2026-07-19","importer_version":"2.1.3","text_redistributed":false}


title: Processing Intergenerational Trauma With Psilocybin-Assisted Therapy
authors: Rachel Yehuda
journal: ClinicalTrials.gov
publication_date: 2025-09-07
source_url: https://clinicaltrials.gov/study/NCT06899165
source_record_id: https://clinicaltrials.gov/study/NCT06899165
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Biomarkers,Wellbeing,Resilience,Healthcare Workers,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06899165
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06899165","source_url":"https://clinicaltrials.gov/study/NCT06899165","doi":"","pmid":"","publication_date":"2025-09-07","importer_version":"2.1.3","text_redistributed":false}


title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2023-04-23
source_url: https://clinicaltrials.gov/study/NCT03775200
source_record_id: https://clinicaltrials.gov/study/NCT03775200
substance_tags: psilocybin
topic_tags: Depression,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03775200
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03775200","source_url":"https://clinicaltrials.gov/study/NCT03775200","doi":"","pmid":"","publication_date":"2023-04-23","importer_version":"2.1.3","text_redistributed":false}


title: Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study
authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2024-04-24
source_url: https://clinicaltrials.gov/study/NCT05384678
source_record_id: https://clinicaltrials.gov/study/NCT05384678
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05384678
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05384678","source_url":"https://clinicaltrials.gov/study/NCT05384678","doi":"","pmid":"","publication_date":"2024-04-24","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin as a Treatment for Chronic Pain in Smokers
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-06-08
source_url: https://clinicaltrials.gov/study/NCT07118332
source_record_id: https://clinicaltrials.gov/study/NCT07118332
substance_tags: psilocybin
topic_tags: Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07118332
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07118332","source_url":"https://clinicaltrials.gov/study/NCT07118332","doi":"","pmid":"","publication_date":"2026-06-08","importer_version":"2.1.3","text_redistributed":false}


authors: Ohio State University
journal: ClinicalTrials.gov
publication_date: 2025-10-29
source_url: https://clinicaltrials.gov/study/NCT06820723
source_record_id: https://clinicaltrials.gov/study/NCT06820723
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06820723
text_rights_status: unverified_not_redistributed
title:
A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety

topic_tags:
Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Healthcare Workers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06820723","source_url":"https://clinicaltrials.gov/study/NCT06820723","doi":"","pmid":"","publication_date":"2025-10-29","importer_version":"2.1.3","text_redistributed":false}


authors: Kyle Greenway
journal: ClinicalTrials.gov
publication_date: 2026-04-21
source_url: https://clinicaltrials.gov/study/NCT07373535
source_record_id: https://clinicaltrials.gov/study/NCT07373535
substance_tags: psilocybin
topic_tags: Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07373535
text_rights_status: unverified_not_redistributed
title:
Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07373535","source_url":"https://clinicaltrials.gov/study/NCT07373535","doi":"","pmid":"","publication_date":"2026-04-21","importer_version":"2.1.3","text_redistributed":false}


authors: Keith Heinzerling
journal: ClinicalTrials.gov
publication_date: 2023-01-16
source_url: https://clinicaltrials.gov/study/NCT04410913
source_record_id: https://clinicaltrials.gov/study/NCT04410913
substance_tags: psilocybin
topic_tags: Anxiety,Addiction,Mystical Experience,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04410913
text_rights_status: unverified_not_redistributed
title:
Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04410913","source_url":"https://clinicaltrials.gov/study/NCT04410913","doi":"","pmid":"","publication_date":"2023-01-16","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2023-10-11
source_url: https://clinicaltrials.gov/study/NCT03341689
source_record_id: https://clinicaltrials.gov/study/NCT03341689
substance_tags: psilocybin
topic_tags: Headache / Migraine,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03341689
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03341689","source_url":"https://clinicaltrials.gov/study/NCT03341689","doi":"","pmid":"","publication_date":"2023-10-11","importer_version":"2.1.3","text_redistributed":false}


authors: University Medical Center Groningen
journal: ClinicalTrials.gov
publication_date: 2026-05-07
source_url: https://clinicaltrials.gov/study/NCT06782724
source_record_id: https://clinicaltrials.gov/study/NCT06782724
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06782724
text_rights_status: unverified_not_redistributed
title:
The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.

topic_tags:
Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06782724","source_url":"https://clinicaltrials.gov/study/NCT06782724","doi":"","pmid":"","publication_date":"2026-05-07","importer_version":"2.1.3","text_redistributed":false}


authors: Khyber Medical University Peshawar
journal: ClinicalTrials.gov
publication_date: 2025-09-01
source_url: https://clinicaltrials.gov/study/NCT06746441
source_record_id: https://clinicaltrials.gov/study/NCT06746441
substance_tags: psilocybin,psilocin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06746441
text_rights_status: unverified_not_redistributed
title:
Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial

topic_tags:
Depression,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06746441","source_url":"https://clinicaltrials.gov/study/NCT06746441","doi":"","pmid":"","publication_date":"2025-09-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.
authors: Multidisciplinary Association for Psychedelic Studies
journal: ClinicalTrials.gov
publication_date: 2023-12-25
source_url: https://clinicaltrials.gov/study/NCT00979693
source_record_id: https://clinicaltrials.gov/study/NCT00979693
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Aging,Spirituality,Mystical Experience,Safety,Immune Function
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT00979693
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT00979693","source_url":"https://clinicaltrials.gov/study/NCT00979693","doi":"","pmid":"","publication_date":"2023-12-25","importer_version":"2.1.3","text_redistributed":false}


authors: University of Zurich
journal: ClinicalTrials.gov
publication_date: 2023-09-20
source_url: https://clinicaltrials.gov/study/NCT04141501
source_record_id: https://clinicaltrials.gov/study/NCT04141501
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04141501
text_rights_status: unverified_not_redistributed
title:
Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder

topic_tags:
Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Observational Study,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04141501","source_url":"https://clinicaltrials.gov/study/NCT04141501","doi":"","pmid":"","publication_date":"2023-09-20","importer_version":"2.1.3","text_redistributed":false}


title: Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids
authors: Roswell Park Cancer Institute
journal: ClinicalTrials.gov
publication_date: 2026-06-21
source_url: https://clinicaltrials.gov/study/NCT06827054
source_record_id: https://clinicaltrials.gov/study/NCT06827054
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06827054
text_rights_status: unverified_not_redistributed
topic_tags:
Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06827054","source_url":"https://clinicaltrials.gov/study/NCT06827054","doi":"","pmid":"","publication_date":"2026-06-21","importer_version":"2.1.3","text_redistributed":false}


authors: Centre Hospitalier St Anne
journal: ClinicalTrials.gov
publication_date: 2025-10-06
source_url: https://clinicaltrials.gov/study/NCT07210112
source_record_id: https://clinicaltrials.gov/study/NCT07210112
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07210112
text_rights_status: unverified_not_redistributed
title:
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

topic_tags:
Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07210112","source_url":"https://clinicaltrials.gov/study/NCT07210112","doi":"","pmid":"","publication_date":"2025-10-06","importer_version":"2.1.3","text_redistributed":false}


title: A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression
authors: University of Washington
journal: ClinicalTrials.gov
publication_date: 2026-05-28
source_url: https://clinicaltrials.gov/study/NCT07336238
source_record_id: https://clinicaltrials.gov/study/NCT07336238
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07336238
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07336238","source_url":"https://clinicaltrials.gov/study/NCT07336238","doi":"","pmid":"","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}


authors: Usona Institute
journal: ClinicalTrials.gov
publication_date: 2026-05-03
source_url: https://clinicaltrials.gov/study/NCT04353921
source_record_id: https://clinicaltrials.gov/study/NCT04353921
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Observational Study
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04353921
text_rights_status: unverified_not_redistributed
title:
A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04353921","source_url":"https://clinicaltrials.gov/study/NCT04353921","doi":"","pmid":"","publication_date":"2026-05-03","importer_version":"2.1.3","text_redistributed":false}


authors: Section for Affective Disorders; Northern Stockholm Psychiatry
journal: ClinicalTrials.gov
publication_date: 2026-04-12
source_url: https://clinicaltrials.gov/study/NCT06319378
source_record_id: https://clinicaltrials.gov/study/NCT06319378
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06319378
text_rights_status: unverified_not_redistributed
title:
CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06319378","source_url":"https://clinicaltrials.gov/study/NCT06319378","doi":"","pmid":"","publication_date":"2026-04-12","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2019-12-29
source_url: https://clinicaltrials.gov/study/NCT02145091
source_record_id: https://clinicaltrials.gov/study/NCT02145091
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Aging,Wellbeing,Spirituality
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02145091
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02145091","source_url":"https://clinicaltrials.gov/study/NCT02145091","doi":"","pmid":"","publication_date":"2019-12-29","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-facilitated Treatment for Cocaine Use
authors: University of Alabama at Birmingham
journal: ClinicalTrials.gov
publication_date: 2026-05-17
source_url: https://clinicaltrials.gov/study/NCT02037126
source_record_id: https://clinicaltrials.gov/study/NCT02037126
substance_tags: psilocybin
topic_tags: Anxiety,Addiction,Brain Imaging,Mechanism of Action,Default Mode Network,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT02037126
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT02037126","source_url":"https://clinicaltrials.gov/study/NCT02037126","doi":"","pmid":"","publication_date":"2026-05-17","importer_version":"2.1.3","text_redistributed":false}


authors: The University of Texas Health Science Center, Houston
journal: ClinicalTrials.gov
publication_date: 2025-07-17
source_url: https://clinicaltrials.gov/study/NCT06706232
source_record_id: https://clinicaltrials.gov/study/NCT06706232
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06706232
text_rights_status: unverified_not_redistributed
title:
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06706232","source_url":"https://clinicaltrials.gov/study/NCT06706232","doi":"","pmid":"","publication_date":"2025-07-17","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-03-19
source_url: https://clinicaltrials.gov/study/NCT06731621
source_record_id: https://clinicaltrials.gov/study/NCT06731621
substance_tags: psilocybin
topic_tags: Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06731621
text_rights_status: unverified_not_redistributed
title:
Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06731621","source_url":"https://clinicaltrials.gov/study/NCT06731621","doi":"","pmid":"","publication_date":"2026-03-19","importer_version":"2.1.3","text_redistributed":false}


authors: King's College London
journal: ClinicalTrials.gov
publication_date: 2019-08-12
source_url: https://clinicaltrials.gov/study/NCT03661125
source_record_id: https://clinicaltrials.gov/study/NCT03661125
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03661125
text_rights_status: unverified_not_redistributed
title:
A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.

topic_tags:
Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Healthy Volunteers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03661125","source_url":"https://clinicaltrials.gov/study/NCT03661125","doi":"","pmid":"","publication_date":"2019-08-12","importer_version":"2.1.3","text_redistributed":false}


authors: Filament Health Corp.
journal: ClinicalTrials.gov
publication_date: 2024-10-29
source_url: https://clinicaltrials.gov/study/NCT06666010
source_record_id: https://clinicaltrials.gov/study/NCT06666010
substance_tags: psilocybin
topic_tags: Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06666010
text_rights_status: unverified_not_redistributed
title:
A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06666010","source_url":"https://clinicaltrials.gov/study/NCT06666010","doi":"","pmid":"","publication_date":"2024-10-29","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2025-12-21
source_url: https://clinicaltrials.gov/study/NCT07296328
source_record_id: https://clinicaltrials.gov/study/NCT07296328
substance_tags: psilocybin
topic_tags: Mechanism of Action,Wellbeing,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07296328
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07296328","source_url":"https://clinicaltrials.gov/study/NCT07296328","doi":"","pmid":"","publication_date":"2025-12-21","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2025-03-26
source_url: https://clinicaltrials.gov/study/NCT06899334
source_record_id: https://clinicaltrials.gov/study/NCT06899334
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology,Consciousness,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06899334
text_rights_status: unverified_not_redistributed
title:
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06899334","source_url":"https://clinicaltrials.gov/study/NCT06899334","doi":"","pmid":"","publication_date":"2025-03-26","importer_version":"2.1.3","text_redistributed":false}


title: Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder
authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2026-07-06
source_url: https://clinicaltrials.gov/study/NCT06349083
source_record_id: https://clinicaltrials.gov/study/NCT06349083
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-13 01:24:36
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06349083
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06349083","source_url":"https://clinicaltrials.gov/study/NCT06349083","doi":"","pmid":"","publication_date":"2026-07-06","importer_version":"2.1.3","text_redistributed":false}


authors: Healing Advocacy Fund
journal: ClinicalTrials.gov
publication_date: 2025-09-23
source_url: https://clinicaltrials.gov/study/NCT07189988
source_record_id: https://clinicaltrials.gov/study/NCT07189988
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07189988
text_rights_status: unverified_not_redistributed
title:
Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07189988","source_url":"https://clinicaltrials.gov/study/NCT07189988","doi":"","pmid":"","publication_date":"2025-09-23","importer_version":"2.1.3","text_redistributed":false}


title: The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
authors: Manoj Doss
journal: ClinicalTrials.gov
publication_date: 2026-06-14
source_url: https://clinicaltrials.gov/study/NCT07079852
source_record_id: https://clinicaltrials.gov/study/NCT07079852
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07079852
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07079852","source_url":"https://clinicaltrials.gov/study/NCT07079852","doi":"","pmid":"","publication_date":"2026-06-14","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin and Affective Function in Chronic Lower Back Pain Depression
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2025-10-13
source_url: https://clinicaltrials.gov/study/NCT06355414
source_record_id: https://clinicaltrials.gov/study/NCT06355414
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Mechanism of Action,Observational Study,Safety
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06355414
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06355414","source_url":"https://clinicaltrials.gov/study/NCT06355414","doi":"","pmid":"","publication_date":"2025-10-13","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2025-04-24
source_url: https://clinicaltrials.gov/study/NCT06518720
source_record_id: https://clinicaltrials.gov/study/NCT06518720
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06518720
text_rights_status: unverified_not_redistributed
title:
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06518720","source_url":"https://clinicaltrials.gov/study/NCT06518720","doi":"","pmid":"","publication_date":"2025-04-24","importer_version":"2.1.3","text_redistributed":false}


authors: University of California, San Francisco
journal: ClinicalTrials.gov
publication_date: 2024-09-24
source_url: https://clinicaltrials.gov/study/NCT05065294
source_record_id: https://clinicaltrials.gov/study/NCT05065294
substance_tags: psilocybin
topic_tags: Depression,Healthcare Workers,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05065294
text_rights_status: unverified_not_redistributed
title:
An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05065294","source_url":"https://clinicaltrials.gov/study/NCT05065294","doi":"","pmid":"","publication_date":"2024-09-24","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Treatment of Obsessive Compulsive Disorder
authors: University of Arizona
journal: ClinicalTrials.gov
publication_date: 2024-08-29
source_url: https://clinicaltrials.gov/study/NCT03300947
source_record_id: https://clinicaltrials.gov/study/NCT03300947
substance_tags: psilocybin
topic_tags: Anxiety,OCD,Mechanism of Action
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:34
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03300947
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03300947","source_url":"https://clinicaltrials.gov/study/NCT03300947","doi":"","pmid":"","publication_date":"2024-08-29","importer_version":"2.1.3","text_redistributed":false}


title: Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
authors: University of California, San Diego
journal: ClinicalTrials.gov
publication_date: 2022-07-24
source_url: https://clinicaltrials.gov/study/NCT04661514
source_record_id: https://clinicaltrials.gov/study/NCT04661514
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04661514
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04661514","source_url":"https://clinicaltrials.gov/study/NCT04661514","doi":"","pmid":"","publication_date":"2022-07-24","importer_version":"2.1.3","text_redistributed":false}


title: Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2026-06-24
source_url: https://clinicaltrials.gov/study/NCT06884514
source_record_id: https://clinicaltrials.gov/study/NCT06884514
substance_tags: psilocybin
study_type: Qualitative Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 23:13:10
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06884514
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Wellbeing,Personality Change,Emotional Processing,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06884514","source_url":"https://clinicaltrials.gov/study/NCT06884514","doi":"","pmid":"","publication_date":"2026-06-24","importer_version":"2.1.3","text_redistributed":false}


title: A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)
authors: Usona Institute
journal: ClinicalTrials.gov
publication_date: 2026-04-21
source_url: https://clinicaltrials.gov/study/NCT03866174
source_record_id: https://clinicaltrials.gov/study/NCT03866174
substance_tags: psilocybin
topic_tags: Depression,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03866174
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03866174","source_url":"https://clinicaltrials.gov/study/NCT03866174","doi":"","pmid":"","publication_date":"2026-04-21","importer_version":"2.1.3","text_redistributed":false}


authors: Anna Rose Childress, Ph.D.
journal: ClinicalTrials.gov
publication_date: 2025-10-28
source_url: https://clinicaltrials.gov/study/NCT06786325
source_record_id: https://clinicaltrials.gov/study/NCT06786325
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06786325
text_rights_status: unverified_not_redistributed
title:
A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?

topic_tags:
Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06786325","source_url":"https://clinicaltrials.gov/study/NCT06786325","doi":"","pmid":"","publication_date":"2025-10-28","importer_version":"2.1.3","text_redistributed":false}


authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2026-03-04
source_url: https://clinicaltrials.gov/study/NCT06760533
source_record_id: https://clinicaltrials.gov/study/NCT06760533
substance_tags: psilocybin
topic_tags: Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06760533
text_rights_status: unverified_not_redistributed
title:
Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06760533","source_url":"https://clinicaltrials.gov/study/NCT06760533","doi":"","pmid":"","publication_date":"2026-03-04","importer_version":"2.1.3","text_redistributed":false}


authors: University of Alabama at Birmingham
journal: ClinicalTrials.gov
publication_date: 2026-03-10
source_url: https://clinicaltrials.gov/study/NCT05227742
source_record_id: https://clinicaltrials.gov/study/NCT05227742
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05227742
text_rights_status: unverified_not_redistributed
title:
Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health

topic_tags:
Brain Imaging,Mechanism of Action,Microdosing,Emotional Processing,Mystical Experience,Observational Study,Abuse Liability

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05227742","source_url":"https://clinicaltrials.gov/study/NCT05227742","doi":"","pmid":"","publication_date":"2026-03-10","importer_version":"2.1.3","text_redistributed":false}


authors: Lakshmi N Yatham
journal: ClinicalTrials.gov
publication_date: 2026-04-30
source_url: https://clinicaltrials.gov/study/NCT06943573
source_record_id: https://clinicaltrials.gov/study/NCT06943573
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06943573
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial

topic_tags:
Depression,Wellbeing,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06943573","source_url":"https://clinicaltrials.gov/study/NCT06943573","doi":"","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin With Intracranial Neural Sensing
authors: Joshua Woolley, MD, PhD
journal: ClinicalTrials.gov
publication_date: 2025-06-05
source_url: https://clinicaltrials.gov/study/NCT06919640
source_record_id: https://clinicaltrials.gov/study/NCT06919640
substance_tags: psilocybin
topic_tags: Chronic Pain
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06919640
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06919640","source_url":"https://clinicaltrials.gov/study/NCT06919640","doi":"","pmid":"","publication_date":"2025-06-05","importer_version":"2.1.3","text_redistributed":false}


title: Safety for Home Administration of Microdose Psilocybin Use
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-02-22
source_url: https://clinicaltrials.gov/study/NCT06450210
source_record_id: https://clinicaltrials.gov/study/NCT06450210
substance_tags: psilocybin
topic_tags: Microdosing,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06450210
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06450210","source_url":"https://clinicaltrials.gov/study/NCT06450210","doi":"","pmid":"","publication_date":"2026-02-22","importer_version":"2.1.3","text_redistributed":false}


title: Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-07-06
source_url: https://clinicaltrials.gov/study/NCT06160284
source_record_id: https://clinicaltrials.gov/study/NCT06160284
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Aging,Toxicity
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-13 01:24:36
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06160284
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06160284","source_url":"https://clinicaltrials.gov/study/NCT06160284","doi":"","pmid":"","publication_date":"2026-07-06","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-03-15
source_url: https://clinicaltrials.gov/study/NCT04123314
source_record_id: https://clinicaltrials.gov/study/NCT04123314
substance_tags: psilocybin
topic_tags: Depression,Receptor Pharmacology
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04123314
text_rights_status: unverified_not_redistributed
title:
Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04123314","source_url":"https://clinicaltrials.gov/study/NCT04123314","doi":"","pmid":"","publication_date":"2026-03-15","importer_version":"2.1.3","text_redistributed":false}


authors: Milan Scheidegger
journal: ClinicalTrials.gov
publication_date: 2023-09-20
source_url: https://clinicaltrials.gov/study/NCT05780216
source_record_id: https://clinicaltrials.gov/study/NCT05780216
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Healthy Volunteers,Drug Interactions
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05780216
text_rights_status: unverified_not_redistributed
title:
Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05780216","source_url":"https://clinicaltrials.gov/study/NCT05780216","doi":"","pmid":"","publication_date":"2023-09-20","importer_version":"2.1.3","text_redistributed":false}


authors: Alan Davis
journal: ClinicalTrials.gov
publication_date: 2026-05-13
source_url: https://clinicaltrials.gov/study/NCT07216404
source_record_id: https://clinicaltrials.gov/study/NCT07216404
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-07-01 11:22:33
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07216404
text_rights_status: unverified_not_redistributed
title:
Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07216404","source_url":"https://clinicaltrials.gov/study/NCT07216404","doi":"","pmid":"","publication_date":"2026-05-13","importer_version":"2.1.3","text_redistributed":false}


